Christopher Bull Granger

Christopher Bull Granger
Professor of Medicine

Research:
My primary research interest is in conduct and methodology of large randomized clinical trials in heart disease. I have led a number of large international clinical studies in heart attacks, unstable angina, heart failure, and atrial fibrillation. I have lead clinical studies of blood thinners and coronary intervention for heart attacks, stroke prevention in atrial fibrillation, and prevention of heart attack for patients with coronary artery disease. I have been co-director of the Reperfusion of Acute MI in Carolina Emergency Departments (RACE) project that is a North Carolina state-wide program to improve reperfusion care for acute myocardial infarction. I serve as the Chairman of the American Heart Association Mission: Lifeline program to improve heart attack care nationally as well as the American College of Cardiology/American Heart Association guideline committee for heart attack care. I have also studied the effects of genetic variation on heart disease. I work with the National Institute of Health and the Federal Drug Administration on evaluation of heart disease and of new drugs. I have developed tools to predict which patients are at risk for death, heart attack, and need for hospitalization.

Current Appointments & Affiliations

Professor of Medicine, Medicine, Cardiology, Medicine 2007
Professor in the School of Nursing, School of Nursing, Duke University 2015
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1988

Contact Information

2400 Pratt Street, Durham, NC 27705
Duke Box 3409, Durham, NC 27710
grang001@mc.duke.edu (919) 668-8900

Background
Education, Training, & Certifications
- Fellow in Cardiology, Medicine, Duke University 1988 - 1990
- Chief Medical Resident, Medicine, University of Colorado at Denver 1987 - 1988
- Medical Resident, Medicine, University of Colorado at Denver 1984 - 1987
- M.D., University of Connecticut 1984
Duke Appointment History
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 2000 - 2007
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 1998 - 2000
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 1993 - 1998
- Associate in the Department of Medicine, Medicine, Clinical Science Departments 1990 - 1993
Recognition
In the News
- NOV 15, 2017 Duke Health News
  
  Coordinated Emergency Care Improves Survival for Patients with Heart Attacks
- AUG 28, 2017 Duke Health News
  
  Education and Monitoring Improves the Use of Stroke-Prevention Therapies
- AUG 3, 2016 Fox News, Reuters
  
  Regional coordination cuts time to heart attack treatment
- NOV 20, 2014
  
  Coordinated Emergency Response Speeds Care to Heart Attack Patients
Awards & Honors
Expertise
Subject Headings
Research
Selected Grants
- Effect of monitoring system design on response time to cardiac arrhythmias awarded by Agency for Healthcare Research and Quality 2015 - 2020
- Janssen AF Quality Improvement Research Study awarded by Janssen Pharmaceutica, Inc. 2017 - 2019
- PARADISE awarded by Novartis Pharmaceuticals Corporation 2017 - 2019
- Evaluating and Improving Cardiac Arrest Resuscitation Efforts in Hemodialysis Clinics awarded by National Institutes of Health 2017 - 2019
- INFORM-AF Janssen awarded by Janssen Scientific Affairs, LLC. 2016 - 2019
- Postdoctoral Training in Cardiovascular Clinical Research awarded by National Institutes of Health 2014 - 2019
- HeartRescue awarded by University of Washington 2016 - 2018
- Integrated Biostatistical Training for CVD Research awarded by North Carolina State University 2017 - 2018
- Regional Systems Accelerator: Implementation of the AHA Mission (TMC) awarded by The Medicines Company 2016 - 2017
- Heart Rescue Flagship Premier Partner Program "RACE CARs" awarded by Medtronic Foundation 2013 - 2017
- HeartRescue awarded by University of Washington 2016 - 2017
- Workload effects on response time to life-threatening arrhythmias awarded by Agency for Healthcare Research and Quality 2012 - 2014
- Rare Thrombotic Diseases Clinical Research Network awarded by National Institutes of Health 2004 - 2010
- GENECARD: Gene identification in Early-Onset CAD awarded by National Institutes of Health 2003 - 2009
- DCRI CERT for Cardiovascular Therapies awarded by National Institutes of Health 1999 - 2002
Publications & Artistic Works
Selected Publications
- Book Sections
  - Kuijt WJ, Williams J, Granger CB, Krucoff MW, Roe MT. Current approaches to prevention and management of reperfusion injury. In: Management of Myocardial Reperfusion Injury. 2012 Nov 1. p. 215-238. Full Text
- Conference Papers
  - Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, Hylek EM, Hanna M, Wallentin L, Gersh BJ, Douglas PS, Alexander JH, Lopes RD. Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial. 2017 Dec:1440-1448.e1. Full Text
  - Hijazi Z, Sharma A, Andersson U, Alexander JH, Al-Khatib SM, Hanna M, Held C, Hylek EM, Lopes RD, Siegbahn A, Granger CB, Wallentin L. Biomarkers Predict Cause of Death More Accurately Than Clinical Variables in Patients With Atrial Fibrillation on Oral Anticoagulation Results From the ARISTOTLE Trial. 2016 Nov 11. Link to Item
  - Kragholm K, Lu D, Chiswell K, Al-Khalidi H, Roettig ML, Roe M, Jollis J, Granger CB. Improvement in Care and Outcomes for Ambulance-Transported ST-Elevation Myocardial Infarction Patients With and Without Out-of-Hospital Cardiac Arrest: A Mission: Lifeline STEMI ACCELERATOR Study. 2016 Nov 11. Link to Item
  - Pokorney SD, Granger CB, Bloom D, Thomas KL, Al-Khatib SM, Anderson J, Heflin MT, Granger BB. Provider Rather Than Patient Misperceptions Appear to be the Most Common Barriers to Oral Anticoagulation Use for Stroke Prevention in Atrial Fibrillation. 2016 Nov 11. Link to Item
  - Pokorney SD, Granger CB, Bloom D, Thomas KL, Al-Khatib SM, Anderson J, Heflin MT, Granger BB. Provider Rather Than Patient Misperceptions Appear to be the Most Common Barriers to Oral Anticoagulation Use for Stroke Prevention in Atrial Fibrillation. 2016 Nov 11. Link to Item
  - Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock S, Simon T, Yasuda S, Vega AM, Brieger D, Investigators TIGRISS. Longer-term oral antiplatelet use in stable post-MI patients: Insights from the TIGRIS study. 2016 Aug 1:30-30. Link to Item
  - Rao P, Alexander JH, Wojdyla D, Atar D, Hylek EM, Hanna M, Parkhomenko A, Vinereanu D, Wallentin L, Lopes RD, Gersh BJ, Granger CB. Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial. 2016 Aug 1:233-234. Link to Item
  - Wolsk E, Claggett B, Køber LV, Pocock S, Yusuf S, Swedberg K, McMurray JJ, Granger CB, Pfeffer MA, Solomon SD. Extra-Cardiac Disease Burden Contributes More Than Cardiac Disease Burden to Risk of Cardiovascular Outcomes in Patient with Preserved Ejection Fraction. 2016 Aug:S65-S66. Full Text
  - Fordyce CB, Hansen CM, Kragholm K, Jollis JG, Roettig ML, Dupre ME, Becker LB, Corbett CC, Monk L, Nelson RD, Pearson DA, Tyson C, Van Diepen S, Anderson ML, McNally B, Granger CB. STATEWIDE INITIATIVES IMPROVE THE CARE AND OUTCOMES OF PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST AT HOME AND IN PUBLIC LOCATIONS: RESULTS FROM THE HEARTRESCUE PROJECT. 2016 Apr:806-806. Full Text
  - Alexander J, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz J, Halvorsen S, Hanna M, Granger CB, Wallentin L. Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. 2015 Aug 1:345-345. Link to Item
  - Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Goto S, Alexander JH, Wallentin L, Granger CB. Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation: insights from the ARISTOTLE trial. 2015 Aug 1:338-339. Link to Item
  - Hansen CM, Kragholm K, Pearson DA, Tyson C, Monk L, Nelson D, Dupre ME, Jollis JG, McNally B, Granger CB. Survival improved for men but not women, despite increased bystander CPR and first resonder defibrillation for both: results form a statewide quality improvement initiative. 2015 Aug 1:195-195. Link to Item
  - Hawkins NM, Jhund PS, Pozzi A, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Virani SA, McMurray JJV. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for novel oral anticoagulant dose adjustment. 2015 Aug 1:340-340. Link to Item
  - Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Granger CB, Hanna M, Lopes RD, Siegbahn A, Wallentin L. Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial. 2015 Aug 1:339-339. Link to Item
  - Hijazi Z, Lindback J, Ostlund O, Siegbahn A, Alexander JH, Granger CB, Held C, Stewart RAH, White HD, Wallentin L. External validation of the biomarker-based ABC-stroke risk score for atrial fibrillation. 2015 Aug 1:710-711. Link to Item
  - Rordorf R, De Ferrari GM, Wojdyla D, De Caterina R, Thomas L, Granger CB, Leonardi S, Alexander JH, Wallentin L, Lopes RD, Trial ARISTOTLE. Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial. 2015 Aug 1:1068-1068. Link to Item
  - Wallentin LC, Lindback J, Held C, Granger CB, Koenig W, Stewart RAH, Tarka E, De Winter RJ, White HD, Siegbahn A. Biomarker-based risk score for prediction of cardiovascular events in stable coronary heart disease - Experiences from the STABILITY biomarker substudy. 2015 Aug 1:1041-1042. Link to Item
  - Durheim MT, Cyr DD, Al-Khatib SM, Thomas LE, Lopes RD, Gersh BJ, Palmer SM, Granger CB. Chronic Obstructive Pulmonary Disease Is Associated With Increased Risk Of Mortality Among Patients With Atrial Fibrillation: Insights From The Aristotle Trial. 2015. Link to Item
  - Sherwood MW, Al-Khalidi HR, Jollis JG, Roettig ML, Berger PB, Corbett CC, Dauerman HL, Fox K, Garvey JL, Henry TD, Rokos IC, Wilson BH, Granger CB. Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study. 2014 Dec 2:2111-2111. Link to Item
  - Cowper PA, Sheng S, Anstrom KJ, Stafford JA, Lopes RD, Davidson-Ray L, Wallentin L, Phatak HM, Ansell J, Dorian P, Husted S, McMurray JJ, Steg PG, Alexander JH, Granger CB, Mark DB. The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group. 2014 Nov 25. Link to Item
  - Hansen CM, Jollis JG, Dupre M, McNally B, Monk L, Tyson C, Pearson DA, Nelson RD, Myers B, Granger CB. Improved Rates of Bystander and First Responder Intervention Are Associated with Improved Survival After Out-of-Hospital Cardiac Arrest Following Statewide Quality Improvement Initiative. 2014 Nov 25. Link to Item
  - Hansen CM, Jollis JG, Dupre M, McNally B, Monk L, Tyson C, Pearson DA, Nelson RD, Myers B, Granger CB. Early Defibrillation, Mainly by Bystanders and First Responders, Associated with Higher Survival in Statewide Data. 2014 Nov 25. Link to Item
  - Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola V-P, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. Does Repeat Measurement of High Sensitivity Troponin I Improve Prediction of Cardiovascular Events in Atrial Fibrillation?. 2014 Nov 25. Link to Item
  - Rao MP, Dupre M, Hansen C, Milford-Beland S, Monk L, Tyson C, Pearson DA, Nelson RD, Meyers B, Jollis JG, Granger CB. Pre-Hospital Initiation of Therapeutic Hypothermia Associated With Better Survival and Neurologic Outcome in a Broad Population of Patients in North Carolina. 2014 Nov 25. Link to Item
  - Wallentin L, Hijazi Z, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola V-P, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Siegbahn A. Single Measurement of GDF-15 Provides Reliable Prognostication of Stroke and Major Bleeding in Atrial Fibrillation. 2014 Nov 25. Link to Item
  - Asberg S, Hijazi Z, Siegbahn A, Andersson U, Granger CB, Hanna M, Horowitz JD, Lopes RD, Lindahl B, Wallentin L, Investigators ARISTOTLE. Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial. 2014 Sep 1:426-426. Link to Item
  - Christersson C, Wallentin L, Andersson U, Hylek EM, Husted S, De Caterina R, Hanna M, Lopes RD, Granger CB, Siegbahn A. The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment. 2014 Sep 1:866-867. Link to Item
  - Hijazi Z, Lindback J, Siegbahn A, Alexander JH, Held C, Hanna M, Lopes RD, Oldgren J, Granger CB, Wallentin L, Investigators ARISTOTLE. A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score. 2014 Sep 1:357-357. Link to Item
  - Bagai A, Wang Y, Wang TY, Curtis J, Gurm HS, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-Hospital ADP Receptor Inhibitor Switching in Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry (R). 2013 Nov 26. Link to Item
  - Granger CB, Bates ER, Jollis JG, Antman E, Nichol G, O'Connor RE, Bjerke C, Gregory T, Peng SA, Ellrodt G, Henry TD, French WJ, Jacobs A. Improving Care of ST Segment Elevation Myocardial Infarction in the United States 2008 to 2012: A Report From Mission: Lifeline. 2013 Nov 26. Link to Item
  - Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BI, Hanna M, Harjola V-P, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. Combining High Sensitivity Troponin I and T Measurements Improves Prediction of Long-Term Clinical Outcomes in Patients With Atrial Fibrillation - An Aristotle Substudy. 2013 Nov 26. Link to Item
  - Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit C, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Margulescu AD, Wallentin L, Atar D. Efficacy and Safety of Apixaban in Patients With Atrial Fibrillation According to Sex: Results From the ARISTOTLE Trial. 2013 Nov 26. Link to Item
  - Avezum A, Lopes RD, Schulte PJ, Lanas F, Hanna M, Pais P, Erol C, Diaz R, Granger CB, Alexander JH, Investigators ARISTOTLE. Apixaban versus warfarin in patients with atrial fibrillation and valvular heart disease: findings from the ARISTOTLE study. 2013 Aug:809-809. Link to Item
  - Held C, Hylek EB, Alexander JH, Hanna M, Lopes RD, Wojdyla D, Granger CB, Wallentin L. Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial. 2013 Aug:99-99. Link to Item
  - Horowitz JD, De Caterina R, Heresztyn T, Andersson U, Lopes R, Hylek E, Mohan P, Hanna M, Granger CB, Wallentin L, Investigators ARISTOTLE. ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation: an ARISTOTLE substudy. 2013 Aug:1040-1041. Link to Item
  - Lopes RD, Garcia DA, Wojdyla D, Dorian P, Alexander JH, Wallentin L, Lanas F, Hanna M, Held C, Granger CB, Investigators ARISTOTLE. Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE. 2013 Aug:98-99. Link to Item
  - Newby LK, Sarov-Blat L, Melloni C, Patel MR, Heitner JF, Hamm CW, Aylward P, Tanguay J-F, De Winter RJ, Marber MS, Lepore JJ, Lerman A, Hasselblad V, Al-Khalidi H, Sprecher DL, Granger CB. Safety and Efficacy of Losmapimod in Non-ST-Segment Elevation Acute Myocardial Infarction: Results of the SOLSTICE Phase 2 Randomized Trial. 2012 Dec 4:2787-2788. Link to Item
  - Christersson C, Schollin M, Alexander JH, Bersh BJ, Horowitz J, Hylek EM, Mohan P, Granger CB, Wallentin L, Siegbahn A. Increased levels of D-dimer in atrial fibrillation identify patients with higher risk of thromboembolic events and death. 2012 Aug:969-969. Link to Item
  - Granger CB, Alexander JH, Hanna M, Wang J, Mohan P, Lawrence J, Hylek E, Ansell JE, Wallentin L, Comm ARISTOTLEI. Events after discontinuation of randomized treatment at the end of the ARISTOTLE trial. 2012 Aug:685-686. Link to Item
  - Gupta DK, Castagno D, Granger CB, Yusuf S, Swedberg K, McMurray JJV, Pfeffer MA, Solomon SD. Prognostic Impact of an Ischemic Etiology of Chronic Heart Failure across the Spectrum of Ejection Fractions in the CHARM Program. 2012 Aug:S78-S78. Full Text Link to Item
  - McMurray JJV, Connolly SJ, Hart R, Flaker G, Lopes RD, Wang J, Hanna M, Alexander JH, Granger CB, Wallentin L, Investigators ARISTOTLE. Effect of apixaban on all-cause mortality in atrial fibrillation: an imputed placebo analysis. 2012 Aug:52-52. Link to Item
  - McMurray JJV, Lewis B, Ezekowitz J, Gersh B, Lopes RD, Wojdyla D, Mohan P, Wallentin L, Alexander JH, Granger CB, Investigators ARISTOTLE. Risk of stroke, systemic embolism or death according to heart failure and left ventricular function status in patients with atrial fibrillation: results of the ARISTOTLE trial. 2012 Aug:519-519. Link to Item
  - Siegbahn A, Christersson C, Schollin M, Alexander JH, Horowitz J, Hylek EM, Lopes RD, Mohan P, Granger CB, Wallentin L. Increased levels of D-dimer identify patients with atrial fibrillation at high risk for bleeding an ARISTOTLE substudy. 2012 Aug:51-51. Link to Item
  - Wallentin LC, Christersson C, Siegbahn A, Schollin M, Alexander JH, Bersh BJ, Hanna M, Hylek EM, McMurray JJV, Granger CB. High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. 2012 Aug:53-53. Link to Item
  - Wallentin LC, Christersson C, Siegbahn A, Schollin M, Alexander JH, Hanna M, Hylek EM, Horowitz J, McMurray JJV, Granger CB. NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. 2012 Aug:51-51. Link to Item
  - Brunner MP, Shah SH, Craig DM, Bain JR, Muehlbauer MJ, Newgard CB, Kraus WE, Granger CB, Sketch MH, Newby LK. EFFECT OF HEPARIN ADMINISTRATION ON METABOLOMIC PROFILES FROM SAMPLES OBTAINED DURING CARDIAC CATHETERIZATION. 2011 Apr 5:E1147-E1147. Full Text Link to Item
  - Truffa AA, Lopes RD, White KR, Mehta RH, Patel MR, Pieper KS, Armstrong PW, Granger CB. SERIOUS INFECTIONS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PCI ARE RARE, BUT ASSOCIATED WITH HIGHER MORTALITY. 2011 Apr 5:E980-E980. Full Text Link to Item
  - Granger CB, Monk LM, Roettig ML, Al-Khalidi HR, Applegate RJ, Corbett CC, Garvey JL, Hathawy WR, Wilson BH, Jollis JG. State-Wide Care is Improved in the Reperfusion of Acute MI in Carolina Emergency Department Emergency Response (RACE-ER) Systems Improvement Program. 2010 Nov 23:2223-2224. Link to Item
  - Ezekowitz J, Armstrong PW, Granger CB, Theroux P, Stebbins A, Patel MR. Early Prediction of Left Ventricular Ejection Fraction 90 Days After STEMI Using NT-proBNP and Cardiac Magnetic Resonance Imaging. 2009 Nov 3:S826-S826. Link to Item
  - Glaser R, Kaul P, Roberts R, Armstrong PW, Granger CB, Barden LG, Hochman J, White H, Mahaffey KW. Women With ST Elevation Myocardial Infarction Treated With Primary PCI Have Worse Outcomes Than Men in the Modern Era: Results From the APEX-AMI Trial. 2009 Nov 3:S936-S936. Link to Item
  - Glickman S, Cairns CB, Chen AY, Granger CB, Cannon CP, Fraulo ES, Peterson ED, Roe MT. Delays in Fibrinolytic Administration for Acute ST-Segment Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry (ACTION-GWTG). 2009 Nov 3:S423-S423. Link to Item
  - Katz JN, Echols MR, Wyman A, Gore JM, Peacock WF, Anderson FA, Granger CB, Peterson E, Investigators STAT. African Americans Hospitalized With Acute, Severe Hypertension Receive Less Intense Treatment and Follow-up Than Peers: Results From the STAT Registry. 2009 Nov 3:S421-S421. Link to Item
  - Mehta RH, Lopes RD, Stebbins A, Rao SV, Pieper KS, Califf RM, Alexander JH, Granger CB. Differences in Bleeding Rates Accounts for All of the Excess Mortality in African Americans Compared With Caucasians With ST-Elevation Myocardial Infarction treated With Fibrinolysis. 2009 Nov 3:S522-S523. Link to Item
  - Newby LK, Shah SH, Sun J-L, Pieper K, Hauser ER, Kraus WE, Granger CB. Red Cell Distribution Width (RDW) is a Strong Predictor of Outcome and is Weakly Associated With Clinical Variables in Patients at Risk for Cardiovascular Events. 2009 Nov 3:S1174-S1174. Link to Item
  - Piccini JP, Schulte PJ, Pieper KS, Mehta RH, Topol EJ, White HD, Van de Werf F, Ardissino D, Califf RM, Granger CB, Ohman EM, Nexander JH. Antiarrhythmic Drug Therapy for Sustained Ventricular Arrhythmias Complicating Acute Myocardial Infarction. 2009 Nov 3:S632-S633. Link to Item
  - Shah SH, Sun J-L, Pieper K, Crosslin DR, Haynes C, Bain JR, Muehlbauer M, Stevens RD, Hauser ER, Kraus WE, Newgard CB, Granger CB, Califf RM, Newby LK. Plasma Metabolomic Profiles Predict Future Cardiovascular Events. 2009 Nov 3:S466-S467. Link to Item
  - Berger JS, Gallup D, Roe M, Armstrong PW, Simes RJ, White HD, Van de Wert F, Topol EJ, Granger CB, Harington RA, Califf RM, Becker RC, Douglas PS. Sex-based differences in mortality following acute coronary syndromes. 2008 Mar 11:A194-A194. Link to Item
  - Berger JS, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Wed F, Topol EJ, Harrington RA, Califf RM, Becker RC, Douglas PS. Sex differences in clinical presentation and angiographic data in acute coronary syndromes. 2008 Mar 11:B55-B56. Link to Item
  - Kim JH-J, Newby LK, Clare R, Shaw LK, Lodge A, Smith P, Jolicceur ME, Mark DB, Granger CB. Clopidogrel and CABG-related bleeding: Not as important as currently believed?. 2008 Mar 11:A223-A224. Link to Item
  - Lopes RD, White HD, Hochman J, Horton JR, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB. New onset atrial fibrillation following myocardial infarction is a strong independent predictor of mortality in patients treated with primary percutaneous coronary intervention. 2008 Mar 11:A11-A12. Link to Item
  - Lopez-Sendon J, Gurfinkel EP, de Sa EL, Agnelli G, Gore JM, Steg PG, FitzGerald G, Granger CB, Investigators GRACE. Factors related to heart rupture in acute coronary syndromes. The global registry of acute coronary events. 2008 Mar 11:A245-A246. Link to Item
  - Therou P, Armstrong PW, Moliterno DJ, Neumann F-J, Stebbins AL, Mahaffey KW, Hochman JS, Hamm CW, Granger CB, Investigators APEXAMI. Do selected markers of inflammatory response during the acute phase of ST-segment elevation myocardial infarction relate to outcome?. 2008 Mar 11:A185-A185. Link to Item
  - Wang TY, Honeycutt EF, Ohman EM, Moll S, Granger CB, Tapson VF. Incidence and management of acquired thrombocytopenia among patients receiving prolonged heparin venous thromboembolism prophylaxis: Insights from the complications after thrombocytopenia caused by heparin (CATCH) registry. 2008 Mar 11:A310-A310. Link to Item
  - Granger CB, Babb JD, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Roettig ML, Wilson BH, Jollis JG. The Reperfusion of Acute MI in Carolina Emergency Departments (RACE) systems improvement program: Primary results. 2007 Nov 27:2629-2629. Link to Item
  - Huber K, Aylward PE, Van'T Hof AW, Montalescot G, Jr HDR, Betriu GA, Widimsky P, Westerhout CM, Granger CB, Armstrong PW. Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI. 2007 Oct 16:673-673. Link to Item
  - Martel C, Theroux P, Labarthe B, Rivard J, Bonnefoy A, Granger CB, Armstrong PW. The serum of pexelizumab-treated ST-Segment elevation MI patients reduces complement activation but not cell apoptosis. 2007 Oct 16:723-723. Link to Item
  - Allen LA, Felker GM, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. 2007 Mar 6:44A-44A. Link to Item
  - Allen LA, Felker GM, Pocock SJ, Shaw LK, McMurray JJV, Pfeffer MA, Swedberg K, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM program and the duke databank. 2007 Mar 6:88A-88A. Link to Item
  - Berger JS, Stebbins A, Granger CB, Armstrong PW, Van de Werf F, White HD, Simes RJ, Pieper K, Harrington RA, Califf RM, Peterson ED. Initial aspirin dose for the treatment of ST elevation myocardial infarction. 2007 Mar 6:202A-202A. Link to Item
  - Frazier CG, Shah S, Nelson CL, Seo D, Hauser ER, Crosslin D, Gregory S, Goldschmidt-Clermont PJ, Granger CB, Newby LK. Variants in genes associated with inflammation and vascular cell function are associated with vulnerable plaque. 2007 Mar 6:199A-199A. Link to Item
  - Hudson MP, Granger CB, O'Neill WW, Stebbins AL, Widimsky P, Aylward P, Ruzyllo W, Holmes D, Mahaffey KW, Armstrong PW. Faster times to primary percutaneous coronary intervention are associated with better survival: Insights from the APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infraction) trial. 2007 Mar 6:42B-43B. Link to Item
  - Jolicoeur ME, Ohman ME, Honeycutt EF, Mazon FJN, Beckerd RC, Crespo EM, Oliveira GBF, Moliterno DJ, Anstrom KJ, Granger CB. Bleeding is common among patients treated with heparin experiencing thrombocyllopenia and confers a high mortality risk: Report from the CATCH registry. 2007 Mar 6:340A-340A. Link to Item
  - O'Neill WW, Armstrong PW, Alkhalidi HR, Hamm CW, Jr HDR, Todaro TG, Adams PX, de Werf FJV, Granger CB, Investigators APEX. Blood transfusion is independently associated with death in acute myocardial infarction: Insights from APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infarction) trial. 2007 Mar 6:36B-36B. Link to Item
  - Rao SV, Kaul P, Liao L, Mark DB, Eisenstein EL, Armstrong PW, Ohman M, Granger CB, Califf RM, Harrington RA. Bleeding complications are a major driver of resource use among patients with acute coronary syndromes. 2007 Mar 6:252A-252A. Link to Item
  - Roe MT, Grimes K, Bates E, Kleiman N, Bode C, Huber K, Granger CB, Costa M, Gibson CM, Solomon SD, Widimsky P, Sadowski Z, Mochly-Rosen D, Harrington RA. Inhibition of 8 delta-protein kinase C to ameliorate reperfusion injury during primary percutaneous coronary intervention for acute ST-elevation myocardial infarction - Preliminary results from the DELTA MI trial. 2007 Mar 6:215A-215A. Link to Item
  - Shah SH, Hauser ER, Nelson C, Gregory S, Crosslin D, Haynes C, Johnson J, Seo D, Kraus WE, Granger CB, Goldschmidt-Clermont P, Newby LK. ALOX5AP genetic variants are associated with in-stent restenosis after percutaneous coronary intervention. 2007 Mar 6:211A-211A. Link to Item
  - Shah SH, Nelson C, Stafford JA, Granger CB, Kraus WE, Hauser ER. Clinical predictors of presence of left main coronary artery disease on angiography in a large cohort. 2007 Mar 6:218A-218A. Link to Item
  - Widimsky P, Weaver WD, Van de Werf F, Neumann F-J, Ardissino D, Stebbins A, van t'Hof A, Nielsen TT, Armstrong PW, Granger CB, investigators APEX. Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes. 2007 Mar 6:241A-241A. Link to Item
  - Armstrong PW, Adams PX, Hamm CW, O'Neill WW, Vahanian AS, Granger CB, Holmes DR, Todaro TG, Van de Werf F. Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. 2006 Nov 28:2425-2425. Link to Item
  - Chang SM, Kosolcharoen P, Murray D, Pfeffer MA, Yusuf S, Swedberg K, McMurray J, Granger CB, Michelson EL, Olofsson B, Johansson PA, Dunlap ME. Lack of interaction between angiotensin receptor blocker and aspirin in patients with heart failure. 2006 Oct 31:767-767. Link to Item
  - Wallentin LC, Mehta SR, Afzal R, Chrolavicius S, Granger CB, Budaj A, Peters RJ, Bassand J-P, Fox KA, Yusuf S, Investigators O. Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment. 2006 Oct 31:699-700. Link to Item
  - Wang L, Hauser ER, Shah SH, Haynes C, Rose JM, Harris M, Rombaut J, Nelson S, Hale AB, Crosslin D, Gregory SG, Granger CB, Haines JL, Jones CJ, Crossman DC, Kraus WE, Pericak-Vance MA, Goldschmidt-Clermont PJ, Vance JM. Identification of kalirin gene as a novel coronary artery disease gene through peak-wide association mapping on chromosome 3q13-21. 2006 Oct 31:887-887. Link to Item
  - Goldstein P, Wiel E, van de Werf F, Steg G, Armstrong P, Ross AM, Bogoerts K, Granger CB, Vahanian A, Danchin N, Puel J, ASSENT-4PCI FI. ASSENT-4 in "French" perspective. Outcomes of STEMI patients treated with pre-hospital thrombolysis in mobile intensive care units in France across trials and registries. 2006 Oct 22:80M-80M. Link to Item
  - Granger CB, Wallentin L, Avezum A, Mehta S, Diaz R, Ruda M, Afzal R, Yusuf S, OASIS 5. Fondaparinux results in less bleeding than enoxaparin, irrespective of heparin use, for patients with acute coronary syndromes. 2006 Aug:448-448. Link to Item
  - Granger CB, Wang D, Pfeffer MA, Swedberg K, Cleland JG, Poole-Wilson P, Charlesworth A, Pocock S, CHARM . A practical, validated model for prediction of risk in chronic heart failure. 2006 Aug:173-173. Link to Item
  - Oliveira G, Granger CB, Van De Werf F, Montalescot G, Fox KAA, Gulba D, Allegrone J, Avezum A, Investigators GRACE. Patients with acute ST-elevation myocardial infarction and prehospital delay to presentation > 12 hours: high risk of worse outcomes and selective use of reperfusion therapies. The GRACE registry. 2006 Aug:912-912. Link to Item
  - Weir RAP, Mcmurray JJV, Granger CB, Puu M, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA, investigators C-AT. Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. 2006 Aug:331-331. Link to Item
  - Al-Khatib S, Shaw L, Velazquez EJ, White H, Granger CB, Pfeffer MA, McMurray JJV, Califf RM. Rhythm versus rate control for atrial fibrillation in post-Ml patients with heart failure: Results from the VALIANT trial. 2006 Feb 21:41A-41A. Link to Item
  - Mehta RH, Greenbaum AB, Lokhnygina Y, Newby LK, de Wert FV, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA. Incidence and not timing of death or myocardial infarction differ according to risk in patients with non-ST elevation acute coronary syndromes: Implications for long-term treatment and follow-up. 2006 Feb 21:207A-207A. Link to Item
  - Mehta RH, Harrington RA, Yang QH, Pieper KS, Califf RM, Granger CB. Initial heart rate and systolic blood pressure provides important insights in the risk-stratification of agerelated mortality among patients presenting with cardiogenic shock and acute ST-elevation myocardial infarction treated with fibrinolysis. 2006 Feb 21:177A-177A. Link to Item
  - Oliveira GB, Anstrom KJ, Honeycutt EF, Abrams CS, Becker RC, Berger PB, Moliterno DJ, Moll S, Rice L, Kleiman N, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB. Prolonged heparin exposure, development of thrombocytopenia, use of GP IIb/IIIa inhibitors, and history of renal dysfunction predict moderate or severe bleeding: A report from the complications after thrombocytopenia caused by heparin (CATCH) registry. 2006 Feb 21:251A-251A. Link to Item
  - Eagle KA, Mehta RH, Nallamothu BK, Granger CB, Steg PG, Van de Werf F, Lopez-Sendon J, Goodman SG, Allegrone J, Fox KA, Investigators GRACE. Global reperfusion therapy in acute myocardial infarction - 1999 to 2004: We're getting better, but we have a long way to go. The Global Registry of Acute Coronary Events. 2005 Oct 25:U860-U861. Link to Item
  - Goyal A, Mahaffey KW, Gang J, Pieper K, Nicolau JC, Armstrong PW, Hochman JS, Weaver WD, Ruzyllo W, Peterson JL, Theroux P, Todaro TG, Mojcik CF, Granger CB, Investigators CARDINAL. Drop in glucose level following acute myocardial intarction predicts improved survival in nondiabetic patients, regardless of baseline glucose level. 2005 Oct 25:U846-U846. Link to Item
  - Kenchaiah S, McMurray JJ, Pocock SJ, Wang DL, Solomon SD, McEntegart M, Michelson EL, Granger CB, Pfeffer MA. Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. 2005 Oct 25:U660-U660. Link to Item
  - Mehta RH, Califf RM, Garg J, Pieper KS, Granger CB. The impact of body anthropomorphic indices on clinical outcomes in patients with acute ST elevation myocardial infarction. 2005 Oct 25:U918-U918. Link to Item
  - Mehta RH, Van De Werf F, Avezum A, Agnelli G, Eagle KA, Goldberg RJ, Dabbous O, Granger CB. Despite geographical heterogeneity in baseline use, guideline-directed treatments for acute coronary syndromes improve in all regions from 1999 to 2003. The Global Registry of Acute Coronary Events. 2005 Oct 25:U860-U860. Link to Item
  - Nallamothu BK, Fox KA, Kennelly BM, Van de Werf F, Gore JM, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA, Investigators GRACE. Is the relationship of time delay in reperfusion and mortality steeper for fibrinolysis than for primary percutaneous coronary intervention? The global registry of acute coronary events. 2005 Oct 25:U859-U859. Link to Item
  - Rao SV, Banerjee A, Pieper K, Granger CB, Newby K, van de Werf F, White HD, Califf RM, Harrington RA. Bleeding and blood transfusion rates are higher among acute coronary syndrome patients in the United States than in other countries. 2005 Oct 25:U632-U633. Link to Item
  - Shah SH, Wang LY, Rose J, Crossman DC, Granger CB, Haines JL, Jones CJ, Mooser V, Haynes C, Pedersen B, Goldschmidt-Clermont P, Vance J, Hauser ER, Kraus WE. Neuropeptide Y gene variants are linked to and associated with premature coronary artery disease in two independent datasets. 2005 Oct 25:U850-U850. Link to Item
  - Westerhout C, Chang WC, Fu YL, Goodman SG, van de Werf F, Granger CB, Armstrong PW. Are STEMI outcomes after fibrinolysis worse during "Off hours"? Insights on circadian rhythm from ASSENT-2. 2005 Oct 25:U376-U376. Link to Item
  - Brieger D, Dabbous O, Eagle KA, Budaj A, Avezum A, Granger CB, Costa B, Steg PG, Investigators GRACE. Deriving a safety index from the GRACE risk score. 2005 Sep:566-566. Link to Item
  - Goldberg RJ, Spencer FA, Lopez-Sendon J, Van de Werf F, Montalescot G, Anderson FA, Malone S, Granger CB, Investigators GRACE. International and time trends in the use and characteristics of patients with acute coronary syndromes treated with clopidogrel: the global registry of acute coronary events experience. 2005 Sep:160-160. Link to Item
  - Granger B, Swedberg K, Ekman I, Ostergren J, Yusuf S, Michelson L, Granger CB, Pfeffer M. Women (especially younger women) with chronic heart failure are less adherent to medication: results from the CHARM program. 2005 Sep:185-185. Link to Item
  - Hawkins NM, Wang D, McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Dunn FG, Committees CHARMIA. Bundle branch block is associated with worse clinical outcomes in heart failure, especially with reduced systolic function: evidence from the CHARM programme. 2005 Sep:381-381. Link to Item
  - Lewis E, McMurray JJV, Granger CB, Michelson E, Carlsson J, Yusuf S, Swedberg K, Pfeffer MA, Comm CHARMI. Predictors of quality of life in symptomatic heart failure patients across the left ventricular ejection fraction spectrum. 2005 Sep:600-600. Link to Item
  - Mcentegart M, Yusuf S, Pfeffer MA, Michelson EL, Ostergren J, Granger CB, Swedberg K, McMurray JJV. Factors precipitating heart failure hospitalisation: a novel analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. 2005 Sep:280-280. Link to Item
  - O'Meara E, Pfeffer MA, Swedberg K, Yusuf S, Michelson EL, Ostergren J, Granger CB, McMurray JJV. Female gender is an independent predictor of better outcome in chronic heart failure: results from the CHARM programme. 2005 Sep:184-184. Link to Item
  - Oliveira GBF, Anstrom KJ, Honeycutt EF, Becker RC, Moliterno DJ, Moll S, Ohman EM, Granger CB, Investigators CATCHR. Intravenous unfractionated heparin, patient profile, and the magnitude of thrombocytopenia are associated with heparin-induced thrombocytopenia (HIT) antibodies: insights from the CATCH registry. 2005 Sep:725-725. Link to Item
  - Olsson LG, Swedberg K, Granger CB, Michelson E, McMurray JJV, Puuh M, Yusuf S, Pfeffer MA. Atrial fibrillation carries similar risks in heart failure irrespective of ejection fraction-results from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM). 2005 Sep:378-379. Link to Item
  - Spencer FA, Gore JM, Oliveira G, Montalescot G, Fox KAA, Goodman SG, Malone S, Granger CB, Investigators GRACE. Determinants of delay in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. The Global Registry of acute coronary events. 2005 Sep:621-621. Link to Item
  - Alghamdi S, Fu YL, Goodman SG, Chang WC, Van de Werf F, Granger CB, Armstrong PW. The baseline ECG in ST elevation myocardial infarction provides powerful prognostic insight: Observations from ASSENT. 2005 Feb 1:208A-209A. Link to Item
  - Ezekowitz JA, Theroux P, Chang WC, Mahaffey KW, Granger CB, Weaver WD, Armstrong PW. Natriuretic peptide insights in acute myocardial infarction. 2005 Feb 1:228A-228A. Link to Item
  - Ohman EM, Abrams CS, Honeycutt EF, Becker RC, Crespo EM, Anstrom KJ, Moliterno DJ, Rice L, Rodgers JE, Steinhubl SR, Granger CB. High mortality after discharge among patients with high risk for developing heparin-induced thrombocytopenia or thrombosis: 6-month follow-up results of the complications after thrombocytopenia caused by heparin (CATCH) registry. 2005 Feb 1:411A-411A. Link to Item
  - Sinnaeve PR, Donahue M, Grass P, Vonderscher J, Seo D, Goldschmidt P, Granger CB. Gene expression profile in circulating leukocytes identifies patients with coronary artery disease. 2005 Feb 1:414A-414A. Link to Item
  - Granger CB. Importance of CHARM in relation to other heart failure trials with ARBs. 2004 Dec:H55-H60. Link to Item
  - Donahue MP, Rose K, Vonderscher J, Bougueleret L, Nelson CL, Cohen D, Granger CB. Proteomic discovery of coronary artery disease proteins using industrial scale analysis of pooled plasma: Results from the pooled plasma proteomics project. 2004 Oct 26:212-212. Link to Item
  - Granger BB, Swedberg K, Ekman I, Ostergren J, Yusuf S, Michelson EL, Zeneca A, Granger CB, Pfeffer MA. Adherence, even to placebo, is strongly and independently related to outcome in patients with chronic heart failure: Results from the CHARM program. 2004 Oct 26:557-557. Link to Item
  - Mehta RH, Marks D, Sohn SH, Granger CB. African Americans have higher long-term mortality and more stroke and bleeding than caucasians following reperfusion therapy for acute myocardial infarction. 2004 Oct 26:798-798. Link to Item
  - Oliveira GB, Anstrom KJ, Honeycutt EF, Abrams CS, Becker RC, Berger PB, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB. Days on intravenous heparin predicts thrombocytopenia and drop platelet count on heparin predicts mortality: Findings from the complications after thrombocytopenia caused by heparin (CATCH) registry. 2004 Oct 26:559-560. Link to Item
  - Oliveira GB, Avezum A, Anderson FA, Dabbous OH, Budaj A, Goldberg RJ, Brieger D, Fox KA, Granger CB. Evidence-based risk stratification is not optimally used to target proven therapies in non-ST-elevation acute coronary syndromes: The global registry of acute coronary events (GRACE). 2004 Oct 26:659-659. Link to Item
  - Pocock SJ, Wang DL, Pfeffer MA, McMurray JJ, Swedberg K, Ostergren J, Yusuf S, Michelson EL, Pieper KS, Granger CB. Predicting mortality and morbidity in chronic heart failure independent of left ventricular systolic function: Results from the CHARM program. 2004 Oct 26:752-752. Link to Item
  - Young JB, Swedberg K, Dunlap ME, Pfeffer MA, Probstfield JL, Granger CB, McKelvey RS, McMurray MJV, Michaelson EL, Olofsson B, Ostergren J, Yusuf S. Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low. 2004 Aug:S76-S76. Full Text Link to Item
  - Shimpi RA, Griffin J, Granger CB, Califf RM, Van de Werf FJJ, Simes RJ, Muir AJ. Predictors of gastrointestinal bleeding in patients receiving thrombolytic therapies for acute ST-elevation myocardial infarction. 2004 Apr:A607-A607. Link to Item
  - Crespo EM, Becker RC, Berger PB, Granger CB, Kleinman NS, Moliterno DJ, Moll S, Rice L, Abrams CS, Rogers JE, Steinhubl SS, Tapson VF, Anstrom KJ, Ohman EM. Incidence and evaluation of heparin-induced thrombocytopenia (HIT) among patients treated with prolonged heparin and among thrombocytopenic patients in the cardiac care unit: Preliminary results of the CATCH Registry. 2004 Mar 3:501A-501A. Full Text Link to Item
  - Oliveira GBF, Newby LK, Lindblad L, Piegras LS, Verheught FW, Harrington RA, Hochman JS, White HD, Van de Werf F, Granger CB. White blood cell count predicts higher risk of intermediate-term outcomes in patients stabilized after acute coronary syndromes: Observations from the SYMPHONY and 2nd SYMPHONY trials. 2004 Mar 3:258A-258A. Full Text Link to Item
  - Patel MR, Mahaffey KW, Armstrong PW, Weaver WD, Tasissa G, Hochman JS, Todaro TG, Malloy KJ, Parish TH, Rollins S, Theroux P, Ruzyllo W, Nicolau JC, Granger CB. Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction: Results from the CARDINAL trial. 2004 Mar 3:291A-292A. Full Text Link to Item
  - O'Meara E, McMurray J, Young J, Pfeffer M, Swedberg K, Yusuf S, Granger CB, Johansson P. Low haemoglobin is associated with more evidence of congestion but less severe systolic dysfunction in patients with chronic heart failure. 2004:498-498. Link to Item
  - Steg PHG, Dabbous OH, Lopez-Sendon J, Anderson FA, Gore JM, Kennelly BM, Granger CB, Fox KAA, Investigators GRACE. "Leading and lagging" hospitals: can processes of care be used to rank hospitals?. 2004:444-444. Link to Item
  - Young J, Swedberg K, Dunlap ME, Granger CB, McMurray JJV, Probstfield JL, Yusuf S, Pfeffer M. Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials. 2004:487-487. Link to Item
  - Rice L, Abrams CS, Anstrom KJ, Becker RC, Berger PB, Granger CB, Kleiman NS, Moliterno DJ, Moll S, Rogers J, Steinhubl SS, Tapson VF, Ohman EM. Thrombocytopenia is common among patients treated with heparin and is rarely detected and evaluated with serologic testing and hematology consultation: Preliminary findings from the CATCH registry. 2003 Nov 16:537A-537A. Link to Item
  - Armstrong PW, Wallentin L, Goldstein P, Granger CB, Bogaerts K, Danays T, Van de Werf F, Investigators ASSENT3, Investigators ASSENT3P. Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS. 2003 Oct 28:580-581. Link to Item
  - Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Granger CB, Harrington RA, Simoons ML, Newby LK. Elevated creatine kinase MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: Results from four large clinical trials. 2003 Oct 28:377-377. Link to Item
  - Velazquez EJ, Jones WS, Smith WT, Kober L, Kilaru R, Rittenhouse LM, Granger CB, Weaver D, Lamas G, Zelenkofske SL, Aylward PE, Henis M, Swedberg K, Pfeffer MA, Van de Werf F, Rouleau JL, Califf RM. International assessment of atrial fibrillation in myocardial infarction: The VALIANT registry. 2003 Oct 28:425-425. Link to Item
  - Sadiq L, Lim MJ, Eagle KA, Gore JM, Goldberg RJ, Mehta RH, Granger CB, Dabbous OH, Spencer FA. Treating patients with non-ST-elevation acute coronary syndromes with aggressive antiplatelet agents in the GRACE registry: No observed improvement in hospital outcomes. 2003 Sep 15:232L-232L. Link to Item
  - Fox KA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer FA, Budaj A, Dabbous OH, Gore JM. Influence of guidelines and results from major clinical trials on medical practice: Findings from the global registry of acute coronary events (GRACE). 2003 Mar 19:518A-518A. Link to Item
  - Roe MT, Giugliano RP, Tuttle R, Hasselblad V, Murphy S, Antman EM, Ohman EM, Harrington RA, Granger CB, Mahaffey KW, Cannon CP, Lincoff AM, Gibson CM, Armstrong PW, van de Werf FJ, Califf RM, Topol EJ, Braunwald E. Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction. 2003 Mar 19:332A-332A. Link to Item
  - Sinnaeve PR, Antman EM, Ross AM, Hasselblad V, Van de Werf FJ, Granger CB. Enoxaparin is superior to unfractionated heparin after fibrinolysis in acute myocardial infarction: Meta-analysis of ASSENT-3, HART-II, and ENTIRE-TIMI-23 trials. 2003 Mar 19:334A-334A. Link to Item
  - Armstrong PW, Mahaffey KW, Weaver WD, Hochman JS, Theroux P, Rollins S, Todaro TG, Granger CB. Mechanism of pexelizumabs mortality benefit in acute myocardial infarction patients treated with primary percutaneous coronary intervention. 2003:199-199. Full Text Link to Item
  - Lim MJ, Eagle KA, Gore JM, Goldberg RJ, Mehta RH, Granger CB, Dabbous OH, Spencer FA, Investigators GRACE. Treating patients with acute coronary syndromes with aggressive anti-platelet agents in the grace registry: no observed decrease in in-hospital mortality but increased bleeding complications. 2003:547-547. Full Text Link to Item
  - Mahaffey KW, Armstrong F, Hochman JS, Nicolau JC, Ruzyllo W, Mojcik CF, Filloon T, Granger CB, Investigators CARDINAL. Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?. 2003:301-301. Full Text Link to Item
  - Sinnaeve PR, Alexander JH, Armstrong PW, Huang Y, Wallentin L, Goldstein P, Van de Werf F, Granger CB. Enoxaparin versus unfractionated heparin with tenecteplase in the elderly: combined ASSENT-3 and ASSENT-3+ results. 2003:542-542. Full Text Link to Item
  - Welsh RC, Goldstein P, Chang WC, Wallentin L, Granger CB, Verheugt F, Van de Werf F, Armstrong PW, Investigators ASSENT3P. Understanding time to treatment in acute myocardial infarction: insights from ASSENT 3+. 2003:502-502. Full Text Link to Item
  - Granger CB, Pieper KS, Eikelboom J, Simes J, Yusuf S. Effect of direct thrombin inhibitors on reducing death and myocardial infarction in acute coronary syndromes is greater in patients undergoing percutaneous coronary intervention. 2002 Nov 5:494-494. Link to Item
  - Kaul P, Armstrong PW, Granger CB, Lee KL, Mark DB. Conservative management of acute myocardial infarction may cost lives in the long-term: US-Canada comparison of 5-year mortality in GUSTO-I. 2002 Nov 5:697-697. Link to Item
  - Kaul P, Armstrong PW, Granger CB, Van de Werf F, Mark DB. ASSENT-3 economic analysis: Costs of reperfusion strategies in acute myocardial infarction. 2002 Nov 5:758-758. Link to Item
  - Sinnaeve PR, Belmans A, Aylward P, Wallentin L, Granger CB, de Werf FV. Pulse pressure and risk of intracranial hemorrhage after thrombolysis for acute myocardial infarction results from GUSTO-1, ASSENT-2 and ASSENT-3 trials. 2002 Nov 5:400-400. Link to Item
  - Alexander J, Tuttle RH, Granger CB, Wallentin L, Verheugt FWA, Armstrong PW, Van de Werf FJ. TNK with reduced dose unfractionated heparin associated with similar efficacy and less bleeding: results from ASSENT-2 and ASSENT-3. 2002:638-638. Link to Item
  - Fox KAA, Goldberg RJ, Pieper K, Cannon CP, Van de Werfs F, Goodman SG, Dabbous O, Granger CB, Investigators GRACE. Predictors of in-hospital mortality in the global registry of acute coronary events (GRACE). 2002:626-626. Link to Item
  - Serebruany VL, Malinin A, Callahan KP, Binbrek AS, van de Werf F, Alexander JH, Granger CB, Gurbel P. Effect of tenecteplase versus alteplase on platelets in patients during the first three hours after acute myocardial infarction. 2002:267-267. Link to Item
  - Wagner G, Fu Y, Goodman SG, Granger CB, Wallentin L, de Werf FV, Armstrong P, Investigators ASSENTIII. How does ST-segment resolution one-hour after fibrinolysis for acute myocardial infarction predict final infarct size? Insights from ASSENT 3. 2002:266-266. Link to Item
  - McGuire DK, Granger CB. Diabetes and ischemic heart disease. 1999 Nov:S366-S375. Link to Item
- Journal Articles
  - Berwanger O, de Barros e Silva PGM, Dall Orto FTC, de Andrade PB, de Castro Bienert IR, Bosso CE, Mangione J, Polanczyk CA, Sousa A, Kalil R, de Moura Santos L, Sposito AC, Rech RL, Sousa ACS, Baldissera F, Nascimento BR, de Andrade Jesuíno I, Santucci EV, Damiani LP, Laranjeira LN, Borges de Oliveira JA, Giraldez RR, Cavalcanti AB, Pereira SB, Mattos LA, Armaganijan LV, Guimarães HP, Sousa JE, Alexander JH, Granger CB, Lopes RD. Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial. American Heart Journal. 2018 Apr 1;198:129-134. Full Text
  - Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. American heart journal. 2018 Mar;197:133-141. PubMed PMID: 29447773. Full Text
  - Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L, ARISTOTLE Committees and Investigators . Digoxin and Mortality in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2018 Mar;71(10):1063-1074. PubMed PMID: 29519345. Full Text
  - Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB, Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators . Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. The American journal of medicine. 2018 Mar;131(3):269-275.e2. PubMed PMID: 29122636. Full Text
  - Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, Swedberg K, Yusuf S, Granger CB, Pfeffer MA, McMurray JJV, Solomon SD. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. European journal of heart failure. 2018 Feb 12. PubMed PMID: 29431256. Full Text
  - Granger CB, Xavier D. Improving Evidence for Implementation of Guideline-Based Care in Low- and Middle-Income Countries. JAMA. 2018 Feb;319(6):554-556. PubMed PMID: 29450511. Full Text
  - Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L, ARISTOTLE and RE-LY Investigators . A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score. European heart journal. 2018 Feb;39(6):477-485. PubMed PMID: 29069359. Full Text
  - Platz E, Jhund PS, Claggett BL, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, McMurray JJ. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. European journal of heart failure. 2018 Feb;20(2):295-303. PubMed PMID: 28872259. Full Text
  - Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial. Journal of the American Heart Association. 2018 Feb;7(3). PubMed PMID: 29419390. Full Text
  - Hagström E, Norlund F, Stebbins A, Armstrong PW, Chiswell K, Granger CB, López-Sendón J, Pella D, Soffer J, Sy R, Wallentin L, White HD, Stewart RAH, Held C. Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease. Journal of internal medicine. 2018 Jan;283(1):83-92. PubMed PMID: 28960596. Full Text
  - Jollis JG, Al-Khalidi HR, Roettig ML, Berger PB, Corbett CC, Doerfler SM, Fordyce CB, Henry TD, Hollowell L, Magdon-Ismail Z, Kochar A, McCarthy JJ, Monk L, O'Brien P, Rea TD, Shavadia J, Tamis-Holland J, Wilson BH, Ziada KM, Granger CB. Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2. Circulation. 2018 Jan;137(4):376-387. PubMed PMID: 29138292. Full Text
  - Westermann D, Goodman SG, Nicolau JC, Requena G, Maguire A, Chen JY, Granger CB, Grieve R, Pocock SJ, Blankenberg S, Vega AM, Yasuda S, Simon T, Brieger D, TIGRIS Study Investigators . Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. Clinical cardiology. 2017 Dec 16;40(12):1197-1204. PubMed PMID: 29247524. Full Text
  - Hirji SA, Stevens SR, Shaw LK, Campbell EC, Granger CB, Patel MR, Sketch MH, Wang TY, Ohman EM, Peterson ED, Brennan JM. Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease. American heart journal. 2017 Dec;194:116-124. PubMed PMID: 29223429. Full Text
  - Kristensen SL, Jhund PS, Lee MMY, Køber L, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, McMurray JJV, CHARM Investigators and Committees . Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes. Cardiovascular drugs and therapy. 2017 Dec;31(5-6):545-549. PubMed PMID: 28948430. Full Text
  - Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH, ARISTOTLE Investigators . Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. Stroke. 2017 Dec;48(12):3266-3273. PubMed PMID: 29089455. Full Text
  - de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. European heart journal. 2017 Dec;38(47):3502-3510. PubMed PMID: 29020248. Full Text
  - Wolsk E, Claggett B, Køber L, Pocock S, Yusuf S, Swedberg K, McMurray JJV, Granger CB, Pfeffer MA, Solomon SD. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. European journal of heart failure. 2017 Nov 30. PubMed PMID: 29193462. Full Text
  - Bossard M, Granger CB, Tanguay J-F, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR. Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association. 2017 Nov 3;6(11). PubMed PMID: 29101117. Full Text
  - Ebinger J, Granger CB, Zhu A, Chang A, Henry TD. Idarucizumab since FDA approval: Use in the real-world. American heart journal. 2017 Nov;193:93-94. PubMed PMID: 29129261. (Letter) Full Text
  - Fordyce CB, Hansen CM, Kragholm K, Dupre ME, Jollis JG, Roettig ML, Becker LB, Hansen SM, Hinohara TT, Corbett CC, Monk L, Nelson RD, Pearson DA, Tyson C, van Diepen S, Anderson ML, McNally B, Granger CB. Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations. JAMA cardiology. 2017 Nov;2(11):1226-1235. PubMed PMID: 28979980. Full Text
  - Kochar A, Granger CB. Q Waves at Presentation in Patients With ST-Segment-Elevation Myocardial Infarction: An Underappreciated Marker of Risk. Circulation. Cardiovascular interventions. 2017 Nov;10(11). PubMed PMID: 29146675. Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017 Oct 30. PubMed PMID: 29084731. (Review) Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017 Oct 30. PubMed PMID: 29084733. (Review) Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart rhythm. 2017 Oct 26. PubMed PMID: 29097319. Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Gillis AM, Bryant WJ, Hlatky MA, Callans DJ, Granger CB, Curtis AB, Hammill SC, Deal BJ, Joglar JA, Dickfeld T, Kay GN, Field ME, Matlock DD, Fonarow GC, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart rhythm. 2017 Oct 26. PubMed PMID: 29097320. Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. 2017 Oct 25. PubMed PMID: 29097296. Full Text
  - Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. 2017 Oct 24. PubMed PMID: 29097294. Full Text
  - Hinohara TT, Al-Khalidi HR, Fordyce CB, Gu X, Sherwood MW, Roettig ML, Corbett CC, Monk L, Tamis-Holland JE, Berger PB, Burchenal JEB, Wilson BH, Jollis JG, Granger CB. Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST-Segment-Elevation Myocardial Infarction. Journal of the American Heart Association. 2017 Oct 24;6(10). PubMed PMID: 29066448. Full Text
  - Kragholm K, Lu D, Chiswell K, Al-Khalidi HR, Roettig ML, Roe M, Jollis J, Granger CB. Improvement in Care and Outcomes for Emergency Medical Service-Transported Patients With ST-Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A Mission: Lifeline STEMI Accelerator Study. Journal of the American Heart Association. 2017 Oct 11;6(10). PubMed PMID: 29021273. Full Text
  - Stewart RAH, Held C, Hadziosmanovic N, Armstrong PW, Cannon CP, Granger CB, Hagström E, Hochman JS, Koenig W, Lonn E, Nicolau JC, Steg PG, Vedin O, Wallentin L, White HD, STABILITY Investigators . Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. Journal of the American College of Cardiology. 2017 Oct;70(14):1689-1700. PubMed PMID: 28958324. Full Text
  - Vinereanu D, Al-Khalidi HR, Rao MP, He W, Lopes RD, Bahit CM, Ciobanu AO, Fox KA, Pokorney SD, Xian Y, Jiang J, Kamath DY, Berwanger O, Tajer C, Huo Y, Xavier D, Granger CB. Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). American heart journal. 2017 Oct;192:38-47. PubMed PMID: 28938962. Full Text
  - van Diepen S, Girotra S, Abella BS, Becker LB, Bobrow BJ, Chan PS, Fahrenbruch C, Granger CB, Jollis JG, McNally B, White L, Yannopoulos D, Rea TD. Multistate 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project. Journal of the American Heart Association. 2017 Sep 22;6(9). PubMed PMID: 28939711. Full Text
  - Guimarães PO, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, Krug-Gourley S, Lonn E, Lopes RD, Stewart RAH, Vinereanu D, Wallentin L, White HD, Hagström E, Danchin N. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Journal of the American Heart Association. 2017 Sep 14;6(9). PubMed PMID: 28912210. Full Text
  - Vinereanu D, Lopes RD, Bahit MC, Xavier D, Jiang J, Al-Khalidi HR, He W, Xian Y, Ciobanu AO, Kamath DY, Fox KA, Rao MP, Pokorney SD, Berwanger O, Tajer C, de Barros E Silva PGM, Roettig ML, Huo Y, Granger CB, IMPACT-AF investigators . A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet (London, England). 2017 Aug 25. PubMed PMID: 28859942. Full Text
  - Auer J, Huber K, Granger CB. Interruption of non-vitamin K antagonist anticoagulants in patients undergoing planned invasive procedures: how long is long enough?. European heart journal. 2017 Aug;38(31):2440-2443. PubMed PMID: 28821168. Full Text
  - Bernstein RA, Kamel H, Granger CB, Kowal RC, Ziegler PD, Schwamm LH. Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale. American heart journal. 2017 Aug;190:19-24. PubMed PMID: 28760209. Full Text
  - Lindholm D, Lindbäck J, Armstrong PW, Budaj A, Cannon CP, Granger CB, Hagström E, Held C, Koenig W, Östlund O, Stewart RAH, Soffer J, White HD, de Winter RJ, Steg PG, Siegbahn A, Kleber ME, Dressel A, Grammer TB, März W, Wallentin L. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. Journal of the American College of Cardiology. 2017 Aug;70(7):813-826. PubMed PMID: 28797349. Full Text
  - Rymer JA, Granger CB. Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI. Annals of internal medicine. 2017 Aug;167(4):JC23-. PubMed PMID: 28806804. Full Text
  - van Diepen S, Fordyce CB, Wegermann ZK, Granger CB, Stebbins A, Morrow DA, Solomon MA, Soble J, Henry TD, Gilchrist IC, Katz JN, Cohen MG, Newby LK. Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States: An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey. Circulation. Cardiovascular quality and outcomes. 2017 Aug;10(8):e003864-. PubMed PMID: 28794122. Full Text
  - Lopes RD, Alings M, Connolly SJ, Beresh H, Granger CB, Mazuecos JB, Boriani G, Nielsen JC, Conen D, Hohnloser SH, Mairesse GH, Mabo P, Camm AJ, Healey JS. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. American heart journal. 2017 Jul;189:137-145. PubMed PMID: 28625370. Full Text
  - Mehta S, Granger C, Grines CL, Jacobs A, Henry TD, Rokos I, Lansky A, Baumbach A, Botelho R, Ferre A, Yepes I, Salwan R, Dalal J, Makkar J, Bhalla N, Mishra S, Vijan V, Hiremath S. Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India. Indian Heart Journal. 2017 Jul. Full Text
  - Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. Declining Risk of Sudden Death in Heart Failure. The New England journal of medicine. 2017 Jul;377(1):41-51. PubMed PMID: 28679089. Full Text
  - Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola V-P, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. Journal of the American Heart Association. 2017 Jun 23;6(6). PubMed PMID: 28645934. Full Text
  - Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock SJ, Simon T, Yasuda S, Vega AM, Brieger D, TIGRIS Study Investigators . Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study. International journal of cardiology. 2017 Jun;236:54-60. PubMed PMID: 28268087. Full Text
  - Guimarães PO, Lopes RD, Wojdyla DM, Abdul-Rahim AH, Connolly SJ, Flaker GC, Wang J, Hanna M, Granger CB, Wallentin L, Lees KR, Alexander JH, McMurray JJV. Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. Cardiovascular drugs and therapy. 2017 Jun;31(3):295-301. PubMed PMID: 28516318. Full Text
  - Guimarães PO, Sun J-L, Kragholm K, Shah SH, Pieper KS, Kraus WE, Hauser ER, Granger CB, Kristin Newby L, MURDOCK Horizon 1 Cardiovascular Study Investigators Durham NC . Corrigendum to 'Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)'[Am. Heart J. (2016) 22-28]. American heart journal. 2017 Jun;188:196-. PubMed PMID: 28577677. Full Text
  - Kosmidou I, Redfors B, Selker HP, Thiele H, Patel MR, Udelson JE, Magnus Ohman E, Eitel I, Granger CB, Maehara A, Kirtane A, Généreux P, Jenkins PL, Ben-Yehuda O, Mintz GS, Stone GW. Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials. European heart journal. 2017 Jun;38(21):1656-1663. PubMed PMID: 28407050. Full Text
  - Kragholm K, Malta Hansen C, Dupre ME, Xian Y, Strauss B, Tyson C, Monk L, Corbett C, Fordyce CB, Pearson DA, Fosbøl EL, Jollis JG, Abella BS, McNally B, Granger CB. Direct Transport to a Percutaneous Cardiac Intervention Center and Outcomes in Patients With Out-of-Hospital Cardiac Arrest. Circulation. Cardiovascular quality and outcomes. 2017 Jun;10(6). PubMed PMID: 28615177. Full Text
  - Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener H-C. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017 Jun;129(22):2980-2987. PubMed PMID: 28356246. Full Text
  - Selker HP, Udelson JE, Ruthazer R, D'Agostino RB, Nichols M, Ben-Yehuda O, Eitel I, Granger CB, Jenkins P, Maehara A, Patel MR, Ohman EM, Thiele H, Stone GW. Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials. American heart journal. 2017 Jun;188:18-25. PubMed PMID: 28577674. (Review) Full Text
  - Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA cardiology. 2017 May;2(5):525-534. PubMed PMID: 28355434. Full Text
  - Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE, ACCELERATE Investigators . Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. The New England journal of medicine. 2017 May;376(20):1933-1942. PubMed PMID: 28514624. Full Text
  - Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart. 2017 Apr;103(8):623-628. PubMed PMID: 27798052. Full Text
  - Fordyce CB, Douglas PS, Roberts RS, Hoffmann U, Al-Khalidi HR, Patel MR, Granger CB, Kostis J, Mark DB, Lee KL, Udelson JE, Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Investigators . Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial. JAMA cardiology. 2017 Apr;2(4):400-408. PubMed PMID: 28199464. Full Text
  - Mehta S, Granger CB, Henry TD, Grines CL, Lansky A, Rokos I, Botelho R, Baumbach A, Mishra S, Cheem TH, Tresukosol D, Zambahari R, Ferré A, Castillo M. Reducing system delays in treatment of ST elevation myocardial infarction and confronting the challenges of late presentation in low and middle-income countries. Indian Heart Journal. 2017 Apr;69:S1-S5. Full Text
  - Diener H-C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. European heart journal. 2017 Mar;38(12):860-868. PubMed PMID: 26848150. Full Text
  - Diener H-C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. European heart journal. 2017 Mar;38(12):852-859. PubMed PMID: 26848149. Full Text
  - Henry TD, Granger CB. Out-of-Hospital Cardiac Arrest: To CT or Not to CT?. JACC. Cardiovascular interventions. 2017 Mar;10(5):460-461. PubMed PMID: 28279313. Full Text
  - Hess PL, Healey JS, Granger CB, Connolly SJ, Ziegler PD, Alexander JH, Kowey PR, Ruff CT, Flaker G, Halperin JL, Hart RG, Lopes RD. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review. JAMA cardiology. 2017 Mar;2(3):324-331. PubMed PMID: 28097334. Full Text
  - Pagidipati NJ, Granger CB. Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age. Annals of internal medicine. 2017 Mar;166(6):JC26-. PubMed PMID: 28320000. Full Text
  - Peterson BE, Al-Khatib SM, Granger CB. Apixaban to prevent stroke in patients with atrial fibrillation: a review. Therapeutic advances in cardiovascular disease. 2017 Mar;11(3):91-104. PubMed PMID: 27342651. (Review) Full Text
  - Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. American heart journal. 2017 Mar;185:140-149. PubMed PMID: 28267467. Full Text
  - Hu PT, Lopes RD, Stevens SR, Wallentin L, Thomas L, Alexander JH, Hanna M, Lewis BS, Verheugt FWA, Granger CB, Jones WS. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial. Journal of the American Heart Association. 2017 Jan 17;6(1). PubMed PMID: 28096100. Full Text
  - Fordyce CB, Al-Khalidi HR, Jollis JG, Roettig ML, Gu J, Bagai A, Berger PB, Corbett CC, Dauerman HL, Fox K, Garvey JL, Henry TD, Rokos IC, Sherwood MW, Wilson BH, Granger CB, STEMI Systems Accelerator Project . Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks. Circulation. Cardiovascular interventions. 2017 Jan;10(1). PubMed PMID: 28082714. Full Text
  - Guimarães PO, Wojdyla DM, Alexander JH, Thomas L, Alings M, Flaker GC, Al-Khatib SM, Hanna M, Horowitz JD, Wallentin L, Granger CB, Lopes RD. Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial. International journal of cardiology. 2017 Jan;227:443-449. PubMed PMID: 27852444. Full Text
  - Piccini JP, Granger CB. Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?. Journal of the American College of Cardiology. 2017 Jan;69(4):420-422. PubMed PMID: 28126159. Full Text
  - Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJV. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. European journal of heart failure. 2016 Dec;18(12):1508-1517. PubMed PMID: 27427441. Full Text
  - Jollis JG, Granger CB. Improving Care of Out-of-Hospital Cardiac Arrest: Next Steps. Circulation. 2016 Dec;134(25):2040-2042. PubMed PMID: 27994023. Full Text
  - Kelly JP, Granger CB. More Evidence That Caffeine Consumption Appears to Be Safe in Patients With Heart Failure. JAMA internal medicine. 2016 Dec;176(12):1759-1760. PubMed PMID: 27749959. Full Text
  - Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay J-F, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. Circulation. Cardiovascular interventions. 2016 Nov;9(11). PubMed PMID: 27803042. (Review) Full Text
  - Garvey JL, Granger C, Peacock WF. Pushing the Envelope on STEMI Response. ED management : the monthly update on emergency department management. 2016 Nov;28(11):121-126. PubMed PMID: 29211410.
  - Granger CB, Ohman EM. Enhancing the value of clinical trials: the role of data sharing. Nature reviews. Cardiology. 2016 Nov;13(11):629-630. PubMed PMID: 27681576. Full Text
  - Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis JS, Joglar JA, Pressler SJ, Wijeysundera DN. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. The Journal of thoracic and cardiovascular surgery. 2016 Nov;152(5):1243-1275. PubMed PMID: 27751237. Full Text
  - Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L, RE-LY and ARISTOTLE Investigators . Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. 2016 Nov;134(22):1697-1707. PubMed PMID: 27569438. Full Text
  - Loley C, Alver M, Assimes TL, Bjonnes A, Goel A, Gustafsson S, Hernesniemi J, Hopewell JC, Kanoni S, Kleber ME, Lau KW, Lu Y, Lyytikäinen L-P, Nelson CP, Nikpay M, Qu L, Salfati E, Scholz M, Tukiainen T, Willenborg C, Won H-H, Zeng L, Zhang W, Anand SS, Beutner F, Bottinger EP, Clarke R, Dedoussis G, Do R, Esko T, Eskola M, Farrall M, Gauguier D, Giedraitis V, Granger CB, Hall AS, Hamsten A, Hazen SL, Huang J, Kähönen M, Kyriakou T, Laaksonen R, Lind L et al. No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis. Scientific reports. 2016 Oct 12;6:35278-. PubMed PMID: 27731410. Full Text
  - Fordyce CB, Henry TD, Granger CB. Implementation of Regional ST-Segment Elevation Myocardial Infarction Systems of Care: Successes and Challenges. Interventional cardiology clinics. 2016 Oct;5(4):415-425. PubMed PMID: 28581992. (Review) Full Text
  - Le May M, van Diepen S, Liszkowski M, Schnell G, Tanguay J-F, Granger CB, Ainsworth C, Diodati JG, Fam N, Haichin R, Jassal D, Overgaard C, Tymchak W, Tyrrell B, Osborne C, Wong G. From Coronary Care Units to Cardiac Intensive Care Units: Recommendations for Organizational, Staffing, and Educational Transformation. The Canadian journal of cardiology. 2016 Oct;32(10):1204-1213. PubMed PMID: 26968391. Full Text
  - Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L. The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. European heart journal. 2016 Oct;37(38):2869-2878. PubMed PMID: 27071819. Full Text
  - van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, Mahaffey KW, Granger CB, Armstrong PW. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction. Journal of thrombosis and thrombolysis. 2016 Oct;42(3):376-385. PubMed PMID: 27324144. Full Text
  - Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L, Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators . Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. JAMA cardiology. 2016 Sep;1(6):673-681. PubMed PMID: 27463942. Full Text
  - Arbel Y, FitzGerald G, Yan AT, Tan MK, Fox KAA, Gore JM, Steg PG, Eagle KA, Brieger D, Montalescot G, Budaj A, Lopez-Sendon J, Avezum A, Granger CB, Goodman SG. Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events. International journal of cardiology. 2016 Sep;218:291-297. PubMed PMID: 27240154. Full Text
  - Calenda BW, Fuster V, Halperin JL, Granger CB. Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. Nature reviews. Cardiology. 2016 Sep;13(9):549-559. PubMed PMID: 27383079. (Review) Full Text
  - Hawkins NM, Jhund PS, Pozzi A, O'Meara E, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, Virani S, McMurray JJV. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European journal of heart failure. 2016 Sep;18(9):1162-1171. PubMed PMID: 27594177. Full Text
  - Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2016 Sep;68(10):1082-1115. PubMed PMID: 27036918. Full Text
  - Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016 Sep;134(10):e123-e155. PubMed PMID: 27026020. (Review) Full Text
  - Rao MP, Dupre ME, Pokorney SD, Hansen CM, Tyson C, Monk L, Pearson DA, Nelson RD, Myers B, Jollis JG, Granger CB. Therapeutic Hypothermia for Patients with Out-of-Hospital Cardiac Arrest in North Carolina. Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors. 2016 Sep;20(5):630-636. PubMed PMID: 26985981. Full Text
  - Granger CB, Thomas KL. Stroke Prediction in Atrial Fibrillation: Is it Black and White?. Journal of the American College of Cardiology. 2016 Aug;68(5):471-472. PubMed PMID: 27470454. Full Text
  - Jollis JG, Al-Khalidi HR, Roettig ML, Berger PB, Corbett CC, Dauerman HL, Fordyce CB, Fox K, Garvey JL, Gregory T, Henry TD, Rokos IC, Sherwood MW, Suter RE, Wilson BH, Granger CB, Mission: Lifeline STEMI Systems Accelerator Project . Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator. Circulation. 2016 Aug;134(5):365-374. PubMed PMID: 27482000. Full Text
  - Pearson DA, Darrell Nelson R, Monk L, Tyson C, Jollis JG, Granger CB, Corbett C, Garvey L, Runyon MS. Comparison of team-focused CPR vs standard CPR in resuscitation from out-of-hospital cardiac arrest: Results from a statewide quality improvement initiative. Resuscitation. 2016 Aug;105:165-172. PubMed PMID: 27131844. Full Text
  - Rajan S, Folke F, Kragholm K, Hansen CM, Granger CB, Hansen SM, Peterson ED, Lippert FK, Søndergaard KB, Køber L, Gislason GH, Torp-Pedersen C, Wissenberg M. Prolonged cardiopulmonary resuscitation and outcomes after out-of-hospital cardiac arrest. Resuscitation. 2016 Aug;105:45-51. PubMed PMID: 27224447. Full Text
  - Granger CB, Berger PB. Understanding the Adverse Effects of Ticagrelor in Practice. JAMA cardiology. 2016 Jul;1(4). PubMed PMID: 27438332. Full Text
  - Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Hanna M, Keltai M, Parkhomenko A, López-Sendón JL, Lopes RD, Siegbahn A, Granger CB, Wallentin L. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial. JAMA cardiology. 2016 Jul;1(4):451-460. PubMed PMID: 27438322. Full Text
  - Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB, Hagström E, Harrington RA, Hochman JS, Koenig W, Krug-Gourley S, Mohler ER, Siegbahn A, Tarka E, Steg PG, Stewart RAH, Weiss R, Östlund O, White HD, STABILITY Investigators . Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. Journal of the American Heart Association. 2016 Jun 21;5(6). PubMed PMID: 27329448. Full Text
  - Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FWA. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. BMJ (Clinical research ed.). 2016 Jun 15;353:i2868-. PubMed PMID: 27306620. Full Text
  - Berry C, Poppe KK, Gamble GD, Earle NJ, Ezekowitz JA, Squire IB, McMurray JJV, McAlister FA, Komajda M, Swedberg K, Maggioni AP, Ahmed A, Whalley GA, Doughty RN, Tarantini L, MAGGIC Collaborative Group . Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. QJM : monthly journal of the Association of Physicians. 2016 Jun;109(6):377-382. PubMed PMID: 25979270. Full Text
  - Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L, ARISTOTLE and RE-LY Investigators . The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet (London, England). 2016 Jun;387(10035):2302-2311. PubMed PMID: 27056738. Full Text
  - Rao MP, Ciobanu AO, Lopes RD, Fox KA, Xian Y, Pokorney SD, Al-Khalidi HR, Jiang J, Kamath DY, Berwanger O, Xavier D, Bahit CM, Tajer C, Vinereanu D, Huo Y, Granger CB. A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale. American heart journal. 2016 Jun;176:107-113. PubMed PMID: 27264227. Full Text
  - De Caterina R, Andersson U, Alexander JH, Al-Khatib SM, Bahit MC, Goto S, Hanna M, Held C, Hohnloser S, Hylek EM, Lanas F, Lopes RD, López-Sendón J, Renda G, Horowitz J, Granger CB, Wallentin L, ARISTOTLE Investigators . History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American heart journal. 2016 May;175:175-183. PubMed PMID: 27179738. Full Text
  - Endorsed by the Latin American Society of Interventional Cardiology , PCI WRITING COMMITTEE , Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, STEMI WRITING COMMITTEE , O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2016 May;87(6):1001-1019. PubMed PMID: 26489034. Full Text
  - Fordyce CB, Wang TY, Chen AY, Thomas L, Granger CB, Scirica BM, Henry TD, Wong GC, Ramanathan K, Hansen CM, Kragholm K, Peterson ED, Anderson ML. Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest. Journal of the American College of Cardiology. 2016 May;67(17):1981-1990. PubMed PMID: 27126525. Full Text
  - Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RAH, White HD, Granger CB, Wallentin L, ARISTOTLE and STABILITY Investigators . The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. European heart journal. 2016 May;37(20):1582-1590. PubMed PMID: 26920728. Full Text
  - Ruff CT, Ansell JE, Becker RC, Benjamin EJ, Deicicchi DJ, Mark Estes NA, Ezekowitz MD, Fanikos J, Fareed J, Garcia D, Giugliano RP, Goldhaber SZ, Granger C, Healey JS, Hull R, Hylek EM, Libby P, Lopes RD, Mahaffey KW, Mega J, Piazza G, Sasahara AA, Sorond FA, Spyropoulos AC, Walenga JM, Weitz JI. North American Thrombosis Forum, AF Action Initiative Consensus Document. The American journal of medicine. 2016 May;129(5 Suppl):S1-S29. PubMed PMID: 27126598. Full Text
  - van Diepen S, Lin M, Bakal JA, McAlister FA, Kaul P, Katz JN, Fordyce CB, Southern DA, Graham MM, Wilton SB, Newby LK, Granger CB, Ezekowitz JA. Do stable non-ST-segment elevation acute coronary syndromes require admission to coronary care units?. American heart journal. 2016 May;175:184-192. PubMed PMID: 27179739. Full Text
  - Guimarães PO, Sun J-L, Kragholm K, Shah SH, Pieper KS, Kraus WE, Hauser ER, Granger CB, Newby LK, MURDOCK Horizon 1 Cardiovascular Study Investigators . Association of standard clinical and laboratory variables with red blood cell distribution width. American heart journal. 2016 Apr;174:22-28. PubMed PMID: 26995366. Full Text
  - Hijazi Z, Aulin J, Andersson U, Alexander JH, Gersh B, Granger CB, Hanna M, Horowitz J, Hylek EM, Lopes RD, Siegbahn A, Wallentin L, ARISTOTLE Investigators . Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Heart (British Cardiac Society). 2016 Apr;102(7):508-517. PubMed PMID: 26839066. Full Text
  - Pokorney SD, O'Brien EC, Granger CB. Assessing generalizability of trial results in general practice. European heart journal. 2016 Apr;37(14):1154-1157. PubMed PMID: 26516173. Full Text
  - Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. Journal of the American College of Cardiology. 2016 Apr;67(14):1674-1683. PubMed PMID: 27056772. Full Text
  - Albers GW, Bernstein RA, Brachmann J, Camm J, Easton JD, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Jaffer AK, Krieger DW, Passman R, Pines JM, Reed SD, Rothwell PM, Kowey PR. Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. Journal of the American Heart Association. 2016 Mar 15;5(3):e002944-. PubMed PMID: 27068633. (Review) Full Text
  - Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology. 2016 Mar;67(10):1235-1250. PubMed PMID: 26498666. (Review) Full Text
  - Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016 Mar;133(11):1135-1147. PubMed PMID: 26490017. Full Text
  - Vavalle JP, van Diepen S, Clare RM, Hochman JS, Weaver WD, Mehta RH, Pieper KS, Patel MR, Patel UD, Armstrong PW, Granger CB, Lopes RD. Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. American heart journal. 2016 Mar;173:57-66. PubMed PMID: 26920597. Full Text
  - Diener H-C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. European heart journal. 2016 Feb 4. PubMed PMID: 28158700. Full Text
  - Diener H-C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. European heart journal. 2016 Feb 4. PubMed PMID: 28158531. Full Text
  - Calenda BW, Granger CB. ACP Journal Club. In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS2 and CHA2DS2-VASc scores. Annals of internal medicine. 2016 Feb;164(4):JC23-. PubMed PMID: 26882308. Full Text
  - Pesaro AEP, Granger CB, Lopes RD. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?. American heart journal. 2016 Feb;172:42-44. PubMed PMID: 26856214. Full Text
  - Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, Fang JC, Scirica BM, Henry TD, Granger CB. Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. Journal of the American College of Cardiology. 2016 Feb;67(7):739-747. PubMed PMID: 26892407. Full Text
  - Durheim MT, Cyr DD, Lopes RD, Thomas LE, Tsuang WM, Gersh BJ, Held C, Wallentin L, Granger CB, Palmer SM, Al-Khatib SM. Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. International journal of cardiology. 2016 Jan;202:589-594. PubMed PMID: 26447668. Full Text
  - Easton JD, Diener HC, Sacco RL, Granger CB, Brueckmann M, Cronin L, Cotton D, Investigators RE-SPECTESUS. RE-SPECT ESUS* Trial: Rationale and Design. CEREBROVASCULAR DISEASES. 2016;42:117-117. Link to Item
  - Diener H-C, Easton JD, Granger CB, Cronin L, Duffy C, Cotton D, Brueckmann M, Sacco RL, RE-SPECT ESUS Investigators . Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS). International journal of stroke : official journal of the International Stroke Society. 2015 Dec;10(8):1309-1312. PubMed PMID: 26420134. Full Text
  - Malta Hansen C, Jollis JG, Granger CB. Initial Interventions for Out-of-Hospital Cardiac Arrest--Reply. JAMA. 2015 Dec;314(22):2414-. PubMed PMID: 26647268. (Letter) Full Text
  - Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators . Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Journal of the American Heart Association. 2015 Dec;4(12). PubMed PMID: 26627878. Full Text
  - Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Mărgulescu AD, Wallentin L, Atar D. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. European heart journal. 2015 Dec;36(46):3268-3275. PubMed PMID: 26371113. Full Text
  - Hansen CM, Kragholm K, Granger CB, Pearson DA, Tyson C, Monk L, Corbett C, Nelson RD, Dupre ME, Fosbøl EL, Strauss B, Fordyce CB, McNally B, Jollis JG. The role of bystanders, first responders, and emergency medical service providers in timely defibrillation and related outcomes after out-of-hospital cardiac arrest: Results from a statewide registry. Resuscitation. 2015 Nov;96:303-309. PubMed PMID: 26386371. Full Text
  - Kraus WE, Granger CB, Sketch MH, Donahue MP, Ginsburg GS, Hauser ER, Haynes C, Newby LK, Hurdle M, Dowdy ZE, Shah SH. A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience. Journal of cardiovascular translational research. 2015 Nov;8(8):449-457. PubMed PMID: 26271459. (Review) Full Text
  - Nikpay M, Goel A, Won H-H, Hall LM, Willenborg C, Kanoni S, Saleheen D, Kyriakou T, Nelson CP, Hopewell JC, Webb TR, Zeng L, Dehghan A, Alver M, Armasu SM, Auro K, Bjonnes A, Chasman DI, Chen S, Ford I, Franceschini N, Gieger C, Grace C, Gustafsson S, Huang J, Hwang S-J, Kim YK, Kleber ME, Lau KW, Lu X, Lu Y, Lyytikäinen L-P, Mihailov E, Morrison AC, Pervjakova N, Qu L, Rose LM, Salfati E, Saxena R, Scholz M, Smith AV, Tikkanen E, Uitterlinden A et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nature genetics. 2015 Oct;47(10):1121-1130. PubMed PMID: 26343387. Full Text
  - Verheugt FWA, Granger CB. Intracerebral haemorrhage, atrial fibrillation, and anticoagulation - Authors' reply. Lancet (London, England). 2015 Oct;386(10005):1737-. PubMed PMID: 26545437. (Letter) Full Text
  - Anderson LL, French WJ, Peng SA, Vora AN, Henry TD, Roe MT, Kontos MC, Granger CB, Bates ER, Hellkamp A, Wang TY. Direct Transfer From the Referring Hospitals to the Catheterization Laboratory to Minimize Reperfusion Delays for Primary Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circulation. Cardiovascular interventions. 2015 Sep;8(9):e002477-. PubMed PMID: 26338881. Full Text
  - Fordyce CB, Gersh BJ, Stone GW, Granger CB. Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury. Trends in pharmacological sciences. 2015 Sep;36(9):605-616. PubMed PMID: 26148636. (Review) Full Text
  - Fordyce CB, Granger CB. Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome. Annals of internal medicine. 2015 Sep;163(6):JC7-. PubMed PMID: 26370034. Full Text
  - Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Cecilia Bahit M, Bartunek J, De Caterina R, Goto S, Ruzyllo W, Zhu J, Granger CB, Alexander JH. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. CIRCULATION. 2015 Aug 25;132(8):624-632. Full Text Link to Item
  - Hansen CM, Kragholm K, Pearson DA, Tyson C, Monk L, Myers B, Nelson D, Dupre ME, Fosbol EL, Jollis JG, Strauss B, Anderson ML, McNally B, Granger CB. Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015 Jul 21;314(3):255-264. PubMed PMID: 26197186. Full Text Link to Item
  - Alnasser SMA, Huang W, Gore JM, Steg PG, Eagle KA, Anderson FA, Fox KAA, Gurfinkel E, Brieger D, Klein W, van de Werf F, Avezum Á, Montalescot G, Gulba DC, Budaj A, Lopez-Sendon J, Granger CB, Kennelly BM, Goldberg RJ, Fleming E, Goodman SG, GRACE Investigators . Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up. The American journal of medicine. 2015 Jul;128(7):766-775. PubMed PMID: 25554379. Full Text
  - Ghosh S, Vivar J, Nelson CP, Willenborg C, Segrè AV, Mäkinen V-P, Nikpay M, Erdmann J, Blankenberg S, O'Donnell C, März W, Laaksonen R, Stewart AFR, Epstein SE, Shah SH, Granger CB, Hazen SL, Kathiresan S, Reilly MP, Yang X, Quertermous T, Samani NJ, Schunkert H, Assimes TL, McPherson R. Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology. 2015 Jul;35(7):1712-1722. PubMed PMID: 25977570. Full Text
  - Verheugt FWA, Granger CB. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet (London, England). 2015 Jul;386(9990):303-310. PubMed PMID: 25777666. (Review) Full Text
  - Bahit MC, Granger C. Anticoagulation for atrial fibrillation in argentina: Progress and opportunity. Revista Argentina de Cardiologia. 2015 Jun 1;83(3):183-184.
  - Pokorney SD, Granger CB. Should patients on vitamin K antagonists be treated differently?. European heart journal. 2015 Jun;36(23):1431-1433. PubMed PMID: 25694462. Full Text
  - Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJV, Ping L, Probstfield JL, Solomon SD, Tardif J-C, Wu Y, Pfeffer MA, ELIXA Investigators . Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. American heart journal. 2015 May;169(5):631-638.e7. PubMed PMID: 25965710. Full Text
  - Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FWA, Zhu J, Granger CB, Wallentin L. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. European heart journal. 2015 May;36(20):1264-1272. PubMed PMID: 25499871. Full Text
  - James S, Rao SV, Granger CB. Registry-based randomized clinical trials--a new clinical trial paradigm. Nature reviews. Cardiology. 2015 May;12(5):312-316. PubMed PMID: 25781411. (Review) Full Text
  - James S, Rao SV, Granger CB. Registry-based randomized clinical trials-a new clinical trial paradigm. NATURE REVIEWS CARDIOLOGY. 2015 May;12(5):312-316. Full Text Link to Item
  - Segall N, Hobbs G, Granger CB, Anderson AE, Bonifacio AS, Taekman JM, Wright MC. Patient load effects on response time to critical arrhythmias in cardiac telemetry: a randomized trial. Critical care medicine. 2015 May;43(5):1036-1042. PubMed PMID: 25746509. Full Text
  - Steinberg BA, Schulte PJ, Hofmann P, Ersbøll M, Alexander JH, Broderick-Forsgren K, Anstrom KJ, Granger CB, Piccini JP, Velazquez EJ, Shah BR. Outcomes after nonemergent electrical cardioversion for atrial arrhythmias. The American journal of cardiology. 2015 May;115(10):1407-1414. PubMed PMID: 25784514. Full Text
  - Correction. American Heart Journal. 2015 Apr;169(4):594-594. Full Text
  - Ezekowitz JA, Lewis BS, Lopes RD, Wojdyla DM, McMurray JJV, Hanna M, Atar D, Cecilia Bahit M, Keltai M, Lopez-Sendon JL, Pais P, Ruzyllo W, Wallentin L, Granger CB, Alexander JH. Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. European heart journal. Cardiovascular pharmacotherapy. 2015 Apr;1(2):86-94. PubMed PMID: 27533976. Full Text
  - Kovacs RJ, Flaker GC, Saxonhouse SJ, Doherty JU, Birtcher KK, Cuker A, Davidson BL, Giugliano RP, Granger CB, Jaffer AK, Mehta BH, Nutescu E, Williams KA. Practical management of anticoagulation in patients with atrial fibrillation. Journal of the American College of Cardiology. 2015 Apr;65(13):1340-1360. PubMed PMID: 25835447. (Review) Full Text
  - Pokorney SD, Granger CB. Practical advice on safe and effective use of non-vitamin K antagonist oral anticoagulants. European heart journal. Cardiovascular pharmacotherapy. 2015 Apr;1(2):146-147. PubMed PMID: 27533985. Full Text
  - Rohla M, Vennekate CK, Tentzeris I, Freynhofer MK, Farhan S, Egger F, Weiss TW, Wojta J, Granger CB, Huber K. Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. International journal of cardiology. 2015 Apr;184:108-114. PubMed PMID: 25700281. Full Text
  - Roger VL, Boerwinkle E, Crapo JD, Douglas PS, Epstein JA, Granger CB, Greenland P, Kohane I, Psaty BM. Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts. American journal of epidemiology. 2015 Mar 4;181(6):363-368. PubMed PMID: 25743324. Full Text
  - Roger VL, Boerwinkle E, Crapo JD, Douglas PS, Epstein JA, Granger CB, Greenland P, Kohane I, Psaty BM. Roger et al. respond to "future of population studies". American journal of epidemiology. 2015 Mar 4;181(6):372-373. PubMed PMID: 25743323. Full Text
  - Vazir A, Claggett B, Jhund P, Castagno D, Skali H, Yusuf S, Swedberg K, Granger CB, McMurray JJV, Pfeffer MA, Solomon SD. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. European heart journal. 2015 Mar;36(11):669-675. PubMed PMID: 25368202. Full Text
  - Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. Journal of cardiovascular electrophysiology. 2015 Feb;26(2):151-157. PubMed PMID: 25332150. Full Text
  - Badar AA, Perez-Moreno AC, Hawkins NM, Brunton APT, Jhund PS, Wong CM, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Gardner RS, Petrie MC, McMurray JJV. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. European journal of heart failure. 2015 Feb;17(2):196-204. PubMed PMID: 25678097. Full Text
  - Granger CB, Gersh BJ. Potential relief for refractory angina. The New England journal of medicine. 2015 Feb;372(6):566-567. PubMed PMID: 25651252. Full Text
  - Halim SA, Neely ML, Pieper KS, Shah SH, Kraus WE, Hauser ER, Califf RM, Granger CB, Newby LK. Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular events. Circulation. Cardiovascular genetics. 2015 Feb;8(1):168-177. PubMed PMID: 25422398. Full Text
  - Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola V-P, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJV, Wallentin L. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clinical chemistry. 2015 Feb;61(2):368-378. PubMed PMID: 25451868. Full Text
  - Vora AN, Holmes DN, Rokos I, Roe MT, Granger CB, French WJ, Antman E, Henry TD, Thomas L, Bates ER, Wang TY. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. JAMA internal medicine. 2015 Feb;175(2):207-215. PubMed PMID: 25485876. Full Text
  - Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB, Granger CB, Trygstad T, Liu LZ, Bosworth HB. Improving diabetes medication adherence: successful, scalable interventions. Patient preference and adherence. 2015 Jan 23;9:139-149. PubMed PMID: 25670885. (Review) Full Text
  - Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. Journal of Cardiovascular Electrophysiology. 2015 Jan 1;26(2):151-157. Full Text
  - Granger CB, Gersh BJ. Potential relief for refractory Angina. New England Journal of Medicine. 2015 Jan 1;372(6):566-567. Full Text
  - Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. American heart journal. 2015 Jan;169(1):25-30. PubMed PMID: 25497244. Full Text
  - Kristensen SL, Køber L, Jhund PS, Solomon SD, Kjekshus J, McKelvie RS, Zile MR, Granger CB, Wikstrand J, Komajda M, Carson PE, Pfeffer MA, Swedberg K, Wedel H, Yusuf S, McMurray JJV. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation. 2015 Jan;131(1):43-53. PubMed PMID: 25406306. Full Text
  - Magee MF, Tamis-Holland JE, Lu J, Bittner VA, Brooks MM, Lopes N, Jacobs AK. Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial. International Journal of Endocrinology. 2015;2015:1-11. Full Text
  - Van Diepen S, Granger CB, Jacka M, Gilchrist IC, Morrow DA, Katz JN. The unmet need for addressing cardiac issues in intensive care research. Critical Care Medicine. 2015 Jan 1;43(1):128-134. Full Text
  - van Diepen S, Granger CB, Jacka M, Gilchrist IC, Morrow DA, Katz JN. The unmet need for addressing cardiac issues in intensive care research. Critical care medicine. 2015 Jan;43(1):128-134. PubMed PMID: 25243816. Full Text
  - Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FWA, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. 2014 Dec;124(25):3692-3698. PubMed PMID: 25320240. Full Text
  - Steinberg BA, Schulte P, Hofmann P, Ersboll M, Alexander JH, Broderick-Forsgren K, Anstrom KJ, Granger CB, Piccini JP, Velazquez EJ, Shah BR. Contemporary Use and Clinical Outcomes Following Non-Emergent Electrical Cardioversion for Atrial Fibrillation. CIRCULATION. 2014 Nov 25;130. Link to Item
  - Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJV, Pocock S, Swedberg K, Yusuf S, Solomon SD. Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circulation. Heart failure. 2014 Nov;7(6):895-902. PubMed PMID: 25326006. Full Text
  - Fosbøl EL, Dupre ME, Strauss B, Swanson DR, Myers B, McNally BF, Anderson ML, Bagai A, Monk L, Garvey JL, Bitner M, Jollis JG, Granger CB. Association of neighborhood characteristics with incidence of out-of-hospital cardiac arrest and rates of bystander-initiated CPR: implications for community-based education intervention. Resuscitation. 2014 Nov;85(11):1512-1517. PubMed PMID: 25180920. Full Text
  - Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?. American heart journal. 2014 Nov;168(5):611-621. PubMed PMID: 25440788. (Review) Full Text
  - Park D-W, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van de Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong M-H, Patel MR. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014 Nov;312(19):2019-2027. PubMed PMID: 25399277. Full Text
  - Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A, ARISTOTLE Investigators . Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Nov;130(21):1847-1858. PubMed PMID: 25294786. Full Text
  - Wallentin L, Kristensen SD, Anderson JL, Tubaro M, Sendon JLL, Granger CB, Bode C, Huber K, Bates ER, Valgimigli M, Steg PG, Ohman EM. How can we optimize the processes of care for acute coronary syndromes to improve outcomes?. American heart journal. 2014 Nov;168(5):622-631. PubMed PMID: 25440789. (Review) Full Text
  - Wallentin L, Kristensen SD, Anderson JL, Tubaro M, Sendon JLL, Granger CB, Bode C, Huber K, Bates ER, Valgimigli M, Steg PG, Ohman EM. How can we optimize the processes of care for acute coronary syndromes to improve outcomes?. American Heart Journal. 2014 Nov 1;168(5):622-631.e2. Full Text
  - Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. American heart journal. 2014 Oct;168(4):503-511.e2. PubMed PMID: 25262260. Full Text
  - Diener HC, Easton JD, Granger CB, Kreuzer J, Duffy C, Cotton D, Brueckmann M, Sacco RL. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). INTERNATIONAL JOURNAL OF STROKE. 2014 Oct;9:216-216. Link to Item
  - Flaker G, Lopes RD, Hylek E, Wojdyla DM, Thomas L, Al-Khatib SM, Sullivan RM, Hohnloser SH, Garcia D, Hanna M, Amerena J, Harjola V-P, Dorian P, Avezum A, Keltai M, Wallentin L, Granger CB, ARISTOTLE Committees and Investigators . Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. Journal of the American College of Cardiology. 2014 Oct;64(15):1541-1550. PubMed PMID: 25301455. Full Text
  - Granger CB, Povsic TJ. Another biomarker for risk assessment in acute myocardial infarction?. Journal of the American College of Cardiology. 2014 Oct;64(16):1708-1710. PubMed PMID: 25323259. Full Text
  - Kelly J, Granger CB. Spironolactone did not reduce cardiac outcomes in symptomatic heart failure with preserved ejection fraction. Annals of internal medicine. 2014 Oct;161(8):JC6-. PubMed PMID: 25329223. Full Text
  - Vinereanu D, Dulgheru R, Magda S, Dragoi Galrinho R, Florescu M, Cinteza M, Granger C, Ciobanu AO. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. American heart journal. 2014 Oct;168(4):446-456. PubMed PMID: 25262253. Full Text
  - Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Siegbahn A. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial. Journal of thrombosis and haemostasis : JTH. 2014 Sep;12(9):1401-1412. PubMed PMID: 24942912. Full Text
  - Hess PL, Mirro MJ, Diener H-C, Eikelboom JW, Al-Khatib SM, Hylek EM, Bosworth HB, Gersh BJ, Singer DE, Flaker G, Mega JL, Peterson ED, Rumsfeld JS, Steinberg BA, Kakkar AK, Califf RM, Granger CB, Atrial Fibrillation Think-Tank Participants . Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012. American heart journal. 2014 Sep;168(3):239-247.e1. PubMed PMID: 25173533. Full Text
  - Karlsson LIM, Wissenberg M, Fosbøl EL, Hansen CM, Lippert FK, Bagai A, McNally B, Granger CB, Christensen EF, Folke F, Rajan S, Weeke P, Nielsen SL, Køber L, Gislason GH, Torp-Pedersen C. Diurnal variations in incidence and outcome of out-of-hospital cardiac arrest including prior comorbidity and pharmacotherapy: a nationwide study in Denmark. Resuscitation. 2014 Sep;85(9):1161-1168. PubMed PMID: 24971509. Full Text
  - Newby LK, Marber MS, Melloni C, Sarov-Blat L, Aberle LH, Aylward PE, Cai G, de Winter RJ, Hamm CW, Heitner JF, Kim R, Lerman A, Patel MR, Tanguay J-F, Lepore JJ, Al-Khalidi HR, Sprecher DL, Granger CB, SOLSTICE Investigators . Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial. Lancet (London, England). 2014 Sep;384(9949):1187-1195. PubMed PMID: 24930728. Full Text
  - Steinberg BA, Broderick SH, Lopes RD, Shaw LK, Thomas KL, DeWald TA, Daubert JP, Peterson ED, Granger CB, Piccini JP. Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2014 Sep;16(9):1284-1290. PubMed PMID: 24755440. Full Text
  - Steinberg BA, Broderick SH, Lopes RD, Shaw LK, Thomas KL, DeWald TA, Daubert JP, Peterson ED, Granger CB, Piccini JP. Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. EUROPACE. 2014 Sep;16(9):1284-1290. Full Text Link to Item
  - Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. Circulation. Cardiovascular interventions. 2014 Aug 5;7(4):585-593. PubMed PMID: 25097196. Full Text
  - Bao MH, Zheng Y, Westerhout CM, Fu Y, Wagner GS, Chaitman B, Granger CB, Armstrong PW. Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction. Journal of electrocardiology. 2014 Jul;47(4):465-471. PubMed PMID: 24853083. Full Text
  - Bello NA, Claggett B, Desai AS, McMurray JJV, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circulation. Heart failure. 2014 Jul;7(4):590-595. PubMed PMID: 24874200. Full Text
  - Diener H-C, Granger CB, Patel MR. Is there a period of liability with initiation of warfarin in patients with atrial fibrillation?. European heart journal. 2014 Jul;35(28):1834-1835. PubMed PMID: 24561547. Full Text
  - Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, Granger CB, Hanna M, Held C, Husted S, Hylek EM, Jansky P, Lopes RD, Ruzyllo W, Thomas L, Wallentin L. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. European heart journal. 2014 Jul;35(28):1864-1872. PubMed PMID: 24561548. Full Text
  - Bagai A, Dangas GD, Stone GW, Granger CB. Reperfusion strategies in acute coronary syndromes. Circulation research. 2014 Jun;114(12):1918-1928. PubMed PMID: 24902975. (Review) Full Text
  - Bainey KR, Gafni A, Rao-Melacini P, Tong W, Steg PG, Faxon DP, Lamy A, Granger CB, Yusuf S, Mehta SR, TIMACS Investigators . The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study. Journal of medical economics. 2014 Jun;17(6):415-422. PubMed PMID: 24702256. Full Text
  - Granger CB, Rao MP. Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data. JACC. Cardiovascular interventions. 2014 Jun;7(6):602-603. PubMed PMID: 24947718. Full Text
  - Huber K, Gersh BJ, Goldstein P, Granger CB, Armstrong PW. The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. European heart journal. 2014 Jun;35(23):1526-1532. PubMed PMID: 24742888. (Review) Full Text
  - Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, Huber K, Jansky P, Steg PG, Hanna M, Thomas L, Wallentin L, Granger CB. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. Journal of the American College of Cardiology. 2014 May;63(20):2141-2147. PubMed PMID: 24657685. Full Text
  - Rogers JK, Pocock SJ, McMurray JJ, Granger CB, Michelson EL, Östergren J, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S. Corrigendum to ‘Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved’ [ Eur J Heart Fail 2014;16:33-40]. European Journal of Heart Failure. 2014 May;16(5):592-592. Full Text
  - STABILITY Investigators , White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER, Nicolau JC, Pais P, Parkhomenko A et al. Darapladib for preventing ischemic events in stable coronary heart disease. The New England journal of medicine. 2014 May;370(18):1702-1711. PubMed PMID: 24678955. Full Text
  - Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, Sacco RL, Connolly SJ, Cryptogenic Stroke/ESUS International Working Group . Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet. Neurology. 2014 Apr;13(4):429-438. PubMed PMID: 24646875. Full Text
  - Nelson JA, Vavalle JP, May CH, Zhang A, Newby LK, Shaw LK, Al-Khatib SM, Alexander JH, Granger CB, Lopes RD. Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation. J Thromb Thrombolysis. 2014 Apr;37(3):331-337. PubMed PMID: 23733104. Full Text Link to Item
  - Rao MP, Granger CB. Improving integrated care in low- and middle-income countries: the final STEMI frontier?. Journal of interventional cardiology. 2014 Apr;27(2):167-170. PubMed PMID: 24697950. Full Text
  - Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT. Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program". Circulation. 2014 Mar;129(9):e372-. PubMed PMID: 24589703. (Letter) Full Text
  - Calvo G, McMurray JJV, Granger CB, Alonso-García Á, Armstrong P, Flather M, Gómez-Outes A, Pocock S, Stockbridge N, Svensson A, Van de Werf F. Large streamlined trials in cardiovascular disease. European heart journal. 2014 Mar;35(9):544-548. PubMed PMID: 24385376. Full Text
  - Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, Zhu J, Mohan P, Garcia D, Bartunek J, Vinereanu D, Husted S, Harjola VP, Rosenqvist M, Alexander JH, Granger CB, ARISTOTLE Committees and Investigators . Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). Journal of the American College of Cardiology. 2014 Mar;63(11):1082-1087. PubMed PMID: 24211508. Full Text
  - Granger CB, Chertow GM. A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease. Circulation. 2014 Mar;129(11):1190-1192. PubMed PMID: 24452751. Full Text
  - Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJV, Wallentin L. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation. 2014 Feb 11;129(6):625-634. Full Text
  - Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola V-P, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJV, Wallentin L, ARISTOTLE Investigators . High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Feb;129(6):625-634. PubMed PMID: 24226808. Full Text
  - Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJV, Granger CB, Investigators ARISTOTLE. High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2014 Jan 7;63(1):52-61. Full Text Link to Item
  - Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJV, Pais P, Pouleur H, Steg PG, Verheugt FWA, Wojdyla DM, Granger CB, Wallentin L. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2014 Jan;35(4):224-232. PubMed PMID: 24144788. Full Text Link to Item
  - Bagai A, Al-Khalidi HR, Sherwood MW, Muñoz D, Roettig ML, Jollis JG, Granger CB. Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: Design and methodology. American Heart Journal. 2014 Jan 1;167(1). Full Text
  - Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. American Heart Journal. 2014 Jan 1;168(4):503-511.e2. Full Text
  - Bao MH, Zheng Y, Westerhout CM, Fu Y, Wagner GS, Chaitman B, Granger CB, Armstrong PW. Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction. Journal of Electrocardiology. 2014 Jan 1;47(4):465-471. Full Text
  - Bhattacharya S, Granger CB, Craig D, Haynes C, Bain J, Stevens RD, Hauser ER, Newgard CB, Kraus WE, Newby LK, Shah SH. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis. 2014 Jan;232(1):191-196. PubMed PMID: 24401236. Full Text Link to Item
  - Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Siegbahn A. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial. Journal of Thrombosis and Haemostasis. 2014 Jan 1;12(9):1401-1412. Full Text
  - Granger CB, Becker LB. Randomized clinical trial progress to inform care for out-of-hospital cardiac arrest. JAMA. 2014 Jan 1;311(1):31-32. PubMed PMID: 24240668. Full Text Link to Item
  - Granger CB, Chertow GM. A pint of sweat will save a gallon of blood: A call for randomized trials of anticoagulation in end-stage renal disease. Circulation. 2014;129(11):1190-1192. Full Text
  - Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. American Heart Journal. 2014 Jan 1;169(1):25-30. Full Text
  - Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG. Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?. American Heart Journal. 2014 Jan 1;168(5):611-621. Full Text
  - Karlsson LIM, Wissenberg M, Fosbøl EL, Hansen CM, Lippert FK, Bagai A, McNally B, Granger CB, Christensen EF, Folke F, Rajan S, Weeke P, Nielsen SL, Køber L, Gislason GH, Torp-Pedersen C. Diurnal variations in incidence and outcome of out-of-hospital cardiac arrest including prior comorbidity and pharmacotherapy: A nationwide study in Denmark. Resuscitation. 2014 Jan 1;85(9):1161-1168. Full Text
  - Nelson JA, Vavalle JP, May CH, Zhang A, Newby LK, Shaw LK, Al-Khatib SM, Alexander JH, Granger CB, Lopes RD. Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation. Journal of Thrombosis and Thrombolysis. 2014 Jan 1;37(3):331-337. Full Text
  - Newby LK, Marber MS, Melloni C, Sarov-Blat L, Aberle LH, Aylward PE, Cai G, De Winter RJ, Hamm CW, Heitner JF, Kim R, Lerman A, Patel MR, Tanguay JF, Lepore JJ, Al-Khalidi HR, Sprecher DL, Granger CBI. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial. The Lancet. 2014 Jan 1;384(9949):1187-1195. Full Text
  - Rao MP, Pokorney SD, Granger CB. Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute. Scientifica. 2014 Jan;2014:901586-. PubMed PMID: 25215263. (Review) Full Text
  - Rogers JK, Pocock SJ, McMurray JJV, Granger CB, Michelson EL, Östergren J, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. European journal of heart failure. 2014 Jan;16(1):33-40. PubMed PMID: 24453096. (Review) Full Text
  - Vinereanu D, Dulgheru R, Magda S, Galrinho RD, Florescu M, Cinteza M, Granger C, Ciobanu AO. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial. American Heart Journal. 2014;168(4):446-456. Full Text
  - Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola V-P, Held C, Horowitz J, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJV, Oh B-H, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB. Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation. 2014 Jan;129(2):e21-e22. PubMed PMID: 24421367. (Letter) Full Text
  - Bagai A, McNally BF, Al-Khatib SM, Myers JB, Kim S, Karlsson L, Torp-Pedersen C, Wissenberg M, van Diepen S, Fosbol EL, Monk L, Abella BS, Granger CB, Jollis JG. Temporal differences in out-of-hospital cardiac arrest incidence and survival. Circulation. 2013 Dec 17;128(24):2595-2602. PubMed PMID: 24045044. Full Text Link to Item
  - Bahit MC, Lopes RD, Wojdyla DM, Hohnloser SH, Alexander JH, Lewis BS, Aylward PE, Verheugt FWA, Keltai M, Diaz R, Hanna M, Granger CB, Wallentin L. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial. International Journal of Cardiology. 2013 Dec 10;170(2):215-220. Full Text
  - Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJV. Clinical Characteristics and Outcomes of Young and Very Young Adults With Heart Failure The CHARM Programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2013 Nov 12;62(20):1845-1854. PubMed PMID: 23850914. Full Text Link to Item
  - Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. Am Heart J. 2013 Nov;166(5):913-919. PubMed PMID: 24176448. Full Text Link to Item
  - Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. American Heart Journal. 2013 Nov 1;166(5):913-919. Full Text
  - Fosbol EL, Granger CB. Learning from regional heterogeneity in outcomes of patients with acute myocardial infarction. EUROPEAN HEART JOURNAL. 2013 Nov;34(41):3171-3172. PubMed PMID: 24046433. Full Text Link to Item
  - Stewart R, Held C, Brown R, Vedin O, Hagstrom E, Lonn E, Armstrong P, Granger CB, Hochman J, Davies R, Soffer J, Wallentin L, White H. Physical activity in patients with stable coronary heart disease: an international perspective. European heart journal. 2013 Nov;34(42):3286-3293. PubMed PMID: 24014220. Full Text
  - Van Diepen S, Newby LK, Stebbins A, Armstrong PW, Granger CB. Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome". International Journal of Cardiology. 2013 Oct 9;168(4):4543-. (Letter) Full Text
  - van Diepen S, Newby LK, Stebbins A, Armstrong PW, Granger CB. Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome". Int J Cardiol. 2013 Oct 9;168(4):4543-. PubMed PMID: 23916777. (Letter) Full Text Link to Item
  - van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann F-J, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P, APEX AMI Investigators . Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. Int J Cardiol. 2013 Oct 3;168(3):2127-2133. PubMed PMID: 23394896. Full Text Link to Item
  - van Diepen S, Abella BS, Bobrow BJ, Nichol G, Jollis JG, Mellor J, Racht EM, Yannopoulos D, Granger CB, Sayre MR. Multistate implementation of guideline-based cardiac resuscitation systems of care: description of the HeartRescue project. Am Heart J. 2013 Oct;166(4):647-653.e2. PubMed PMID: 24093843. (Review) Full Text Link to Item
  - Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt J-U, Simoons ML, Van de Werf F, RE-ALIGN Investigators . Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013 Sep 26;369(13):1206-1214. PubMed PMID: 23991661. Full Text Link to Item
  - Reith C, Landray M, Devereaux PJ, Bosch J, Granger CB, Baigent C, Califf RM, Collins R, Yusuf S. Randomized clinical trials--removing unnecessary obstacles. N Engl J Med. 2013 Sep 12;369(11):1061-1065. PubMed PMID: 24024845. Full Text Link to Item
  - Hess CN, Al-Khatib SM, Granger CB, Lopes R. A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE. Expert review of cardiovascular therapy. 2013 Sep 2;11(9):1105-1114. PubMed PMID: 23992517. (Review) Full Text
  - Alonso A, Gore JM, Awad HH, Quill AL, Montalescot G, van de Werf F, Gulba DC, Fox KAA, Eagle KA, Granger CB, Wyman A, Steg PG, GRACE Investigators . Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry. European heart journal. Acute cardiovascular care. 2013 Sep;2(3):280-291. PubMed PMID: 24222840. Full Text
  - Fullwood JE, Mostaghimi Z, Granger CB, Washam JB, Bride W, Zhao Y, Granger BB. Alcohol withdrawal prevention: a randomized evaluation of lorazepam and ethanol--a pilot study. Am J Crit Care. 2013 Sep;22(5):398-406. PubMed PMID: 23996419. Full Text Link to Item
  - van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med. 2013 Sep;41(9):2080-2087. PubMed PMID: 23760155. Full Text Link to Item
  - Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, Ezekowitz J, Alings M, Yang H, Alexander JH, Flaker G, Hanna M, Granger CB. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013 Aug;34(31):2464-2471. PubMed PMID: 23594592. Full Text Link to Item
  - Bagai A, Al-Khalidi HR, Muñoz D, Monk L, Roettig ML, Corbett CC, Garvey JL, Wilson BH, Granger CB, Jollis JG. Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments project. Circ Cardiovasc Interv. 2013 Aug;6(4):399-406. PubMed PMID: 23861465. Full Text Link to Item
  - Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT. Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Circulation. 2013 Jul 23;128(4):352-359. PubMed PMID: 23788525. Full Text Link to Item
  - Lopes RD, Becker RC, Newby LK, Peterson ED, Hylek EM, Giugliano R, Granger CB, Mahaffey KW, Carvalho AC, Berwanger O, Giraldez RR, Feitosa-Filho GS, Barbosa MM, da Consolacao V Moreira M, Kalil RAK, Freitas M, de Campos Guerra JC, Barros MVL, da Rocha Rodrigues T, Lopes AC, Garcia DA. Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil. J Thromb Thrombolysis. 2013 Jul;36(1):115-130. PubMed PMID: 23494487. Full Text Link to Item
  - O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, American College of Cardiology Foundation , American Heart Association Task Force on Practice Guidelines , American College of Emergency Physicians , Society for Cardiovascular Angiography and Interventions . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2013 Jul;82(1):E1-27. PubMed PMID: 23299937. (Review) Full Text
  - Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJV, Granger CB. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013 Jun 4;61(22):2274-2284. PubMed PMID: 23563134. Full Text Link to Item
  - Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola V-P, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJV, Oh B-H, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013 Jun 4;127(22):2166-2176. PubMed PMID: 23640971. Full Text Link to Item
  - Bagai A, Granger CB. Acute coronary syndromes. STREAMlining care for patients with STEMI. Nat Rev Cardiol. 2013 Jun;10(6):304-306. PubMed PMID: 23609173. Full Text Link to Item
  - Lopes RD, Lokhnygina Y, Hasselblad V, Newby KL, Yow E, Granger CB, Armstrong PW, Hochman JS, Mills JS, Ruzyllo W, Mahaffey KW. Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy. (Published online) Trials. 2013 May 2;14:123-. PubMed PMID: 23782531. Full Text Open Access Copy Link to Item
  - Lopes RD, Granger CB, Alexander KP. The reply. Am J Med. 2013 May;126(5):e21-. PubMed PMID: 23582944. (Letter) Full Text Link to Item
  - McMurray JJV, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh B-H, Harjola V-P, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB, ARISTOTLE Committees and Investigators . Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail. 2013 May;6(3):451-460. PubMed PMID: 23575255. Full Text Link to Item
  - Wong C, Hawkins NM, Jhund P, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, Mcmurray JJV. Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme. EUROPEAN JOURNAL OF HEART FAILURE. 2013 May;12:S110-S110. Link to Item
  - Rose JJ, Newby LK, Broderick S, Chiswell K, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, Giugliano RP, Goodman SG, White HD, Califf RM, Granger CB, Lopes RD. Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes. J Am Coll Cardiol. 2013 Apr 2;61(13):1461-1463. PubMed PMID: 23500249. (Letter) Full Text Link to Item
  - Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013 Apr;6(2):176-183. PubMed PMID: 23549644. Full Text Link to Item
  - Fosbøl EL, Granger CB, Peterson ED, Lin L, Lytle BL, Shofer FS, Lohmeier C, Mears GD, Garvey JL, Corbett CC, Jollis JG, Glickman SW. Prehospital system delay in ST-segment elevation myocardial infarction care: a novel linkage of emergency medicine services and in hospital registry data. Am Heart J. 2013 Mar;165(3):363-370. PubMed PMID: 23453105. Full Text Link to Item
  - O’Malley RG, Olenchock B, Bohula-May E, Barnett C, Fintel DJ, Granger CB, Katz JN, Kontos MC, Kuvin JT, Murphy SA, Parrillo JE, Morrow DA. Organization and staffing practices in US cardiac intensive care units: a survey on behalf of the American Heart Association Writing Group on the Evolution of Critical Care Cardiology. European Heart Journal: Acute Cardiovascular Care. 2013 Mar;2(1):3-8. Full Text
  - Westerhout CM, Pieper KS, James SK, Mahaffey KW, de Werf FV, Califf RM, Granger CB, Armstrong PW. Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. American heart journal. 2013 Mar;165(3):354-62.e2. PubMed PMID: 23453104. Full Text
  - Khazanie P, Granger CB. A 10-year exercise program improved oxygen consumption and quality of life in stable chronic heart failure. ANNALS OF INTERNAL MEDICINE. 2013 Feb 19;158(4). PubMed PMID: 23420254. Full Text Link to Item
  - Fosbol EL, Granger CB, Jollis JG, Monk L, Lin L, Lytle BL, Xian Y, Garvey JL, Mears G, Corbett CC, Peterson ED, Glickman SW. The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times. Circulation. 2013 Feb 5;127(5):604-612. PubMed PMID: 23275382. Full Text Link to Item
  - Huber K, Goldstein P, Danchin N, Fox KAA, Welsh R, Granger CB, Henry T, Gersh BJ. Enhancing the efficacy of delivering reperfusion therapy: a European and North American experience with ST-segment elevation myocardial infarction networks. Am Heart J. 2013 Feb;165(2):123-132. PubMed PMID: 23351814. (Review) Full Text Link to Item
  - Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J. 2013 Feb;165(2):226-233. PubMed PMID: 23351826. Full Text Link to Item
  - Alexander JH, Levy E, Lawrence J, Hanna M, Waclawski AP, Wang J, Califf RM, Wallentin L, Granger CB. Documentation of study medication dispensing in a prospective large randomized clinical trial: Experiences from the ARISTOTLE Trial. American Heart Journal. 2013. PubMed PMID: 24016507. Full Text
  - Alexander JH, Levy E, Lawrence J, Hanna M, Waclawski AP, Wang J, Califf RM, Wallentin L, Granger CB. Documentation of study medication dispensing in a prospective large randomized clinical trial: Experiences from the ARISTOTLE Trial. American Heart Journal. 2013;166(3):559-565.e1. Full Text
  - Alherbish A, Westerhout CM, Fu Y, White HD, Granger CB, Wagner G, Armstrong PW. The forgotten lead: Does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?. American Heart Journal. 2013. PubMed PMID: 23895817. Full Text
  - Alherbish A, Westerhout CM, Fu Y, White HD, Granger CB, Wagner G, Armstrong PW. The forgotten lead: Does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?. American Heart Journal. 2013;166(2):333-339. Full Text
  - Bagai A, Al-Khalidi HR, Sherwood MW, Muñoz D, Roettig ML, Jollis JG, Granger CB. Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: Design and methodology. American Heart Journal. 2013. PubMed PMID: 24332137.
  - Bagai A, Granger CB. Acute coronary syndromes: STREAMlining care for patients with STEMI. Nature Reviews Cardiology. 2013;10(6):304-306. Full Text
  - Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT. Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: A report from the American heart association mission: Lifeline program. Circulation. 2013;128(4):352-359. Full Text
  - Bahit MC, Lopes RD, Clare RM, Newby LK, Pieper KS, Werf FVD, Armstrong PW, Mahaffey KW, Harrington RA, Diaz R, Ohman EM, White HD, James S, Granger CB. Heart failure complicating non-st-segment elevation acute coronary syndrome: Timing, predictors, and clinical outcomes. JACC: Heart Failure. 2013;1(3):223-229. PubMed PMID: 24621874. Full Text
  - Bahit MC, Lopes RD, Wojdyla DM, Hohnloser SH, Alexander JH, Lewis BS, Aylward PE, Verheugt FWA, Keltai M, Diaz R, Hanna M, Granger CB, Wallentin L. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial. International Journal of Cardiology. 2013. PubMed PMID: 24192334.
  - Cannon C, Ezekowitz MD, Granger C. Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation. The American journal of cardiology. 2013;112(4):S3-. PubMed PMID: 23910054. Full Text
  - Desai J, Granger CB, Weitz JI, Aisenberg J. Novel oral anticoagulants in gastroenterology practice. Gastrointestinal Endoscopy. 2013. PubMed PMID: 23725876. Full Text
  - Desai J, Granger CB, Weitz JI, Aisenberg J. Novel oral anticoagulants in gastroenterology practice. Gastrointestinal Endoscopy. 2013;78(2):227-239. Full Text
  - Diepen SV, Cook DJ, Jacka M, Granger CB. Critical care cardiology research: A call to action. Circulation: Cardiovascular Quality and Outcomes. 2013;6(2):237-242. PubMed PMID: 23463810. Full Text
  - Diepen SV, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann F-J, al E. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy. International Journal of Cardiology. 2013;168(3):2127-2133. Full Text
  - Diepen SV, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Critical Care Medicine. 2013;41(9):2080-2087. Full Text
  - Eapen ZJ, Vavalle JP, Granger CB, Harrington RA, Peterson ED, Califf RM. Rescuing clinical trials in the United States and beyond: A call for action. American Heart Journal. 2013. PubMed PMID: 23708153. Full Text
  - Eapen ZJ, Vavalle JP, Granger CB, Harrington RA, Peterson ED, Califf RM. Rescuing clinical trials in the united states and beyond:A call for action. American Heart Journal. 2013;165(6):837-847. Full Text
  - Garcia DA, Wallentin L, Lopes RD, Thomas L, Alexander JH, Hylek EM, Ansell J, Hanna M, Lanas F, Flaker G, Commerford P, Xavier D, Vinereanu D, Yang H, Granger CB. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American Heart Journal. 2013;166(3):549-558. Full Text
  - Garcia DA, Wallentin L, Lopes RD, Thomas L, Alexander JH, Hylek EM, Ansell J, Hanna M, Lanas F, Flaker G, al E. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American Heart Journal. 2013. PubMed PMID: 24016506. Full Text
  - Henry TD, Jacobs AK, Granger CB. Regional systems of care for ST-elevation myocardial infarction: Do they save lives?. American Heart Journal. 2013. PubMed PMID: 24016484. Full Text
  - Henry TD, Jacobs AK, Granger CB. Regional systems of care for ST-elevation myocardial infarction: Do they save lives?. American Heart Journal. 2013;166(3):389-391. Full Text
  - Hijazi Z, Granger CB, Wallentin L. Reply: Higher N-terminal pro-B-type natriuretic peptide may be related to very different conditions. Journal of the American College of Cardiology. 2013;62(17):1635-1636. PubMed PMID: 23892249. Full Text
  - Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation: A clinical review. European Heart Journal. 2013;34(20):1475-1480. PubMed PMID: 23386711. Full Text
  - Huber K, Goldstein P, Danchin N, Fox KAA, Welsh R, Granger CB, Henry T, Gersh BJ. Enhancing the efficacy of delivering reperfusion therapy: A European and North American experience with ST-segment elevation myocardial infarction networks. American Heart Journal. 2013;165(2):123-132. Full Text
  - Khazanie P, Granger CB. Commentary. Annals of Internal Medicine. 2013;158(4):JC6-.
  - Lopes RD, Becker RC, Newby LK, Peterson ED, Hylek EM, Giugliano R, Granger CB, Mahaffey KW, Carvalho AC, Berwanger O, Giraldez RR, Feitosa-Filho GS, Barbosa MM, Moreira MDCV, Kalil RAK, Freitas M, Guerra JCDC, Barros MVL, Rodrigues TDR, Lopes AC, Garcia DA. Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), october 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil. Journal of Thrombosis and Thrombolysis. 2013;36(1):115-130. Full Text
  - Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America. American Heart Journal. 2013. PubMed PMID: 23708154. Full Text
  - Nicolau JC, Corbalan R, Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD. Cardiovascular clinical research in South America. American Heart Journal. 2013;165(6):848-853. Full Text
  - O'Gara PT, Kushner FG, Ascheim DD, Jr DEC, Chung MK, Lemos JAD, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: Executive summary: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. Journal of the American College of Cardiology. 2013;61(4):485-510. PubMed PMID: 23256913. Full Text
  - O'Gara PT, Kushner FG, Ascheim DD, Jr DEC, Chung MK, Lemos JAD, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction: A report of the American college of cardiology foundation/american heart association task force on practice guidelines. Journal of the American College of Cardiology. 2013;61(4):e78-e140. PubMed PMID: 23256914. Full Text
  - Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW. Aborted myocardial infarction after primary percutaneous coronary intervention: Magnetic resonance imaging insights from the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial. American Heart Journal. 2013;165(2):226-233. Full Text
  - Kaul P, Fu Y, Westerhout CM, Granger CB, Armstrong PW. Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. The American journal of cardiology. 2012 Dec;110(11):1555-1560. PubMed PMID: 22920928. Full Text
  - Wang TY, Honeycutt EF, Tapson VF, Moll S, Granger CB, Ohman EM. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. Am J Med. 2012 Dec;125(12):1214-1221. PubMed PMID: 22939359. Full Text Link to Item
  - Alherbish A, Westerhout CM, Fu Y, Granger CB, Armstrong PW. The Forgotten Lead: Does aVR ST-Deviation Add Insight into STEMI Patients?. CIRCULATION. 2012 Nov 20;126(21). Link to Item
  - Bagai A, Iollis JG, Dauerman HL, Peng SA, Bates ER, French WJ, Granger CB, Roe MT. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the ACTION Registry (R)-GWTG (TM). CIRCULATION. 2012 Nov 20;126(21). Link to Item
  - Cecilia Bahit M, Lopes RD, Hohnloser SH, Wojdyla D, Alexander JH, Lewis BS, Aylward P, Verheugt FW, Keltai M, Diaz R, Mohan P, Granger CB, Wallentin L. Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial. CIRCULATION. 2012 Nov 20;126(21). Link to Item
  - Vavalle JP, van Diepen S, Lopes R, Clare R, Hochman JS, Weaver D, Mehta R, Pieper KS, Patel MR, Armstrong PW, Granger CB. Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial. CIRCULATION. 2012 Nov 20;126(21). Link to Item
  - van Diepen S, Vavalle IP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB. The Systemic Inflammatory Response Syndrome is associated with Worse Outcomes in ST-Elevation Myocardial Infarction Patients: Insights from the CARDINAL Trial. CIRCULATION. 2012 Nov 20;126(21). Link to Item
  - Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJV, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet. 2012 Nov 17;380(9855):1749-1758. PubMed PMID: 23036896. Full Text Link to Item
  - Melloni C, Sprecher DL, Sarov-Blat L, Patel MR, Heitner JF, Hamm CW, Aylward P, Tanguay J-F, DeWinter RJ, Marber MS, Lerman A, Hasselblad V, Granger CB, Newby LK. The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale. Am Heart J. 2012 Nov;164(5):646-653.e3. PubMed PMID: 23137494. Full Text Link to Item
  - Vavalle JP, Lopes RD, Chen AY, Newby LK, Wang TY, Shah BR, Ho PM, Wiviott SD, Peterson ED, Roe MT, Granger CB. Hospital length of stay in patients with non-ST-segment elevation myocardial infarction. Am J Med. 2012 Nov;125(11):1085-1094. PubMed PMID: 22921886. Full Text Link to Item
  - Hess CN, Broderick S, Piccini JP, Alexander KP, Newby LK, Shaw LK, Mahaffey KW, Alexander JH, Peterson ED, Granger CB, Lopes RD. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J. 2012 Oct;164(4):607-615. PubMed PMID: 23067921. Full Text Link to Item
  - Ciervo CA, Granger CB, Schaller FA, Engelke KA. A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillation. The Journal of the American Osteopathic Association. 2012 Sep;112(9 Suppl 2):eS9-e21. PubMed PMID: 23014815.
  - Ciervo CA, Granger CB, Schaller FA. Stroke prevention in patients with atrial fibrillation: disease burden and unmet medical needs. The Journal of the American Osteopathic Association. 2012 Sep;112(9 Suppl 2):eS2-eS8. PubMed PMID: 23014814. (Review)
  - Johnson RW, Zhao Y, Newby LK, Granger CB, Granger BB. Reasons for noncompletion of advance directives in a cardiac intensive care unit. Am J Crit Care. 2012 Sep;21(5):311-320. PubMed PMID: 22941703. Full Text Link to Item
  - Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M, Peterson ED, Alexander KP. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. Am J Med. 2012 Sep;125(9):897-905. PubMed PMID: 22795814. Full Text Link to Item
  - Yancy CW, Granger CB, Nichol G. Systems of health care. 2012 Sep 1:67-74. (Chapter) Full Text
  - van Diepen S, Newby L, Lopes R, Stebbins A, Hasselblad V, James S, Roe M, Ezekowitz J, Moliterno D, Neumann F, Reist C, Hochman J, Mahaffey K, Hamm C, Armstrong P, Granger C, Theroux P. 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy. Canadian Journal of Cardiology. 2012 Sep;28(5):S378-S378. Full Text
  - Muñoz D, Roettig ML, Monk L, Al-Khalidi H, Jollis JG, Granger CB. Transport time and care processes for patients transferred with ST-segment-elevation myocardial infarction: the reperfusion in acute myocardial infarction in Carolina emergency rooms experience. Circ Cardiovasc Interv. 2012 Aug 1;5(4):555-562. PubMed PMID: 22872054. Full Text Link to Item
  - Jollis JG, Al-Khalidi HR, Monk L, Roettig ML, Garvey JL, Aluko AO, Wilson BH, Applegate RJ, Mears G, Corbett CC, Granger CB, Regional Approach to Cardiovascular Emergencies (RACE) Investigators . Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state. Circulation. 2012 Jul 10;126(2):189-195. PubMed PMID: 22665718. Full Text Link to Item
  - Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, Pratt FD, Rokos IC, Acuña AR, Roettig ML, Jacobs AK. Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):423-428. PubMed PMID: 22619274. Full Text Link to Item
  - Lopes RD, Becker RC, Newby LK, Peterson ED, Hylek EM, Granger CB, Crowther M, Wang T, Carvalho AC, Berwanger O, Giraldez RR, Feitosa GS, Ribeiro JP, Darze E, Kalil RAK, Andrande M, Boas FV, Andrade J, Rocha AT, Harrington RA, Lopes AC, Garcia DA. Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil. J Thromb Thrombolysis. 2012 Jul;34(1):143-163. PubMed PMID: 22427055. Full Text Link to Item
  - Martel C, Granger CB, Ghitescu M, Stebbins A, Fortier A, Armstrong PW, Bonnefoy A, Theroux P. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. American heart journal. 2012 Jul;164(1):43-51. PubMed PMID: 22795281. Full Text
  - Truffa AAM, Granger CB, White KR, Newby LK, Mehta RH, Hochman JS, Patel MR, Pieper KS, Al-Khalidi HR, Armstrong PW, Lopes RD. Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes. JACC Cardiovasc Interv. 2012 Jul;5(7):769-776. PubMed PMID: 22814783. Full Text Link to Item
  - van Diepen S, Roe MT, Lopes RD, Stebbins A, James S, Newby LK, Moliterno DJ, Neumann F-J, Ezekowitz JA, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Theroux P, Granger CB. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. J Thromb Thrombolysis. 2012 Jul;34(1):106-113. PubMed PMID: 22307842. Full Text Link to Item
  - van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AWJ, Armstrong PW, Granger CB. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):437-444. PubMed PMID: 22589297. Full Text Link to Item
  - Steinberg BA, Jollis JG, Winkler A, Granger C, Newby LK. Treatment pathways and quality improvement for patients with acute myocardial infarction at a tertiary care center. Crit Pathw Cardiol. 2012 Jun;11(2):77-80. PubMed PMID: 22595818. Full Text Link to Item
  - Wiggins NB, Granger CB, Alexander JH. Novel oral anticoagulants after acute coronary syndromes. Cardiovasc Drugs Ther. 2012 Jun;26(3):265-271. PubMed PMID: 22434545. (Review) Full Text Link to Item
  - Zeymer U, Huber K, Fu Y, Ross A, Granger C, Goldstein P, van de Werf F, Armstrong P. Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study. European Heart Journal: Acute Cardiovascular Care. 2012 Jun;1(2):136-142. Full Text
  - Mehta RH, Kaul P, Lopes RD, Patel MR, Zheng Y, Pieper KS, Welsh RC, Armstrong PW, Granger CB. Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial. Am Heart J. 2012 May;163(5):797-803. PubMed PMID: 22607857. Full Text Link to Item
  - Shah SH, Sun J-L, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, Haynes C, Hauser ER, Kraus WE, Granger CB, Newgard CB, Califf RM, Newby LK. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012 May;163(5):844-850.e1. PubMed PMID: 22607863. Full Text Link to Item
  - Munoz D, Granger CB. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk. ANNALS OF INTERNAL MEDICINE. 2012 Apr 17;156(8). PubMed PMID: 22508747. Full Text Link to Item
  - Glickman SW, Greiner MA, Lin L, Curtis LH, Cairns CB, Granger CB, Peterson ED. Assessment of temporal trends in mortality with implementation of a statewide ST-segment elevation myocardial infarction (STEMI) regionalization program. Ann Emerg Med. 2012 Apr;59(4):243-252.e1. PubMed PMID: 21862177. Full Text Link to Item
  - Shah AA, Craig DM, Sebek JK, Haynes C, Stevens RC, Muehlbauer MJ, Granger CB, Hauser ER, Newby LK, Newgard CB, Kraus WE, Hughes GC, Shah SH. Metabolic profiles predict adverse events after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012 Apr;143(4):873-878. PubMed PMID: 22306227. Full Text Link to Item
  - Glickman SW, Shofer FS, Wu MC, Scholer MJ, Ndubuizu A, Peterson ED, Granger CB, Cairns CB, Glickman LT. Development and validation of a prioritization rule for obtaining an immediate 12-lead electrocardiogram in the emergency department to identify ST-elevation myocardial infarction. Am Heart J. 2012 Mar;163(3):372-382. PubMed PMID: 22424007. Full Text Link to Item
  - Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB, CARDINAL investigators . Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction. Coron Artery Dis. 2012 Mar;23(2):118-125. PubMed PMID: 22217457. Full Text Link to Item
  - van Diepen S, Granger CB. Acute coronary syndromes. Challenging accepted post-MI serum potassium targets. (Published online) Nat Rev Cardiol. 2012 Feb 28;9(5):259-260. PubMed PMID: 22371108. Full Text Link to Item
  - Nolan DK, Sutton B, Haynes C, Johnson J, Sebek J, Dowdy E, Crosslin D, Crossman D, Sketch MH, Granger CB, Seo D, Goldschmidt-Clermont P, Kraus WE, Gregory SG, Hauser ER, Shah SH. Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. (Published online) BMC Genet. 2012 Feb 27;13:12-. PubMed PMID: 22369142. Full Text Link to Item
  - Al-Khatib SM, Alexander JH, Lopes RD, Mahaffey KW, Patel MR, Granger CB. Promise of factor Xa inhibition in atrial fibrillation. Curr Cardiol Rep. 2012 Feb;14(1):70-78. PubMed PMID: 22109539. (Review) Full Text Link to Item
  - Mehta RH, Stebbins AS, Lopes RD, Califf RM, Pieper KS, Armstrong PW, Van de Werf F, Hochman JS, White HD, Topol EJ, Alexander JH, Granger CB. Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. Am J Cardiol. 2012 Feb 1;109(3):320-326. PubMed PMID: 22078221. Full Text Link to Item
  - Hernandez AF, Granger CB. Prediction is very hard, especially about the future: comment on "factors associated with 30-day readmission rates after percutaneous coronary intervention". Arch Intern Med. 2012 Jan 23;172(2):117-119. PubMed PMID: 22123750. Full Text Link to Item
  - Garvey JL, Monk L, Granger CB, Studnek JR, Roettig ML, Corbett CC, Jollis JG. Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina Catheterization Laboratory Activation Registry. Circulation. 2012 Jan 17;125(2):308-313. PubMed PMID: 22147904. Full Text Link to Item
  - Granger CB, Hanna M, Wallentin L. Apixaban versus Warfarin in Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2012 Jan 5;366(1):89-89. Link to Item
  - Kociol RD, Lopes RD, Clare R, Thomas L, Mehta RH, Kaul P, Pieper KS, Hochman JS, Weaver WD, Armstrong PW, Granger CB, Patel MR. International variation in and factors associated with hospital readmission after myocardial infarction. JAMA. 2012 Jan 4;307(1):66-74. PubMed PMID: 22215167. Full Text Link to Item
  - Granger CB, Armaganijan LV. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. Circulation. 2012 Jan 3;125(1):159-164. PubMed PMID: 22215890. (Review) Full Text Link to Item
  - Bagai A, Granger CB. Regionalization of ST-segment elevation myocardial infarction care: A task unfinished. American Heart Journal. 2012;164(5):633-635. PubMed PMID: 23137491. Full Text
  - Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJV, Solomon SD. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: Results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. Journal of the American College of Cardiology. 2012;59(20):1785-1795. PubMed PMID: 22575317. Full Text
  - Davies RW, Wells GA, Stewart AFR, Erdmann J, Shah SH, Ferguson JF, Hall AS, Anand SS, Burnett MS, Epstein SE, Dandona S, Chen L, Nahrstaedt J, Loley C, König IR, Kraus WE, Granger CB, Engert JC, Hengstenberg C, Wichmann H-E, Schreiber S, Tang WHW, Ellis SG, Rader DJ, Hazen SL, Reilly MP, Samani NJ, Schunkert H, Roberts R, McPherson R. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circulation: Cardiovascular Genetics. 2012;5(2):217-225. PubMed PMID: 22319020. Full Text
  - Diener H-C, Eikelboom J, Granger CB, Hacke W. The king is dead (warfarin): Direct thrombin and factor Xa inhibitors: The next Diadochian War?. International Journal of Stroke. 2012;7(2):139-141. PubMed PMID: 22264366. Full Text
  - Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener H-C. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial. The Lancet Neurology. 2012;11(6):503-511. PubMed PMID: 22572202. Full Text
  - Garcia DA, Granger CB. Anticoagulation, novel agents, and procedures: Can we pardon the interruption?. Circulation. 2012;126(3):255-257. PubMed PMID: 22700855. Full Text
  - Granger CB, Hanna M, Wallentin L. The authors reply. New England Journal of Medicine. 2012;366(1):89--.
  - Granger CB. Apixaban reduced stroke and systemic embolism compared with warfarin in atrial fibrillation. Annals of Internal Medicine. 2012;156(2). Full Text
  - Guzman LA, Li S, Wang TY, Daviglus ML, Exaire J, Rodriguez CJ, Torres VI, Funk M, Saucedo J, Granger C, Pia IL, Cohen MG. Differences in treatment patterns and outcomes between hispanics and non-hispanic whites treated for ST-segment elevation myocardial infarction: Results from the NCDR ACTION registry-GWTG. Journal of the American College of Cardiology. 2012;59(6):630-631. PubMed PMID: 22300700. Full Text
  - Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, Keltai M, Lanas F, Lopes RD, Lopez-Sendon J, Granger CB, Wallentin L. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: Insights from the ARISTOTLE trial. European Heart Journal. 2012;33(22):2821-2830. PubMed PMID: 22933567. Full Text
  - Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction. Coronary artery disease. 2012 Jan;23(1):22-30. PubMed PMID: 22113063. Full Text
  - Morrow DA, Fang JC, Fintel DJ, Granger CB, Katz JN, Kushner FG, Kuvin JT, Lopez-Sendon J, McAreavey D, Nallamothu B, 2nd RLP, Parrillo JE, Peterson PN, Winkelman C, Cardiopulmonary AHACO, Clinical CCPARCO, Quality CCOCNACO, Research OCAO. Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association. Circulation. 2012;126(11):1408-1428.
  - Morrow DA, Fang JC, Fintel DJ, Granger CB, Katz JN, Kushner FG, Kuvin JT, Lopez-Sendon J, McAreavey D, Nallamothu B, II RLP, Parrillo JE, Peterson PN, Winkelman C. Evolution of critical care cardiology: Transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: A scientific statement from the American Heart Association. Circulation. 2012. PubMed PMID: 22893607. Full Text
  - Turakhia MP, Estes NAM, Drew BJ, Granger CB, Wang PJ, Knight BP, Page RL. Latency of ECG displays of hospital telemetry systems: A science advisory from the American heart association. Circulation. 2012;126(13):1665-1669. PubMed PMID: 22927339. Full Text
  - Werf FVD, Brueckmann M, Connolly SJ, Friedman J, Granger CB, Härtter S, Harper R, Kappetein AP, Lehr T, Mack MJ, Noack H, Eikelboom JW. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN). American Heart Journal. 2012;163(6):931-937.e1. PubMed PMID: 22709744. Full Text
  - Werf FVD, Connolly SJ, Kappetein AP, Brueckmann M, MacK MJ, Granger CB, Eikelboom J. Letter by Van de Werf et al regarding article, "using dabigatran in patients with stroke: A practical guide for clinicians". Stroke. 2012;43(5):e46-e47. PubMed PMID: 22461333. Full Text
  - Wang TY, Granger CB. ACP Journal Club. Review: Reduced function CYP2C19 genotypes may increase risk for stent clots in patients receiving clopidogrel. Ann Intern Med. 2011 Dec 20;155(12):JC6-J13. PubMed PMID: 22184714. Full Text Link to Item
  - Brunner MP, Shah SH, Craig DM, Stevens RD, Muehlbauer MJ, Bain JR, Newgard CB, Kraus WE, Granger CB, Sketch MH, Newby LK. Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterization. Circ Cardiovasc Genet. 2011 Dec;4(6):695-700. PubMed PMID: 22010138. Full Text Link to Item
  - Bhattacharya S, Craig D, Haynes C, Granger CB, Stevens RD, Hauser ER, Kraus WE, Newgard CB, Newby LK, Shah SH. Peripheral Metabolite Profiles Discriminate Coronary Artery Disease in a Sequential Cohort of Cardiac Catheterization Patients. CIRCULATION. 2011 Nov 22;124(21). Link to Item
  - Cecilia Bahit M, Lopes RD, Clare R, Pieper KS, Newby LK, Van de Werf FF, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, Diaz R, White HD, Hernandez AF, Wallentin L, Califf RM, Granger CB. Heart Failure Occurring at any Time During Hospitalization is Associated with Higher Mortality in Non-ST Elevation-Acute Coronary Syndromes. CIRCULATION. 2011 Nov 22;124(21). Link to Item
  - Guptill JT, Lopes RD, Mehta RH, Horton J, Laskowitz D, Pieper KS, Armstrong PW, Granger CB. Most Strokes Occur More Than 48 Hours Following Primary Percutaneous Coronary Intervention in STEMI: the Stroke Experience in APEX-AMI Trial. CIRCULATION. 2011 Nov 22;124(21). Link to Item
  - Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FWA, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators . Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-992. PubMed PMID: 21870978. Full Text Link to Item
  - Lopes RD, Siha H, Fu Y, Mehta RH, Patel MR, Armstrong PW, Granger CB. Diagnosing acute myocardial infarction in patients with left bundle branch block. Am J Cardiol. 2011 Sep 15;108(6):782-788. PubMed PMID: 21726838. Full Text Link to Item
  - Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, Daniel JG, Ekman I, Ho M, Johnson M, Kimmel SE, Liu LZ, Musaus J, Shrank WH, Whalley Buono E, Weiss K, Granger CB. Medication adherence: a call for action. Am Heart J. 2011 Sep;162(3):412-424. PubMed PMID: 21884856. (Review) Full Text Link to Item
  - Fosbol EL, Granger CB. ACP Journal Club. Meta-analysis: high-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI. Ann Intern Med. 2011 Aug 16;155(4):JC2-JC8. PubMed PMID: 21844541. Full Text Link to Item
  - Vavalle JP, Granger CB. The need for regional integrated care for ST-segment elevation myocardial infarction. Circulation. 2011 Aug 16;124(7):851-856. PubMed PMID: 21844091. Full Text Link to Item
  - Lopes RD, Becker RC, Alexander JH, Armstrong PW, Califf RM, Chan MY, Crowther M, Granger CB, Harrington RA, Hylek EM, James SK, Jolicoeur EM, Mahaffey KW, Newby LK, Peterson ED, Pieper KS, Van de Werf F, Wallentin L, White HD, Carvalho AC, Giraldez RR, Guimaraes HP, Nader HB, Kalil RAK, Bizzachi JMA, Lopes AC, Garcia DA. Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil. J Thromb Thrombolysis. 2011 Aug;32(2):242-266. PubMed PMID: 21547405. Full Text Link to Item
  - Mehta RH, Kaul P, Lopes RD, Patel MR, Pieper KS, Armstrong PW, Granger CB. Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the APEX-AMI trial. EUROPEAN HEART JOURNAL. 2011 Aug;32:872-872. Link to Item
  - Mehta RH, Stebbins A, Lopes RD, Califf RM, Alexander JH, Granger CB. Gender paradox: higher incidence but lower one-year mortality with bleeding among women compared with men following fibrinolysis for acute ST-elevation myocardial infarction. EUROPEAN HEART JOURNAL. 2011 Aug;32:166-166. Link to Item
  - French JK, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". American heart journal. 2011 Jul;162(1):89-97. PubMed PMID: 21742094. Full Text
  - Glickman SW, Lytle BL, Ou F-S, Mears G, O'Brien S, Cairns CB, Garvey JL, Bohle DJ, Peterson ED, Jollis JG, Granger CB. Care processes associated with quicker door-in-door-out times for patients with ST-elevation-myocardial infarction requiring transfer: results from a statewide regionalization program. Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):382-388. PubMed PMID: 21712523. Full Text Link to Item
  - Gersh BJ, Freedman JE, Granger CB. [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments]. Rev Esp Cardiol. 2011 Apr;64(4):260-268. PubMed PMID: 21411211. (Review) Full Text Link to Item
  - Gersh BJ, Freedman JE, Granger CB. Antiplatelet and Anticoagulant Therapy for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation: Evidence Based Strategies and New Developments. REVISTA ESPANOLA DE CARDIOLOGIA. 2011 Apr;64(4):260-268. PubMed PMID: 24775187. Full Text Link to Item
  - Gersh BJ, Freedman JE, Granger CB. Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: Evidence based strategies and new developments. Revista Espanola de Cardiologia. 2011 Apr 1;64(4):260-268. Full Text
  - Mehta RH, Starr AZ, Lopes RD, Piccini JP, Patel MR, Pieper KS, Armstrong PW, Granger CB. Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk. Am Heart J. 2011 Apr;161(4):782-789. PubMed PMID: 21473979. Full Text Link to Item
  - Teo KK, Sleight P, Gao P, Yusuf S, Connolly S, Yusuf S, Swedberg K, Pfeffer MA, Granger CB, McMurray JJV, Sjoelie AK, Massie BM, Carson P, Lewis JB, Wachtell K, Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Ibsen H, Lindholm LH, Olsen MH, Okin PM, Califf R, Holman RR, Haffner SM, Dagenais G, Probstfield J, Anderson C, Diaz R, Dans A, Levine M, Unger T, Fagard R, Diener H-C, Sacco RL, Zanchetti A, Cohn JN, Weber M, Collaboration ARBT. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration. JOURNAL OF HYPERTENSION. 2011 Apr;29(4):623-635. Full Text Link to Item
  - Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Circulation. Cardiovascular quality and outcomes. 2011 Mar;4(2):183-192. PubMed PMID: 21304097. Full Text
  - Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW, APEX-AMI Investigators . Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Contemporary clinical trials. 2011 Mar;32(2):178-187. PubMed PMID: 21220052. Full Text
  - Mehta RH, O'Shea JC, Stebbins AL, Granger CB, Armstrong PW, White HD, Topol EJ, Califf RM, Ohman EM. Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis. J Am Coll Cardiol. 2011 Jan 11;57(2):138-146. PubMed PMID: 21211684. Full Text Link to Item
  - Ariti CA, Cleland JGF, Pocock SJ, Pfeffer MA, Swedberg K, Granger CB, McMurray JJV, Michelson EL, Östergren J, Yusuf S. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal. 2011;162(5):900-906. PubMed PMID: 22093207. Full Text
  - Boer SPMD, Barnes EH, Westerhout CM, Simes RJ, Granger CB, Kastrati A, Widimsky P, Boer MJD, Zijlstra F, Boersma E. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration. American Heart Journal. 2011;161(3):500-507.e1. PubMed PMID: 21392604. Full Text
  - Chan MY, Shah BR, Gao F, Sim LL, Chua T, Tan HC, Yeo TC, Ong HY, Foo D, Goh PP, Surrun SK, Pieper KS, Granger CB, Koh TH, Salim A, Tai ES. Recalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian population. American Heart Journal. 2011;162(2):291-299. PubMed PMID: 21835290. Full Text
  - Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen S-A, Ching CK, Commerford P, Dans A, Davy J-M, Delacrétaz E, Pasquale GD, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim K-H, Stiles MK, Tanomsup S, Toivonen L et al. Dronedarone in high-risk permanent atrial fibrillation. New England Journal of Medicine. 2011;365(24):2268-2276. PubMed PMID: 22082198. Full Text
  - Gharacholou SM, Lopes RD, Alexander KP, Mehta RH, Stebbins AL, Pieper KS, James SK, Armstrong PW, Granger CB. Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: Findings from the APEX-AMI trial. Archives of Internal Medicine. 2011;171(6):559-567. PubMed PMID: 21444846. Full Text
  - Granger CB. Who should have a routine early invasive approach after fibrinolytic therapy?. European Heart Journal. 2011;32(16):1961-1963. PubMed PMID: 21447512. Full Text
  - Holmes DR, Becker JA, Granger CB, Limacher MC, Page RL, Sila C. ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: A report of the american college of cardiology foundation clinical quality committee. Circulation. 2011;124(11):1290-1310. PubMed PMID: 21844072. Full Text
  - Jr DRH, Becker JA, Granger CB, Limacher MC, II RLP, Sila C, Jr JPD, Cacchione JG, Jr BDE, Harrington RA, Kennett JD, Krumholz HM, Masoudi FA, Peterson ED, Poppas A, Sahn DJ, Sanz ML, Shahian DM, Windle JR, Wyman JF. ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: A report of the american college of cardiology foundation clinical quality committee. Journal of the American College of Cardiology. 2011;58(12):1287-1307. PubMed PMID: 21849242. Full Text
  - Mayer SA, Kurtz P, Wyman A, Sung GY, Multz AS, Varon J, Granger CB, Kleinschmidt K, Lapointe M, Peacock WF, Katz JN, Gore JM, Oneil B, Anderson FA. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension registry. Critical Care Medicine. 2011;39(10):2330-2336. PubMed PMID: 21666448. Full Text
  - Mehta RH, Stebbins A, Lopes RD, Rao SV, Bates ER, Pieper KS, Armstrong PW, Van de Werf F, White HD, Califf RM, Alexander JH, Granger CB. Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy. Am J Med. 2011 Jan;124(1):48-57. PubMed PMID: 21187185. Full Text Link to Item
  - Muñoz D, Granger CB. ST-segment-elevation myocardial infarction treatment and the seductive lure of observational analyses. Circulation. 2011;124(23):2477-2479. PubMed PMID: 22144629. Full Text
  - Oldgren J, Budaj A, Granger CB, Khder Y, Roberts J, Siegbahn A, Tijssen JGP, Werf FVD, Wallentin L. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: A randomized, double-blind, phase II trial. European Heart Journal. 2011;32(22):2781-2789. PubMed PMID: 21551462. Full Text
  - Peacock F, Amin A, Granger CB, Pollack CV, Levy P, Nowak R, Kleinschmidt K, Varon J, Wyman A, Gore JM. Hypertensive heart failure: Patient characteristics, treatment, and outcomes. American Journal of Emergency Medicine. 2011;29(8):855-862. PubMed PMID: 20825913. Full Text
  - Piccini JP, Schulte PJ, Pieper KS, Mehta RH, White HD, Van de Werf F, Ardissino D, Califf RM, Granger CB, Ohman EM, Alexander JH. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. Crit Care Med. 2011 Jan;39(1):78-83. PubMed PMID: 20959785. Full Text Link to Item
  - Ranasinghe I, Alprandi-Costa B, Chow V, Elliott JM, Waites J, Counsell JT, Lopéz-Sendón J, Avezum Á, Goodman SG, Granger CB, Brieger D. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. American Journal of Cardiology. 2011;108(5):617-624. PubMed PMID: 21714948. Full Text
  - Steg PG, Mehta SR, Jukema JW, Lip GYH, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB. RUBY-1: A randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. European Heart Journal. 2011;32(20):2541-2554. PubMed PMID: 21878434. Full Text
  - Szczech LA, Granger CB, Katz JN, Dasta JF, Amin A, Peacock WF, McCullough PA, Devlin JW, Weir MR, Wyman A, Anderson FA, Varon J. Response to letter regarding article, acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation. 2011;123(9):e268-. Full Text
  - Vuylsteke A, Vincent J-L, de La Garanderie DP, Anderson FA, Emery L, Wyman A, Rushton-Smith S, Gore JM, Euro-STAT Investigators . Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). Critical care (London, England). 2011 Jan;15(6):R271-. PubMed PMID: 22087790. Full Text
  - Wang TY, Granger CB. Review: Reduced function CYP2C19 genotypes may increase risk for stent clots in patients receiving clopidogrel. Annals of Internal Medicine. 2011;155(12):JC6-J13.
  - Weed J, Finkel K, Beach ML, Granger CB, Gallagher JD, Sites BD. Spinal anesthesia for orthopedic surgery: a detailed video assessment of quality. Regional anesthesia and pain medicine. 2011 Jan;36(1):51-55. PubMed PMID: 21455090. Full Text
  - Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M, Peterson ED, Alexander KP. Discharge Warfarin is Underused in High Risk Atrial Fibrillation Patients With Myocardial Infarction. CIRCULATION. 2010 Nov 23;122(21). Link to Item
  - Patel MR, Westerhout CM, Granger CB, Fu Y, Kim RJ, Armstrong PW. Aborted Myocardial Infarction after Primary PCI: Insights from Magnetic Resonance Imaging in the APEX-AMI Trial. CIRCULATION. 2010 Nov 23;122(21).
  - Stewart AF, Dandona S, Fan M, Almontashiri N, Chen L, Davies RW, Wells GA, Tang W, Hazen SL, Ellix S, Reilley MP, Epstein S, Rader DJ, Engert JC, Anand S, Kathiresan S, Cupples AL, O'Donnell CJ, Shah S, Kraus WE, Granger CB, McPherson R, Roberts R. Identification of a Rare Variant Near Neurexin 1 Associated with Coronary Artery Disease. CIRCULATION. 2010 Nov 23;122(21). Link to Item
  - Stebbins A, Mehta RH, Armstrong PW, Lee KL, Hamm C, Van de Werf F, James S, Toftegaard-Nielsen T, Seabra-Gomes R, White HD, Granger CB, Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators) . A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. Circ Cardiovasc Interv. 2010 Oct;3(5):414-422. PubMed PMID: 20858863. Full Text Link to Item
  - Toma M, Fu Y, Ezekowitz JA, McAlister FA, Westerhout CM, Granger CB, Armstrong PW. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. American heart journal. 2010 Oct;160(4):671-677. PubMed PMID: 20934561. Full Text
  - Granger CB, Laskowitz DT. Biomarkers in stroke: when will they impact care?. J Am Coll Cardiol. 2010 Sep 21;56(13):1054-1055. PubMed PMID: 20846605. Full Text Link to Item
  - Glickman SW, Granger CB, Ou F-S, O'Brien S, Lytle BL, Cairns CB, Mears G, Hoekstra JW, Garvey JL, Peterson ED, Jollis JG. Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly. Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):514-521. PubMed PMID: 20807883. Full Text Link to Item
  - Shah SH, Granger CB, Hauser ER, Kraus WE, Sun J-L, Pieper K, Nelson CL, Delong ER, Califf RM, Newby LK, MURDOCK Horizon 1 Cardiovascular Disease Investigators . Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study. Am Heart J. 2010 Sep;160(3):371-379.e2. PubMed PMID: 20826242. Full Text Link to Item
  - Huber K, Holmes DR, van 't Hof AW, Montalescot G, Aylward PE, Betriu GA, Widimsky P, Westerhout CM, Granger CB, Armstrong PW. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. European heart journal. 2010 Jul;31(14):1708-1716. PubMed PMID: 20501476. Full Text
  - Johnson RW, Newby LK, Granger CB, Cook WA, Peterson ED, Echols M, Bride W, Granger BB. Differences in level of care at the end of life according to race. Am J Crit Care. 2010 Jul;19(4):335-343. PubMed PMID: 20595215. Full Text Link to Item
  - Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes DR, Hamm CW, Granger CB, Armstrong PW, APEX-AMI Investigators . Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. European heart journal. 2010 Jul;31(14):1701-1707. PubMed PMID: 20530505. Full Text
  - van Diepen S, Siha H, Fu Y, Westerhout CM, Lopes RD, Granger CB, Armstrong PW, APEX AMI Investigators . Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. J Electrocardiol. 2010 Jul;43(4):351-358. PubMed PMID: 20444469. Full Text Link to Item
  - Eisenstein EL, Honeycutt EF, Anstrom KJ, Becker RC, Granger CB, Rao SV, Jolicoeur ME, Ohman EM, CATCH Investigators . Economic assessment of thrombocytopenia: CATCH Registry. J Med Syst. 2010 Jun;34(3):379-386. PubMed PMID: 20503623. Link to Item
  - Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJV, Califf RM, Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart. 2010 Jun;96(11):838-842. PubMed PMID: 20406769. Full Text Link to Item
  - Simes RJ, O'Connell RL, Aylward PE, Varshavsky S, Diaz R, Wilcox RG, Armstrong PW, Granger CB, French JK, Van de Werf F, Marschner IC, Califf R, White HD, HERO-2 Investigators . Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. American heart journal. 2010 Jun;159(6):988-997. PubMed PMID: 20569711. Full Text
  - Szczech LA, Granger CB, Dasta JF, Amin A, Peacock WF, McCullough PA, Devlin JW, Weir MR, Katz JN, Anderson FA, Wyman A, Varon J, Studying the Treatment of Acute Hypertension Investigators . Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation. 2010 May 25;121(20):2183-2191. PubMed PMID: 20458014. Full Text Link to Item
  - Alhadramy O, Westerhout CM, Brener SJ, Granger CB, Armstrong PW, APEX AMI Investigators . Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. American heart journal. 2010 May;159(5):899-904. PubMed PMID: 20435202. Full Text
  - Lopes RD, Garcia D, Becker RC, Granger CB, Newby LK, Alexander JH, Jolicoeur EM, Handler A, Pieper KS, Carvalho AC, Guimaraes HP, Chamone DAF, Baruzzi AC, Machado FS, Timerman A, Lopes AC. Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil. J Thromb Thrombolysis. 2010 May;29(4):395-408. PubMed PMID: 20157840. Full Text Link to Item
  - Trendelenburg M, Theroux P, Stebbins A, Granger C, Armstrong P, Pfisterer M. Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. European heart journal. 2010 May;31(10):1181-1187. PubMed PMID: 20089518. Full Text
  - Granger CB, Patel CB. Review: statins do not reduce mortality in patients with heart failure. Ann Intern Med. 2010 Apr 20;152(8):JC4-JC6. PubMed PMID: 20404375. Full Text Link to Item
  - Califf RM, Armstrong PW, Granger CB, Harrington RA, Lee K, Simes RJ, Van de Werf F, Wallentin L, White HD, Virtual Coordinating Centre for Global Collaborative Cardiovascular Research Organization . Towards a new order in cardiovascular medicine: re-engineering through global collaboration. Eur Heart J. 2010 Apr;31(8):911-917. PubMed PMID: 20130014. Full Text Link to Item
  - Granger CB, Gersh BJ. Clinical trials and registries in cardiovascular disease: competitive or complementary?. Eur Heart J. 2010 Mar;31(5):520-521. PubMed PMID: 20093257. Full Text Link to Item
  - Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJV, Verheugt FWA, Wallentin L, ARISTOTLE Investigators . Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J. 2010 Mar;159(3):331-339. PubMed PMID: 20211292. Full Text Link to Item
  - Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR, O'Neill WW, Hamm CW, Van de Werf F, Armstrong PW, APEX AMI Investigators . Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. JACC. Cardiovascular interventions. 2010 Mar;3(3):343-351. PubMed PMID: 20298996. Full Text
  - Granger CB. No difference in peak troponin level in immediate versus delayed (next working day) intervention for acute coronary syndrome without ST-segment elevation. Evid Based Med. 2010 Feb;15(1):26-27. PubMed PMID: 20176883. Full Text Link to Item
  - Katz JN, Shah BR, Volz EM, Horton JR, Shaw LK, Newby LK, Granger CB, Mark DB, Califf RM, Becker RC. Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. Crit Care Med. 2010 Feb;38(2):375-381. PubMed PMID: 20029344. Full Text Link to Item
  - Lopes RD, Starr A, Pieper CF, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Mahaffey KW, Armstrong PW, Harrington RA, White HD, Wallentin L, Granger CB. Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes. Am J Med. 2010 Feb;123(2):134-140. PubMed PMID: 20103022. Full Text Link to Item
  - Assimes TL, Hlm H, Kathiresan S, Reilly MP, Thorleifsson G, Voight BF, Erdmann J, Willenborg C, Vaidya D, Xie C, Patterson CC, Morgan TM, Burnett MS, Li M, Hlatky MA, Knowles JW, Thompson JR, Absher D, Iribarren C, Go A, Fortmann SP, Sidney S, Risch N, Tang H, Myers RM, Berger K, Stoll M, Shah SH, Thorgeirsson G, Andersen K, Havulinna AS, Herrera JE, Faraday N, Kim Y, Kral BG, Mathias RA, Ruczinski I, Suktitipat B, Wilson AF, Yanek LR, Becker LC et al. Lack of Association between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies. Journal of the American College of Cardiology. 2010;56(19):1552-1563. PubMed PMID: 20933357. Full Text
  - Bassand J-P, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, Fox KAA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. 2010;31(1):50-58. PubMed PMID: 19825809. Full Text
  - Boer SPMD, Westerhout CM, Simes RJ, Granger CB, Zijlstra F, Boersma E. Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age. JACC: Cardiovascular Interventions. 2010;3(3):324-331. PubMed PMID: 20298993. Full Text
  - Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJV, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: A cohort study from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 2010;12(7):738-745. PubMed PMID: 20418272. Full Text
  - Devlin JW, Dasta JF, Kleinschmidt K, Roberts RJ, Lapointe M, Varon J, Anderson FA, Wyman A, Granger CB. Patterns of antihypertensive treatment in patients with acute severe hypertension from a nonneurologic cause: Studying the Treatment of Acute Hypertension (STAT) Registry. Pharmacotherapy. 2010;30(11):1087-1096. PubMed PMID: 20973682. Full Text
  - Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An assessment of pexelizumab in acute myocardial infarction (APEX-AMI) substudy. American Heart Journal. 2010;160(2):272-278. PubMed PMID: 20691832. Full Text
  - Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, Anand IS, Hart R, Connolly SJ. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circulation: Cardiovascular Quality and Outcomes. 2010;3(3):277-283. PubMed PMID: 20233976. Full Text
  - Fox KAA, Carruthers K, Steg PG, Avezum Á, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? the global registry of acute coronary events. European Heart Journal. 2010;31(6):667-675. PubMed PMID: 20007159. Full Text
  - French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Holmes DR, Hochman JS, Granger CB, Mahaffey KW. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). The American journal of cardiology. 2010 Jan;105(1):59-63. PubMed PMID: 20102891. Full Text
  - Gore JM, Peterson E, Amin A, Jr FAA, Dasta JF, Levy PD, O'Neil BJ, Sung GY, Varon J, Wyman A, Granger CB. Predictors of 90-day readmission among patients with acute severe hypertension. the cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study. American Heart Journal. 2010;160(3):521-527.e1. PubMed PMID: 20826262. Full Text
  - Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, Heijer MD, Vries J-PPMD, Kranendonk SE, Zeebregts CJAM, Sterkenburg SMV, Geelkerken RH, Rij AMV, Williams MJA, Boll APM, Kostic JP, Jonasdottir A, Jonasdottir A, Walters GB, Masson G, Sulem P, Saemundsdottir J, Mouy M, Magnusson KP, Tromp G, Elmore JR, Sakalihasan N, Limet R, Defraigne J-O, Ferrell RE, Ronkainen A, Ruigrok YM, Wijmenga C, Grobbee DE, Shah SH, Granger CB, Quyyumi AA, Vaccarino V, Patel RS et al. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nature Genetics. 2010;42(8):692-697. PubMed PMID: 20622881. Full Text
  - Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Östergren J, Michelson EL, Pocock SJ, Maggioni AP, McMurray JJV. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. European Journal of Heart Failure. 2010;12(6):557-565. PubMed PMID: 20356870. Full Text
  - Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, Sinnaeve PR, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ, ASSENT IV-PCI investigators . Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. American heart journal. 2010 Jan;159(1):131-140. PubMed PMID: 20102879. Full Text
  - Lopes RD, Granger CB. Interpreting the TRITON results in light of the event adjudication process. Cardiology. 2010;115(2):89-90. PubMed PMID: 19907170. Full Text Link to Item
  - López-Sendón J, Gurfinkel EP, Sa ELD, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB. Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. European Heart Journal. 2010;31(12):1449-1456. PubMed PMID: 20231153. Full Text
  - Mehta SR, Bassand J-P, Chrolavicius S, Diaz R, Eikelboom JW, Fox KAA, Granger CB, Jolly S, Joyner CD, Rupprecht H-J, Widimsky P, Afzal R, Pogue J, Yusuf S. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. New England Journal of Medicine. 2010;363(10):930-942. PubMed PMID: 20818903. Full Text
  - Mehta SR, Tanguay J-F, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht H-J, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand J-P, Montalescot G, MacAya C, Pasquale GD, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial. The Lancet. 2010;376(9748):1233-1243. PubMed PMID: 20817281. Full Text
  - Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. PubMed PMID: 20129531. Full Text Link to Item
  - Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Velleti US, Barsness GW, Werf FVD, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Erratum: Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial (J Am Coll Cardiol Img (2010) 3 (52-60)). JACC: Cardiovascular Imaging. 2010;3(7):796--. Full Text
  - Spencer FA, Montalescot G, Fox KAA, Goodman SG, Granger CB, Goldberg RJ, Oliveira GBF, Anderson FA, Eagle KA, Fitzgerald G, Gore JM. Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: An international perspective. European Heart Journal. 2010;31(11):1328-1336. PubMed PMID: 20231154. Full Text
  - Steg PG, Mehta S, Jolly S, Xavier D, Rupprecht H-J, Lopez-Sendon JL, Chrolavicius S, Rao SV, Granger CB, Pogue J, Laing S, Yusuf S. Fondaparinux with unfractionated heparin during revascularization in acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux. American Heart Journal. 2010;160(6):1029-1034.e1. PubMed PMID: 21146654. Full Text
  - Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. American Journal of Cardiology. 2010;106(5):630-634. PubMed PMID: 20723636. Full Text
  - Tjandrawidjaja MC, Fu Y, Westerhout CM, White HD, Todaro TG, Werf FVD, Mahaffey KW, Wagner GS, Granger CB, Armstrong PW. Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction. European Heart Journal. 2010;31(5):573-581. PubMed PMID: 19952006. Full Text
  - Berger JS, Roe MT, Gibson CM, Kilaru R, Green CL, Melton L, Blankenship JD, Metzger DC, Granger CB, Gretler DD, Grines CL, Huber K, Zeymer U, Buszman P, Harrington RA, Armstrong PW. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial. Am Heart J. 2009 Dec;158(6):998-1004.e1. PubMed PMID: 19958867. Full Text Link to Item
  - Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJV, Yusuf S, Pfeffer MA, Swedberg K. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009 Nov;11(11):1092-1098. PubMed PMID: 19875409. Full Text Link to Item
  - Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB, APEX-AMI Investigators . Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2009 Nov;30(21):2575-2583. PubMed PMID: 19596659. Full Text Link to Item
  - Lopes RD, Ohman EM, Granger CB, Honeycutt EF, Anstrom KJ, Berger PB, Crespo EM, Oliveira GBF, Moll S, Moliterno DJ, Abrams CS, Becker RC. Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). Am J Cardiol. 2009 Nov 1;104(9):1285-1291. PubMed PMID: 19840578. Full Text Link to Item
  - Granger CB. Concomitant use of proton pump inhibitors with clopidogrel may increase risk of readmission after discharge for acute MI. Evid Based Med. 2009 Oct;14(5):154-. PubMed PMID: 19794029. Full Text Link to Item
  - Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, Kleinschmidt K, Mayer SA, Multz AS, Peacock WF, Peterson E, Pollack C, Sung GY, Shorr A, Varon J, Wyman A, Emery LA, Granger CB, STAT Investigators . Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009 Oct;158(4):599-606.e1. PubMed PMID: 19781420. Full Text Link to Item
  - Ross AM, Huber K, Zeymer U, Armstrong PW, Granger CB, Goldstein P, Bogaerts K, Van de Werf F. The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention. JACC. Cardiovascular interventions. 2009 Oct;2(10):925-930. PubMed PMID: 19850250. Full Text
  - Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout S-D, Kraus WE, Sketch M, Nelson C, Ginsburg GS, Goldschmidt-Clermont PJ, Granger CB. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. (Published online) PLoS One. 2009 Sep 14;4(9):e7037-. PubMed PMID: 19750006. Full Text Link to Item
  - Mehta RH, Armstrong PW, Granger CB. In reply. JAMA - Journal of the American Medical Association. 2009 Sep 2;302(9):944-945. (Letter) Full Text
  - Mehta RH, Armstrong PW, Granger CB. Prognostic Importance of Ventricular Arrhythmia in Patients Treated With Percutaneous Coronary Intervention Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2009 Sep 2;302(9):944-945. Link to Item
  - Jackson CE, Solomon SD, Gerstein HC, Andersson S, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, Mcmurray JJV, Investigators CHARM. Prevalence & prognostic importance of micro-& macro-albuminuria in heart failure- an analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. EUROPEAN HEART JOURNAL. 2009 Sep;30:876-876. Link to Item
  - Sinnaeve PR, Ezekowitz JA, Bogaerts K, Droogne W, Jarai R, Huber K, Granger CB, Desmet WJ, Armstrong PW, Van de Werf FJ, ASSENT-4 PCI Investigators . Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis. European heart journal. 2009 Sep;30(18):2213-2219. PubMed PMID: 19586960. Full Text
  - Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Topol EJ, Hochman JS, Newby LK, Harrington RA, Califf RM, Becker RC, Douglas PS. Sex differences in mortality following acute coronary syndromes. JAMA. 2009 Aug 26;302(8):874-882. PubMed PMID: 19706861. Full Text Link to Item
  - Granger CB. ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI. Ann Intern Med. 2009 Aug 18;151(4):JC2-J13. PubMed PMID: 19687487. Full Text Link to Item
  - Granger CB. Concomitant use of proton-pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI Commentary. ANNALS OF INTERNAL MEDICINE. 2009 Aug 18;151(4). Link to Item
  - Bainey KR, Fu Y, Granger CB, Hamm CW, Holmes DR, O'Neill WW, Seabra-Gomes R, Pfisterer ME, Van de Werf F, Armstrong PW, APEX AMI Investigators . Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?. Heart. 2009 Aug;95(16):1331-1336. PubMed PMID: 19447835. Full Text
  - Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009 Aug;30(16):2019-2028. PubMed PMID: 19502623. Full Text Link to Item
  - Jolicoeur EM, Ohman EM, Honeycutt E, Becker RC, Crespo EM, Oliveira GBF, Moliterno DJ, Anstrom KJ, Granger CB. Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin. Am J Cardiol. 2009 Jul 15;104(2):292-297. PubMed PMID: 19576363. Full Text Link to Item
  - Lopes RD, Becker RC, Garcia D, Hylek EM, Granger CB, Lourenço DM, Nader HB, Maffei FHA, Cesena FHY, Nicolau JC, Timmerman A, Rocha AT, de Paiva EF, Guimaraes HP, Carvalho AC, D'Amico EA, Moreira-Filho CA, Aldrighi JM, Lopes AC. Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil. J Thromb Thrombolysis. 2009 Jul;28(1):106-116. PubMed PMID: 19322521. (Review) Full Text Link to Item
  - Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, Steg G, Eagle KA, Anderson FA, Budaj A, Fox KAA, Global Registry of Acute Coronary Events (GRACE) Investigators . Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J. 2009 Jun;157(6):1097-1105. PubMed PMID: 19464422. Full Text Link to Item
  - Mehta SR, Granger CB, Boden WE, Steg PG, Bassand J-P, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht H-J, Zhu J, Col J, Natarajan MK, Horsman C, Fox KAA, Yusuf S, TIMACS Investigators . Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009 May 21;360(21):2165-2175. PubMed PMID: 19458363. Full Text Link to Item
  - Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KS, Armstrong PW, Granger CB, APEX AMI Investigators . Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009 May 6;301(17):1779-1789. PubMed PMID: 19417195. Full Text Link to Item
  - Hernandez AF, Granger CB. Advancing care for acute heart failure--no time to relax. Lancet. 2009 Apr 25;373(9673):1401-1402. PubMed PMID: 19329180. Full Text Link to Item
  - Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, Todaro TG, Adams PX, Aylward PEG, Granger CB. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Journal of the American College of Cardiology. 2009 Apr;53(17):1503-1509. PubMed PMID: 19389560. Full Text
  - Crespo EM, Oliveira GBF, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM, CATCH Registry Investigators . Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009 Apr;157(4):651-657. PubMed PMID: 19332191. Full Text Link to Item
  - Granger CB. Accelerating ST-segment elevation myocardial infarction care: emergency medical services take center stage. JACC Cardiovasc Interv. 2009 Apr;2(4):347-349. PubMed PMID: 19463448. Full Text Link to Item
  - Gore JM, Katz J, Kleinschmidt K, Wyman A, Peacock F, Anderson FA, Granger CB, Investigators STAT. Readmission in Patients With Acute Severe Hypertension Is Common and Predictable: The Studying the Treatment of Acute hyperTension Registry. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009 Mar 10;53(10):A214-A214. Link to Item
  - Lopes RD, Siha H, Fu Y, Armstrong PW, Granger CB. Left Bundle Branch Block Without Concordant ST-Elevation In Suspected ST-Elevation Myocardial Infarction Identifies Patients With High False Positive Rates: Insights From the APEX-AMI Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009 Mar 10;53(10):A323-A323. Link to Item
  - Lopes RD, Starr A, Al-Khatib SM, Newby LK, Mehta RH, de Werf FV, Mahaffey KW, Armstrong PW, Harrington RA, White HD, Wallentin L, Granger CB. Warfarin Is Independently Associated With Lower Risk of Six-Month Death or Myocardial Infarction in Patients With Atrial Fibrillation Following Acute Coronary Syndromes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2009 Mar 10;53(10):A354-A354. Link to Item
  - Crosslin DR, Shah SH, Nelson SC, Haynes CS, Connelly JJ, Gadson S, Goldschmidt-Clermont PJ, Vance JM, Rose J, Granger CB, Seo D, Gregory SG, Kraus WE, Hauser ER. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet. 2009 Mar;125(2):217-229. PubMed PMID: 19130089. Full Text Link to Item
  - Allen LA, Felker GM, Pocock S, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators . Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009 Feb;11(2):170-177. PubMed PMID: 19168515. Full Text Link to Item
  - Granger CB. Review: an early invasive strategy has similar benefits in men and women with NSTEMI or unstable angina. Evid Based Med. 2009 Feb;14(1):19-. PubMed PMID: 19181951. Full Text Link to Item
  - Abrahamsson P, Dobson J, Granger CB, McMurray JJV, Michelson EL, Pfeffer M, Pocock S, Solomon SD, Yusuf S, Swedberg K. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. European Heart Journal. 2009;30(3):338-345. PubMed PMID: 19001475. Full Text
  - Allen LA, Granger CB. Risk assessment in the genomic era: Are we missing the low-hanging fruit?. American Heart Journal. 2009;157(5):799-801. PubMed PMID: 19376302. Full Text
  - Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. American Heart Journal. 2009;158(5):755-760. PubMed PMID: 19853693. Full Text
  - Brieger D, Fitzgerald G, Fox KAA, Eagle KA, Budaj A, Avezum Á, Costa B, Granger CB, Anderson FA, Steg PG. The authors' reply. Heart. 2009;95(16):1355-1356. Full Text
  - Brieger D, Fox KAA, FitzGerald G, Eagle KA, Budaj A, Avezum Á, Granger CB, Costa B, Jr FAA, Steg PG. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Heart. 2009;95(11):888-894. PubMed PMID: 19246481. Full Text
  - Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand J-P, Fox KAA, Wallentin L, Peters RJG, Granger CB, Joyner CD, Yusuf S. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. European Heart Journal. 2009;30(6):655-661. PubMed PMID: 18713759. Full Text
  - Gore JM, Spencer FA, Gurfinkel EP, López-Sendón J, Steg PG, Granger CB, FitzGerald G, Agnelli G. Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]). American Journal of Cardiology. 2009;103(2):175-180. PubMed PMID: 19121432. Full Text
  - Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H, Williams C, Hui J, Beilby J, Warrington NM, James A, Palmer LJ, Koppelman GH, Heinzmann A, Krueger M, Boezen HM, Wheatley A, Altmuller J, Shin HD, Uh S-T, Cheong HS, Jonsdottir B, Gislason D, Park C-S, Rasmussen LM, Porsbjerg C, Hansen JW, Backer V, Werge T, Janson C, Jönsson U-B, Ng MCY, Chan J, So WY, Ma R et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nature Genetics. 2009;41(3):342-347. PubMed PMID: 19198610. Full Text
  - Hoekstra J, Cohen M, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Saucedo JF, Jr CVP. Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion. The American journal of emergency medicine. 2009;27(6):720-728. PubMed PMID: 19757551.
  - Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJV. Albuminuria in chronic heart failure: prevalence and prognostic importance. The Lancet. 2009;374(9689):543-550. PubMed PMID: 19683640. Full Text
  - Johanson P, Fu Y, Wagner GS, Goodman SG, Granger CB, Wallentin L, Werf FVD, Armstrong PW. ST Resolution 1 Hour After Fibrinolysis for Prediction of Myocardial Infarct Size: Insights from ASSENT 3. American Journal of Cardiology. 2009;103(2):154-158. PubMed PMID: 19121428. Full Text
  - Jolly SS, Faxon DP, Fox KAA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner CD, Chrolavicius S, Yusuf S, Mehta SR. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines. Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial. Journal of the American College of Cardiology. 2009;54(5):468-476. PubMed PMID: 19628124. Full Text
  - Joyner CD, Peters RJG, Afzal R, Chrolavicius S, Mehta SR, Fox KAA, Granger CB, Franzosi MG, Flather M, Budaj A, Bassand J-P, Yusuf S. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk. American Heart Journal. 2009;157(3):502-508. PubMed PMID: 19249421. Full Text
  - Lopes RD, Granger CB. β-blockers in myocardial infarction: An overview. Acute Coronary Syndromes. 2009;9(4):141-147.
  - Lopes RD, Granger CB. Highlights from the American Heart Association (AHA) Scientific Sessions 2008. Acute Coronary Syndromes. 2009;9(3):121-124.
  - McMurray JJV, Granger CB, Östergren J, Yusuf S, Pfeffer MA, Swedberg K. Dual Renin-Angiotensin System Blockade in Heart Failure. Journal of the American College of Cardiology. 2009;54(3):278--. PubMed PMID: 19589444. Full Text
  - Mehta SR, Yusuf S, Granger C. The authors reply. New England Journal of Medicine. 2009;361(9):926-927.
  - Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB, APEX-AMI Investigators . Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). The American journal of cardiology. 2009 Jan;103(2):181-186. PubMed PMID: 19121433. Full Text
  - Preiss D, Zetterstrand S, McMurray JJV, Östergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009;32(5):915-920. PubMed PMID: 19196892. Full Text
  - Ruisi CP, Goldberg RJ, Kennelly BM, Goodman SG, Lopez-Sendon J, Granger CB, Avezum A, Eagle KA, FitzGerald G, Gore JM. Pulmonary artery catheterization in patients with acute coronary syndromes. American Heart Journal. 2009;158(2):170-176. PubMed PMID: 19619691. Full Text
  - Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, Nelson S, Wang L, Connelly JJ, Muehlbauer M, Ginsburg GS, Crossman DC, Jones CJH, Vance J, Sketch MH, Granger CB, Newgard CB, Gregory SG, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet. 2009 Jan;5(1):e1000318-. PubMed PMID: 19119412. Full Text Open Access Copy Link to Item
  - Shah SH, Hauser ER, Bain JR, Muehlbauer MJ, Haynes C, Stevens RD, Wenner BR, Dowdy ZE, Granger CB, Ginsburg GS, Newgard CB, Kraus WE. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol. 2009;5:258-. PubMed PMID: 19357637. Full Text Link to Item
  - Sinnaeve PR, Gabriel PS, Fox KAA, Werf FVD, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: The global registry of acute coronary events. Archives of Internal Medicine. 2009;169(4):402-409. PubMed PMID: 19237725. Full Text
  - Lopes RD, Piccini JP, Hylek EM, Granger CB, Alexander JH. Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician. J Thromb Thrombolysis. 2008 Dec;26(3):167-174. PubMed PMID: 18807225. (Review) Full Text Link to Item
  - Granger CB. Review: an early invasive strategy has similar benefits in men and women with NSTEMI or unstable angina. ACP J Club. 2008 Nov 18;149(5):7-. PubMed PMID: 19014174. Link to Item
  - Kim JH-J, Newby LK, Clare RM, Shaw LK, Lodge AJ, Smith PK, Jolicoeur EM, Rao SV, Becker RC, Mark DB, Granger CB. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J. 2008 Nov;156(5):886-892. PubMed PMID: 19061702. Full Text Link to Item
  - Mahaffey KW, Reist CJ, Fu Y, Brener SJ, Theroux P, Patel MR, Stebbins A, Westerhout CM, Todaro TG, Adams PX, Granger CB, Armstrong PW, APEX Library Study Investigators . Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library. Contemporary clinical trials. 2008 Nov;29(6):887-895. PubMed PMID: 18644468. Full Text
  - Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL, Seo D, Gregory S, Kraus WE, Granger CB, Goldschmidt-Clermont P, Newby LK. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis. 2008 Nov;201(1):148-154. PubMed PMID: 18374923. Full Text Link to Item
  - Armstrong PW, Fu Y, Westerhout CM, White HD, Hudson MP, Mahaffey KW, Todaro TG, Aylward PE, Granger CB. Baseline Q Trumps Time from Symptom Onset as a Prognostic Marker in STEMI Patients Treated with Primary PCI. CIRCULATION. 2008 Oct 28;118(18):S1076-S1076. Link to Item
  - Berger JS, Elliott LE, Newby LK, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Hochman JS, Topol EJ, Harrington RA, Califf RM, Douglas PS. Sex Differences in 1-Year Mortality Following Acute Coronary Syndromes. CIRCULATION. 2008 Oct 28;118(18):S1057-S1058. Link to Item
  - Ezekowitz JA, Bakal JA, Huber K, Theroux P, James SK, Betriu A, Weaver WD, Granger CB, Armstrong PW. NT-proBNP is an Important Independent Predictor of Clinical Events after Primary PCI for STEMI. CIRCULATION. 2008 Oct 28;118(18):S582-S583. Link to Item
  - Granger CB, Sinnaeve P, Bengtsson O, McMurray JJ, Michelson EL, Pfeffer MA, Swedberg K, Yusuf S, Thornton M, Armstrong M, Roberts R. No Clear Association Between Candidate Gene Variants and Outcomes In 3239 Patients with Chronic Heart Failure: Results from the CHARM Program. CIRCULATION. 2008 Oct 28;118(18):S623-S624. Link to Item
  - Lopes RD, Granger CB, Honeycutt EF, Crespo EM, Anstrom KJ, Ohman EM, Becker RC. Patients with Thrombocytopenia following Heparin Therapy Have Early but not Late Risk of Death: Results from the CATCH Registry. CIRCULATION. 2008 Oct 28;118(18):S1052-S1052. Link to Item
  - Mehta RH, Starr AZ, Lopes RD, Pieper KS, Armstrong PW, Granger CB, Investigators APEX-AMIT. Association of Sustained Ventricular Tachycardia/Fibrillation and the Timing of its Occurrence on Outcomes in Patients Undergoing Primary Percutaneous Coronary Interventions: Insights from the APEX-AMI Trial. CIRCULATION. 2008 Oct 28;118(18):S1058-S1058. Link to Item
  - Tjandrawidjaja MC, Fu Y, Westerhout CM, White HD, Todaro TG, Van de Werf F, Mahaffey KW, Wagner GS, Granger CB, Armstrong PW. Resolution of ST-Segment Depression: A New Prognostic Marker of Clinical Outcome in ST-Segment Elevation Myocardial Infarction. CIRCULATION. 2008 Oct 28;118(18):S1076-S1076. Link to Item
  - Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Jr HDR, Hamm CW, Granger CB, Armstrong PW. Mortality after Acute Non-Culprit Coronary Intervention in STEMI: Insights from APEX AMI. CIRCULATION. 2008 Oct 28;118(18):S974-S974. Link to Item
  - Flaker G, Pogue J, Pfeffer MA, Goldhaber S, Granger CB, Anand IS, Yusuf S, Connolly SJ, Tr AFC. Cognitive function and anticoagulation control in patients with atrial fibrillation. EUROPEAN HEART JOURNAL. 2008 Sep;29:258-258. Link to Item
  - Fox KA, Carruthers K, Motivala A, Avezum A, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KM, Investigators GRACE. Has the frequency of bleeding improved over time for patients presenting with an acute coronary syndrome? The GRACE Registry. EUROPEAN HEART JOURNAL. 2008 Sep;29:326-326. Link to Item
  - French JK, Mahaffey KW, Hellkamp AS, Cohen E, O'connor CM, Kleiman NS, Holmes DR, Hochman JS, Granger CB, Armstrong PW. Mechanical complications are uncommon in STEMI treated with primary-PCI: insights from APEX-AMI. EUROPEAN HEART JOURNAL. 2008 Sep;29:137-138. Link to Item
  - French JK, Mahaffey KW, Hellkamp AS, O'connor CM, Cohen E, Kleiman NS, Holmes DR, Hochman JS, Granger CB, Armstrong PW. Mortality after cardiogenic shock remains high in ST-elevation myocardial infarction treated with primary PCI: insights from APEX AMI. EUROPEAN HEART JOURNAL. 2008 Sep;29:447-447. Link to Item
  - Granger CB, Gore J, Katz J, Kleinschmidt K, Wyman A, Peacock F, Anderson F, Investigators STATR. Acute severe hypertension has high morbidity, mortality, and readmission rates: results from the STAT registry. EUROPEAN HEART JOURNAL. 2008 Sep;29:513-513. Link to Item
  - Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008 Jul;94(7):867-873. PubMed PMID: 18332062. Full Text Link to Item
  - Wang L, Hauser ER, Shah SH, Seo D, Sivashanmugam P, Exum ST, Gregory SG, Granger CB, Haines JL, Jones CJH, Crossman D, Haynes C, Kraus WE, Freedman NJ, Pericak-Vance MA, Goldschmidt-Clermont PJ, Vance JM. Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. Ann Hum Genet. 2008 Jul;72(Pt 4):443-453. PubMed PMID: 18318786. Full Text Link to Item
  - Granger CB. In patients with suspected CAD and normal ECG, a nomogram model based on clinical and exercise variables predicted mortality. ACP J Club. 2008 Jun 17;148(4):14-. PubMed PMID: 18588265. Link to Item
  - Granger CB. In patients with suspected CAD and normal ECG, a nomogram model based on clinical and exercise variables predicted mortality. ANNALS OF INTERNAL MEDICINE. 2008 Jun 17;148(12). Full Text Link to Item
  - Brener SJ, Moliterno DJ, Aylward PE, van't Hof AWJ, Ruźyllo W, O'Neill WW, Hamm CW, Westerhout CM, Granger CB, Armstrong PW, APEX-AMI Investigators . Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. European heart journal. 2008 May;29(9):1127-1135. PubMed PMID: 18375399. Full Text
  - Jackson K, Gersh BJ, Stockbridge N, Fleming TR, Temple R, Califf RM, Connolly SJ, Wallentin L, Granger CB, Duke Clinical Research Institute/American Heart Journal Expert Meeting on Antithrombotic Drug Development for Atrial Fibrillation . Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005. Am Heart J. 2008 May;155(5):829-840. PubMed PMID: 18440329. (Review) Full Text Link to Item
  - Connelly JJ, Shah SH, Doss JF, Gadson S, Nelson S, Crosslin DR, Hale AB, Lou X, Wang T, Haynes C, Seo D, Crossman DC, Mooser V, Granger CB, Jones CJH, Kraus WE, Hauser ER, Gregory SG. Genetic and functional association of FAM5C with myocardial infarction. (Published online) BMC Med Genet. 2008 Apr 22;9:33-. PubMed PMID: 18430236. Full Text Link to Item
  - Mehta RH, Rao SV, Ohman EM, Bates ER, Marcucci G, Zhang M, Pieper KS, Armstrong PW, White HD, Van de Werf F, Califf RM, Granger CB. Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb. Eur Heart J. 2008 Apr;29(7):880-887. PubMed PMID: 18334473. Full Text Link to Item
  - Granger CB. Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects. ACP J Club. 2008 Mar;148(2):35-. PubMed PMID: 18311865. Link to Item
  - Jolicoeur EM, Granger CB, Henry TD, Holmes DJ, Pepine CJ, Mark D, Chaitman BR, Gersh BJ, Ohman EM, Working Group Members . Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies. Am Heart J. 2008 Mar;155(3):418-434. PubMed PMID: 18294474. (Review) Full Text Link to Item
  - Jolicoeur EM, Ohman EM, Temple R, Stockbridge N, Smith S, Mark D, Califf RM, Henry TD, Chaitman BR, Granger CB, Working Group Members . Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. Am Heart J. 2008 Mar;155(3):435-444. PubMed PMID: 18294475. (Review) Full Text Link to Item
  - Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators , Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19;117(7):886-896. PubMed PMID: 18250271. Full Text Link to Item
  - Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2008 Feb;155(2):369-374. PubMed PMID: 18215610. Full Text Link to Item
  - Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy. Circulation. 2008 Jan 15;117(2):192-199. PubMed PMID: 18086929. Full Text Link to Item
  - Oliveira GBF, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB, Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators . Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008 Jan 14;168(1):94-102. PubMed PMID: 18195201. Full Text Link to Item
  - Aronow HD, Lincoff AM, Quinn MJ, McRae AT, Gurm HS, Houghtaling PL, Granger CB, Harrington RA, Werf FVD, Topol EJ, Lauer MS. Relation Between Previous Lipid-Lowering Therapy and Infarct Size (Creatine Kinase-MB Level) in Patients Presenting With Acute Myocardial Infarction. American Journal of Cardiology. 2008;102(9):1119-1124. PubMed PMID: 18940276. Full Text
  - Bainey KR, Fu Y, Wagner GS, Goodman SG, Ross A, Granger CB, Werf FVD, Armstrong PW. Spontaneous reperfusion in ST-elevation myocardial infarction: Comparison of angiographic and electrocardiographic assessments. American Heart Journal. 2008;156(2):248-255. PubMed PMID: 18657653. Full Text
  - Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, Hof AWJV', Werf FJVD, Wagner GS, Granger CB, Armstrong PW. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial. Circulation. 2008;118(13):1335-1346. PubMed PMID: 18779444. Full Text
  - Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Jr CVP, Saucedo JF. Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: An evidence-based review of clinical trial results and treatment guidelines: Report on a roundtable discussion. Journal of Interventional Cardiology. 2008;21(4):283-299. PubMed PMID: 18754964. Full Text
  - Cohen-Solal A, McMurray JJV, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB. Benefits and safety of candesartan treatment in heart failure are independent of age: Insights from the Candesartan in heart failure - Assessment of reduction in mortality and morbidity programme. European Heart Journal. 2008;29(24):3022-3028. PubMed PMID: 18987098. Full Text
  - Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Werf FVD, López-Sendón J, Goodman SG, Quill A, Fox KAA. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: We are getting better but we have got a long way to go. European Heart Journal. 2008;29(5):609-617. PubMed PMID: 18310671. Full Text
  - Eisenstein EL, Collins R, Cracknell BS, Podesta O, Reid ED, Sandercock P, Shakhov Y, Terrin ML, Sellers MA, Califf RM, Granger CB, Diaz R. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008;5(1):75-84. PubMed PMID: 18283084. Full Text Link to Item
  - Granger CB, Ohman EM, Becker RC. Risk factors for thrombocytopenia in patients treated with prolonged heparin therapy - Reply. Archives of Internal Medicine. 2008;168(19):2171--.
  - Granger CB, Stockbridge NL, Vogel VG, Cummings SR. Response to letter of Meinert et al. Clinical Trials. 2008;5(5):558--. Full Text
  - Granger CB, Vogel V, Cummings SR, Held P, Fiedorek F, Lawrence M, Neal B, Reidies H, Santarelli L, Schroyer R, Stockbridge NL, Feng Zhao . Do we need to adjudicate major clinical events?. Clin Trials. 2008;5(1):56-60. PubMed PMID: 18283081. (Review) Full Text Link to Item
  - Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A, Jones GT, Rinkel GJE, Blankensteijn JD, Ronkainen A, Jääskeläinen JE, Kyo Y, Lenk GM, Sakalihasan N, Kostulas K, Gottsäter A, Flex A, Stefansson H, Hansen T, Andersen G, Weinsheimer S, Borch-Johnsen K, Jorgensen T, Shah SH, Quyyumi AA, Granger CB, Reilly MP, Austin H, Levey AI, Vaccarino V, Palsdottir E, Walters GB, Jonsdottir T, Snorradottir S, Magnusdottir D et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nature Genetics. 2008;40(2):217-224. PubMed PMID: 18176561. Full Text
  - MacDonald MR, Petrie MC, Varyani F, Östergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJV. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure - An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal. 2008;29(11):1377-1385. PubMed PMID: 18413309. Full Text
  - McDonald MA, Fu Y, Zeymer U, Wagner G, Goodman SG, Ross A, Granger CB, Werf FVD, Armstrong PW. Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: Insights from the ASSENT-4 PCI electrocardiographic substudy. European Heart Journal. 2008;29(7):871-879. PubMed PMID: 18319519. Full Text
  - Mehta SR, Bassand J-P, Chrolavicius S, Diaz R, Fox KAA, Granger CB, Jolly S, Rupprecht H-J, Widimsky P, Yusuf S. Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. American Heart Journal. 2008;156(6):1080-1088.e1. PubMed PMID: 19033002. Full Text
  - Mehta SR, Boden WE, Eikelboom JW, Flather M, Steg PG, Avezum A, Afzal R, Piegas LS, Faxon DP, Widimsky P, Budaj A, Chrolavicius S, Rupprecht H-J, Jolly S, Granger CB, Fox KAA, Bassand J-P, Yusuf S. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST-and non-ST-segment elevation acute coronary syndromes an individual patient-level combined analysis of the fifth and sixth organization to assess strategies in ischemic syndromes (OASIS 5 and 6) randomized trials. Circulation. 2008;118(20):2038-2046. PubMed PMID: 18955665. Full Text
  - Meredith PA, Östergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJV. Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program. Journal of the American College of Cardiology. 2008;52(24):2000-2007. PubMed PMID: 19055992. Full Text
  - Oldgren J, Wallentin L, Afzal R, Bassand J-P, Budaj A, Chrolavicius S, Fox KAA, Granger CB, Mehta SR, Pais P, Peters RJG, Xavier D, Zhu J, Yusuf S. Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. European Heart Journal. 2008;29(3):315-323. PubMed PMID: 18084015. Full Text
  - Pocock SJ, McMurray JJV, Dobson J, Yusuf S, Granger CB, Michelson EL, Östergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme. European Heart Journal. 2008;29(21):2641-2650. PubMed PMID: 18819960. Full Text
  - Rao SV, Chiswell K, Sun J-L, Granger CB, Newby LK, Van de Werf F, White HD, Armstong PW, Califf RM, Harrington RA. International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 2008 Jan 1;101(1):25-29. PubMed PMID: 18157960. Full Text Link to Item
  - Roberts WC, Granger CB, Patel MR, Rao SV, Sinnaeve PR, Sulkes DJ. The Editor's Roundtable: Management and Treatment of Non-ST-Segment Elevation in Acute Coronary Syndromes. American Journal of Cardiology. 2008;101(11):1580-1598. PubMed PMID: 18489936. Full Text
  - Solomon SD, Pfeffer MA, Pocock S, Marro J, McMurray JJV, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson E. Response to letter regarding article, "influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure". Circulation. 2008;118(1):e8-. Full Text
  - Toma M, Fu Y, Wagner G, Goodman SG, Granger C, Wallentin L, Werf FVD, Armstrong P. Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolution. Heart (British Cardiac Society). 2008;94(3):e6-. PubMed PMID: 17932094.
  - Weir RAP, McMurray JJV, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. European Journal of Heart Failure. 2008;10(2):157-163. PubMed PMID: 18242128. Full Text
  - Yan RT, Yan AT, Granger CB, Lopez-Sendon J, Brieger D, Kennelly B, Budaj A, Steg PG, Georgescu AA, Hassan Q, Goodman SG. Usefulness of Quantitative Versus Qualitative ST-Segment Depression for Risk Stratification of Non-ST Elevation Acute Coronary Syndromes in Contemporary Clinical Practice. American Journal of Cardiology. 2008;101(7):919-924. PubMed PMID: 18359308. Full Text
  - Yusuf S, Bosch J, Devereaus PJ, Collins R, Baigent C, Granger C, Califf R, Temple R. Sensible guidelines for the conduct of large randomized trials. Clinical Trials. 2008;5(1):38-39. PubMed PMID: 18283078. Full Text
  - Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox WT, Shiber JR, Valeri FS, Watling BA, Wilson BH, Granger CB, Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) Investigators . Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007 Nov 28;298(20):2371-2380. PubMed PMID: 17982184. Full Text Link to Item
  - Jolicoeur ME, O'Neil WW, Armstrong PW, Pieper K, Hamm C, Holmes DR, Van de Werf F, Granger CB. Predictors of transfusion in acute myocardial infarction: Insights from APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial. CIRCULATION. 2007 Oct 16;116(16):945-945. Link to Item
  - Lopes RD, Mahaffey K, Harrington RA, Horton J, Armstrong P, Newby K, Ohman M, De Werf FV, Al-Khatib SM, Wallentin L, Granger CB. Atrial fibrillation is independently associated with a high risk of death in patients with acute coronary syndromes. CIRCULATION. 2007 Oct 16;116(16):315-315. Link to Item
  - Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, Mcafee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW, Investigators APEXAMI. Efficient adjudication of endpoints in an international trial: Strategic lessons from the clinical events committee (CEC) of the assessment of pexelizumab in acute myocardial infarction (APEX AMI) trial. CIRCULATION. 2007 Oct 16;116(16):317-317. Link to Item
  - Westerhout CM, Lee KL, James SK, De Wert FV, O'Neill WW, Nielsen TT, Weaver WD, Granger CB, Invest APEXAMI. Dynamic mortality modeling in PCI-treated ST-elevation myocardial infarction: Implications for clinical decision making. CIRCULATION. 2007 Oct 16;116(16):710-710. Link to Item
  - Granger CB. Carvedilol was more effective than metoprolol for preventing cardiovascular events in heart failure. Evid Based Med. 2007 Oct;12(5):141-. PubMed PMID: 17909232. Full Text Link to Item
  - Mehta RH, Greenbaum AB, Lokhnygina Y, Newby LK, Van De Werf F, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials. J Interv Cardiol. 2007 Oct;20(5):299-306. PubMed PMID: 17880325. Full Text Link to Item
  - Brener SJ, Moliterno DJ, Aylward P, Van'T Hof AWJ, Ruzyllo W, Ardissino D, Hamm CW, Westerhout CM, Granger CB, Armstrong PW, Investigators APEXAMI. Predictors of angiographic success and relationship to clinical outcomes during primary PCI for ST elevation acute myocardial infarction: insights from APEX-AMI. EUROPEAN HEART JOURNAL. 2007 Sep;28:660-660. Link to Item
  - Fox KA, Steg PG, Goldberg RJ, Gore JM, Granger CB, Avezum A, Eagle KA, Fitzgerald G, De Werf FV, Investigators GRACE. Can we predict non-fatal cardiovascular events in acute coronary syndrome? The Global Registry of Acute Coronary Events. EUROPEAN HEART JOURNAL. 2007 Sep;28:689-689.
  - Jolly S, Mehta SR, Wallentin L, Afzal R, Budaj A, Fox KAA, Col J, Rupprecht HJ, Granger CB, Yusuf S. The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: insights from the OASIS 5 trial. EUROPEAN HEART JOURNAL. 2007 Sep;28:187-187. Link to Item
  - Jolly S, Mehta SR, Widimsky P, Afzal R, Steg PG, Valentin V, Budaj A, Fox KAA, Granger CB, Yusuf S. Bleeding risk of Glycoprotein (GP) IIb IIIa inhibitors or thienopyridines with fondaparinux vs. enoxaparin in Acute Coronary Syndromes: insights from the OASIS 5 trial. EUROPEAN HEART JOURNAL. 2007 Sep;28:516-516. Link to Item
  - Lopes RD, Mahaffey KM, Harrington RH, Lan LL, Armstrong PA, Newby KN, Ohman MO, Van de Werf FVW, Al-Khatib SAK, Granger CBG. Atrial fibrillation is associated with worse outcomes in ST elevation and non ST elevation acute coronary syndromes. EUROPEAN HEART JOURNAL. 2007 Sep;28:259-260. Link to Item
  - McDonald MA, Fu Y, Zeymer U, Wagner GS, Goodman SG, Ross AM, Granger CB, Van de Werf F, Armstrong PW, Investigators APCI. Adverse outcomes in fibrinolytic-based facilitated PCI: insights from the ASSENT-4 PCI electrocardiographic substudy. EUROPEAN HEART JOURNAL. 2007 Sep;28:59-59. Link to Item
  - Patel MR, Pfisterer ME, Betriu A, Widimsky P, Holmes DR, O' Neill WW, Stebbins AL, Van De Werf F, Armstrong PW, Granger CB, Investigators APEXAMI. Short-term outcomes are at least as good with drug eluting vs. bare metal stents: insights from APEX AMI. EUROPEAN HEART JOURNAL. 2007 Sep;28:9-9. Link to Item
  - Stebbins AL, Lee K, Armstrong PW, Hamm C, Van de Werf F, James S, Nielsen TT, Seabra-Gomes R, White HD, Granger CB, Investigators APEXAMI. A new model for predicting mortality in acute ST elevation myocardial infarction treated with primary PCI: results from the APEX AMI trial. EUROPEAN HEART JOURNAL. 2007 Sep;28:59-59. Link to Item
  - Theroux P, Neumann FJ, Hamm CW, Mahaffey KW, Hochman JS, James S, Montalescot G, Stebbins AL, Armstrong PW, Granger CB, Investigators APEXAMI. Why did pexelizumab fail to benefit acute myocardial infarction (STEMI) patients undergoing primary PCI? Insights into the role of inflammation and immunity and the complement inhibitor pexelizumab. EUROPEAN HEART JOURNAL. 2007 Sep;28:384-385. Link to Item
  - Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators . Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 3;50(1):40-47. PubMed PMID: 17601544. Full Text Link to Item
  - Barbagelata A, Perna ER, Clemmensen P, Uretsky BF, Canella JPC, Califf RM, Granger CB, Adams GL, Merla R, Birnbaum Y. Time to reperfusion in acute myocardial infarction. It is time to reduce it!. J Electrocardiol. 2007 Jul;40(3):257-264. PubMed PMID: 17478179. (Review) Full Text Link to Item
  - Strauss DG, Sprague PQ, Underhill K, Maynard C, Adams GL, Kessenich A, Sketch MH, Berger PB, Marcozzi D, Granger CB, Wagner GS. Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction. J Electrocardiol. 2007 Jul;40(3):265-270. PubMed PMID: 17292381. Full Text Link to Item
  - Armstrong PW, Granger CB. Pexelizumab and the APEX AMI trial. JAMA. 2007 May;297(17):1881-. PubMed PMID: 17473297. (Letter) Full Text
  - Jolicoeur EM, Granger CB, Fakunding JL, Mockrin SC, Grant SM, Ellis SG, Weisel RD, Goodell MA, National Heart Lung and Blood Institute Cell Therapy Working Group Members . Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J. 2007 May;153(5):732-742. PubMed PMID: 17452146. (Review) Full Text Link to Item
  - Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand J-P. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007 May;28(10):1193-1204. PubMed PMID: 17456480. (Review) Full Text Link to Item
  - Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D, Harris M, Nelson S, Hale AB, Granger CB, Haines JL, Jones CJH, Crossman D, Seo D, Gregory SG, Kraus WE, Goldschmidt-Clermont PJ, Vance JM. Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet. 2007 Apr;80(4):650-663. PubMed PMID: 17357071. Full Text Link to Item
  - Mehta RH, Califf RM, Yang Q, Pieper KS, White HD, Ohman EM, Harrington RA, Granger CB. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. Am J Cardiol. 2007 Mar 15;99(6):793-796. PubMed PMID: 17350367. Full Text Link to Item
  - Mehta RH, Califf RM, Garg J, White HD, Van de Werf F, Armstrong PW, Pieper KS, Topol EJ, Granger CB. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J. 2007 Feb;28(4):415-424. PubMed PMID: 17040928. Full Text Link to Item
  - APEX AMI Investigators , Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007 Jan;297(1):43-51. PubMed PMID: 17200474. Full Text
  - Boden WE, Eagle K, Granger CB. Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction. A Comprehensive Review of Contemporary Management Options. Journal of the American College of Cardiology. 2007;50(10):917-929. PubMed PMID: 17765117. Full Text
  - Bradley EH, Nallamothu BK, Curtis JP, Webster TR, Magid DJ, Granger CB, Moscucci M, Krumholz HM. Summary of evidence regarding hospital strategies to reduce door-to-balloon times for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Critical Pathways in Cardiology. 2007;6(3):91-97. PubMed PMID: 17804968. Full Text
  - Brieger D, Werf FVD, Avezum Á, Montalescot G, Kennelly BM, Granger CB, Goodman SG, Dabbous OH, Agnelli G. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). American Heart Journal. 2007;153(6):960-969. PubMed PMID: 17540196. Full Text
  - Desai AS, Swedberg K, McMurray JJV, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure. An Analysis of the CHARM Program. Journal of the American College of Cardiology. 2007;50(20):1959-1966. PubMed PMID: 17996561. Full Text
  - Fox KAA, Steg PG, Eagle KA, Goodman SG, Jr FAA, Granger CB, Flather MD, Budaj A, Quill A, Gore JM. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. Journal of the American Medical Association. 2007;297(17):1892-1900. PubMed PMID: 17473299. Full Text
  - Friedewald VE, Bates ER, Granger CB, Yusuf S, Roberts WC. The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes. American Journal of Cardiology. 2007;100(6):974-980. PubMed PMID: 17826381. Full Text
  - Granger CB, Henry TD, Bates WER, Cercek B, Weaver WD, Williams DO. Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. Circulation. 2007;116(2):e55-e59. PubMed PMID: 17538039. Full Text
  - Granger CB, McMurray JJV. Reply. Journal of the American College of Cardiology. 2007;49(6):729--. Full Text
  - Granger CB, Patel MR. The Search for Myocardial Protection. Is There Still Hope?^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2007;50(5):406-408. PubMed PMID: 17662391. Full Text
  - Hawkins NM, Wang D, McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Östergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: Evidence from the CHARM programme. Heart. 2007;93(1):59-64. PubMed PMID: 16952975. Full Text
  - Hawkins NM, Wang D, McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Östergren J, Michelson EL, Dunn FG. Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme. European Journal of Heart Failure. 2007;9(5):510-517. PubMed PMID: 17317308. Full Text
  - Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson D, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Obstetrical and Gynecological Survey. 2007;62(9):585-587. Full Text
  - Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-1493. PubMed PMID: 17478679. Full Text
  - Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LAM, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJV, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007;116(6):627-636. PubMed PMID: 17638930. Full Text
  - Lewis EF, Lamas GA, Meara EO, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJV, Yusuf S, Swedberg K, Pfeffer MA. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure. 2007;9(1):83-91. PubMed PMID: 17188020. Full Text
  - Mehta SR, Granger CB, Eikelboom JW, Bassand J-P, Wallentin L, Faxon DP, Peters RJG, Budaj A, Afzal R, Chrolavicius S, Fox KAA, Yusuf S. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Results From the OASIS-5 Trial. Journal of the American College of Cardiology. 2007;50(18):1742-1751. PubMed PMID: 17964037. Full Text
  - Nallamothu BK, Fox KAA, Kennelly BM, Werf FVD, Gore JM, Steg PG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart. 2007;93(12):1552-1555. PubMed PMID: 17591643. Full Text
  - O'Meara E, Clayton T, McEntegart MB, McMurray JJV, Piña IL, Granger CB, Östergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007;115(24):3111-3120. PubMed PMID: 17562950. Full Text
  - Oliveira GBF, Avezum A, Jr FAA, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KAA, Gore JM, Granger CB. Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. American Heart Journal. 2007;153(4):493-499. PubMed PMID: 17383284. Full Text
  - Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJV, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116(13):1482-1487. PubMed PMID: 17724259. Full Text
  - Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KAA. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation. 2007;116(24):2793-2801. PubMed PMID: 18025530. Full Text
  - Timmer JR, Ottervanger JP, Boer M-JD, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: Results from the primary coronary angioplasty vs thrombolysis-2 trial. Archives of Internal Medicine. 2007;167(13):1353-1359. PubMed PMID: 17620527. Full Text
  - Tjandrawidjaja MC, Fu Y, Al-Khalidi H, Todaro TG, Adams P, Werf FVD, Granger CB, Armstrong PW. Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: Lessons from APEX-AMI. European Heart Journal. 2007;28(23):2850-2857. PubMed PMID: 17967823. Full Text
  - Yan RT, Yan AT, Allegrone J, López-Sendón J, Granger CB, Gore JM, Budaj A, Georgescu AA, Hassan Q, Luchansky J, Werf FVD, Goodman SG. Differences Between Local Hospital and Core Laboratory Interpretation of the Admission Electrocardiogram in Patients With Acute Coronary Syndromes and Their Relation to Outcome. American Journal of Cardiology. 2007;100(2):169-174. PubMed PMID: 17631063. Full Text
  - Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout SD, Nelson CL, Sinnaeve P, Goldschmidt-Clermont PJ, Granger CB. Discovery of proteins related to coronary artery disease using industrial scale proteomics analysis of pooled plasma (vol 152, pg 478, 2006). AMERICAN HEART JOURNAL. 2006 Dec;152(6):1021-1021. Link to Item
  - Madsen LH, Christensen G, Lund T, Serebruany VL, Granger CB, Hoen I, Grieg Z, Alexander JH, Jaffe AS, Van Eyk JE, Atar D. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res. 2006 Nov 10;99(10):1141-1147. PubMed PMID: 17038641. Full Text Link to Item
  - Granger CB. Bleeding in acute coronary syndromes. (Published online) Timely Top Med Cardiovasc Dis. 2006 Nov 1;10:E30-. PubMed PMID: 17136236. Link to Item
  - Jollis JG, Mehta RH, Roettig ML, Berger PB, Babb JD, Granger CB. Reperfusion of acute myocardial infarction in North Carolina emergency departments (RACE): study design. Am Heart J. 2006 Nov;152(5):851.e1-851.11. PubMed PMID: 17070144. Full Text Link to Item
  - Shah SH, Kraus WE, Crossman DC, Granger CB, Haines JL, Jones CJH, Mooser V, Huang L, Haynes C, Dowdy E, Vega GL, Grundy SM, Vance JM, Hauser ER. Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. Ann Hum Genet. 2006 Nov;70(Pt 6):738-748. PubMed PMID: 17044848. Full Text Link to Item
  - Gore JM, Spencer FA, Gurfinkel EP, Lopez-Sendon J, Jr AFA, FitzGerald G, Granger CB, Investigators GRACE. Incidence of heparin-induced thrombocytopenia lower than expected patients with acute coronary syndromes. The global registry of acute coronary events. CIRCULATION. 2006 Oct 31;114(18):863-863. Link to Item
  - Lopez-Sendon J, Goodman SG, Steg PG, Brieger D, Eagle KA, Granger CB, Gurfinkel EP, Dedrick R, Gore JM, Investigators GRACE. Heparin therapy during fibrinolysis in ST-segment elevation myocardial infarction: Registry data support clinical trial results. CIRCULATION. 2006 Oct 31;114(18):863-863. Link to Item
  - Steg PG, Cottin Y, du Bocage C, Montalescot G, Van De Werf F, Gulba DC, Fox KA, Mehta RH, Tchetche D, Dedrick R, Granger CB, Investigators GRACE. Patients on chronic warfarin therapy who present with an acute coronary syndrome are high risk and receive delayed and inadequate treatment. CIRCULATION. 2006 Oct 31;114(18):860-860. Link to Item
  - Sinnaeve PR, Huang Y, Bogaerts K, Vahanian A, Adgey J, Armstrong PW, Wallentin L, Van de Werf FJ, Granger CB, ASSENT-3 and ASSENT-3 PLUS investigators . Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. American heart journal. 2006 Oct;152(4):684.e1-684.e9. PubMed PMID: 16996833. Full Text
  - Armstrong PW, Granger CB. Reflections on early stopping of a clinical trial. American heart journal. 2006 Sep;152(3):407-409. PubMed PMID: 16923403. Full Text
  - Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout S-D, Nelson CL, Sinnaeve P, Goldschmidt-Clermont PJ, Granger CB. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J. 2006 Sep;152(3):478-485. PubMed PMID: 16923417. Full Text Link to Item
  - Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, Crosslin DR, Hale AB, Nelson S, Crossman DC, Granger CB, Haines JL, Jones CJH, Vance JM, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER, Gregory SG. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet. 2006 Aug 25;2(8):e139-. PubMed PMID: 16934006. Full Text Link to Item
  - Goodman SG, Fu Y, Langer A, Barr A, Tan M, Wagner GS, Barbagelata A, Sgarbossa EB, Birnbaum Y, Granger CB, Califf RM, Van de Werf F, Topol EJ, Armstrong PW, GUSTO-IIb Investigators . The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience. American heart journal. 2006 Aug;152(2):277-284. PubMed PMID: 16875908. Full Text
  - Granger CB, McMurray JJV. Using measures of disease progression to determine therapeutic effect: a sirens' song. J Am Coll Cardiol. 2006 Aug 1;48(3):434-437. PubMed PMID: 16875965. (Review) Full Text Link to Item
  - Mahaffey KW, Van de Werf F, Shernan SK, Granger CB, Verrier ED, Filloon TG, Todaro TG, Adams PX, Levy JH, Hasselblad V, Armstrong PW. Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview. American heart journal. 2006 Aug;152(2):291-296. PubMed PMID: 16875911. (Academic Article) Full Text
  - Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, Smith PK, Califf RM, Harrington RA, Sketch MH. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. Circulation. 2006 Jul 4;114(1 Suppl):I396-I401. PubMed PMID: 16820607. Full Text Link to Item
  - Yusuf S, Granger CB, Mehta SR. Fondaparinux versus enoxaparin in acute coronary syndromes - Reply. NEW ENGLAND JOURNAL OF MEDICINE. 2006 Jun 29;354(26):2830-2830. Link to Item
  - Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GBF, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. European heart journal. 2006 Jun;27(11):1289-1297. PubMed PMID: 16611669. Full Text
  - Van de Werf F, Ross A, Armstrong P, Granger C, Danays T. Facilitated versus primary PCI for acute myocardial infarction – Authors' reply. The Lancet. 2006 Jun;367(9525):1813-1814. Full Text
  - Armstrong PW, Chang W-C, Wallentin L, Goldstein P, Granger CB, Bogaerts K, Danays T, Van de Werf F, ASSENT-3 and ASSENT-3 PLUS Investigators . Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data. CMAJ : Canadian Medical Association Journal. 2006 May;174(10):1421-1426. PubMed PMID: 16682709. Full Text
  - Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJG, Bassand JP, Wallentin L, Joyner C, Fox KAA, Grp OT. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction - The OASIS-6 randomized trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Apr 5;295(13):1519-1530. PubMed PMID: 16537725. Link to Item
  - Armstrong PW, Mahaffey KW, Chang W-C, Weaver WD, Hochman JS, Theroux P, Rollins S, Todaro TG, Granger CB, COMMA Investigators . Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction. American heart journal. 2006 Apr;151(4):787-790. PubMed PMID: 16569534. Full Text
  - Ezekowitz JA, Théroux P, Chang W, Mahaffey KW, Granger CB, Weaver WD, Hochman JS, Armstrong PW. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction. The Canadian journal of cardiology. 2006 Apr;22(5):393-397. PubMed PMID: 16639474. Full Text
  - Orlandini A, Díaz R, Wojdyla D, Pieper K, Van de Werf F, Granger CB, Harrington RA, Boersma E, Califf RM, Armstrong P, White H, Simes J, Paolasso E. Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes. European heart journal. 2006 Mar;27(5):527-533. PubMed PMID: 16410369. (Review) Full Text
  - Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Harrington RA. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol. 2006 Feb 21;47(4):809-816. PubMed PMID: 16487850. Full Text Link to Item
  - Chang W-C, Kaul P, Fu Y, Westerhout CM, Granger CB, Mahaffey KW, Wallentin L, Van de Werf F, Armstrong PW, ASSENT-3 Investigators . Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction. European heart journal. 2006 Feb;27(4):419-426. PubMed PMID: 16407373. Full Text
  - Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, Van de Werf F, White H, Califf RM, Harrington RA. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am Heart J. 2006 Feb;151(2):316-322. PubMed PMID: 16442893. Full Text Link to Item
  - Al-Faleh H, Fu Y, Wagner G, Goodman S, Sgarbossa E, Granger C, Werf FVD, Wallentin L, Armstrong PW. Unraveling the spectrum of left bundle branch block in acute myocardial infarction: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials. American Heart Journal. 2006;151(1):10-15. PubMed PMID: 16368285. Full Text
  - Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, Crosslin DR, Hale AB, Nelson S, Crossman DC, Granger CB, Haines JL, Jones CJH, Vance JM, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER, Gregory SG. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genetics. 2006;2(8):1265-1273. Full Text
  - Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJV, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American heart journal. 2006;152(1):86-92. PubMed PMID: 16838426.
  - Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJV, Olsson L, Rouleau JL, Young JB, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal. 2006;151(5):985-991. PubMed PMID: 16644319. Full Text
  - Eisenstein EL, Honeycutt EF, Anstrom KJ, Granger CB, Becker RC, Ohman EM. Heparin-related thrombocytopenia associated with major increase in hospital costs. VALUE IN HEALTH. 2006;9(6):A248-A248. Full Text Link to Item
  - Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Werf FVD, Avezum Á, Goodman SG, Flather MD, Jr FAA, Granger CB. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). British Medical Journal. 2006;333(7578):1091-1094. PubMed PMID: 17032691. Full Text
  - Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, Granger CB, Armstrong PW, Harrington RA, White HD, Simoons ML, Newby LK, Califf RM, Topol EJ. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. Am Heart J. 2006 Jan;151(1):16-24. PubMed PMID: 16368286. Full Text Link to Item
  - Goodman SG, Steg PG, Eagle KA, Fox KAA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE). American Heart Journal. 2006;151(3):654-660. PubMed PMID: 16504627. Full Text
  - Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Oliveira GBF, Todaro TT, Granger CB. Glucose, insulin, and acute myocardial infarction: Reply [4]. European Heart Journal. 2006;27(17):2142-2143. Full Text
  - Granger CB. Prediction and prevention of chemotherapy-induced cardiomyopathy: Can it be done?. Circulation. 2006;114(23):2432-2433. PubMed PMID: 17146002. Full Text
  - Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJV, Yusuf S, Granger CB, Michelson EL, Östergren J, Cornel JH, Zeeuw DD, Pocock S, Veldhuisen DJV. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671-678. PubMed PMID: 16461840. Full Text
  - Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JJV, Rouleau J-L, Aylward PE, White HD, Califf RM, Schulman KA. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J. 2006 Jan;151(1):206-212. PubMed PMID: 16368320. Full Text Link to Item
  - McMurray JJV, Andersson FL, Stewart S, Svensson K, Solal AC, Dietz R, Vanhaecke J, Veldhuisen DJV, Östergren J, Granger CB, Yusuf S, Pfeffer MA, Swedberg K. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal. 2006;27(12):1447-1458. PubMed PMID: 16754631. Full Text
  - McMurray JJV, Young JB, Dunlap ME, Granger CB, Hainer J, Michelson EL, Earle S, Olofsson B, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. American heart journal. 2006;151(5):985-991.
  - McMurray JJV, Young JB, Dunlap ME, Granger CB, Hainer J, Michelson EL, Earle S, Olofsson B, Östergren J, Yusuf S, Swedberg K, Pfeffer MA. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. American Heart Journal. 2006;151(5):992-998. Full Text
  - Mehta RH, Marks D, Califf RM, Sohn S, Pieper KS, Van de Werf F, Peterson ED, Ohman EM, White HD, Topol EJ, Granger CB. Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. Am J Med. 2006 Jan;119(1):70.e1-70.e8. PubMed PMID: 16431189. Full Text Link to Item
  - Mitchell GF, Arnold JMO, Dunlap ME, O'Brien TX, Marchiori G, Warner E, Granger CB, Desai SS, Pfeffer MA. Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: The CHARM Program. European Journal of Heart Failure. 2006;8(2):191-197. PubMed PMID: 16188495. Full Text
  - O'Meara E, Clayton T, McEntegart MB, McMurray JJV, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Östergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure - Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. Circulation. 2006;113(7):986-994. PubMed PMID: 16476847. Full Text
  - Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJV, Puu M, Yusuf S, Pfeffer MA. Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction. Results From the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program. Journal of the American College of Cardiology. 2006;47(10):1997-2004. PubMed PMID: 16697316. Full Text
  - Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, Östergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. European Heart Journal. 2006;27(1):65-75. PubMed PMID: 16219658. Full Text
  - Rokos IC, Larson DM, Henry TD, Koenig WJ, Eckstein M, French WJ, Granger CB, Roe MT. Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks. American Heart Journal. 2006;152(4):661-667. PubMed PMID: 16996830. Full Text
  - Yusuf S, Granger CB, Mehta SR. The Authors Reply [2]. New England Journal of Medicine. 2006;354(26):2830--. Full Text
  - Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJG, Bassand J-P, Wallentin L, Joyner C, Fox KAA. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. New England Journal of Medicine. 2006;354(14):1464-1476. PubMed PMID: 16537663. Full Text
  - Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJV, Yusuf S, Michelson EL, Pfeffer MA, CHARM investigators . Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005 Dec 10;366(9502):2005-2011. PubMed PMID: 16338449. Full Text Link to Item
  - Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, Mahaffey KW, Califf RM, Harrington RA. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005 Nov 1;96(9):1200-1206. PubMed PMID: 16253582. Full Text Link to Item
  - Sinnaeve PR, Simes J, Yusuf S, Garg J, Mehta S, Eikelboom J, Bittl JA, Serruys P, Topol EJ, Granger CB. Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. Eur Heart J. 2005 Nov;26(22):2396-2403. PubMed PMID: 16214829. Full Text Link to Item
  - Welsh RC, Chang W, Goldstein P, Adgey J, Granger CB, Verheugt FWA, Wallentin L, Van de Werf F, Armstrong PW, ASSENT-3 PLUS Investigators . Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial. Heart (British Cardiac Society). 2005 Nov;91(11):1400-1406. PubMed PMID: 15774607. Full Text
  - Barbagelata A, Di Carli MF, Califf RM, Garg J, Birnbaum Y, Grinfeld L, Gibbons RJ, Granger CB, Goodman SG, Wagner GS, Mahaffey KW, AMISTAD Investigators . Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. American heart journal. 2005 Oct;150(4):659-665. PubMed PMID: 16209961. Full Text
  - Savonitto S, Cohen MG, Politi A, Hudson MP, Kong DF, Huang Y, Pieper KS, Mauri F, Wagner GS, Califf RM, Topol EJ, Granger CB. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2005 Oct;26(20):2106-2113. PubMed PMID: 15987706. Full Text Link to Item
  - Théroux P, Armstrong PW, Mahaffey KW, Hochman JS, Malloy KJ, Rollins S, Nicolau JC, Lavoie J, Luong TM, Burchenal J, Granger CB. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. European heart journal. 2005 Oct;26(19):1964-1970. PubMed PMID: 15872036. Full Text
  - Granger CB, Steg PG, Peterson E, López-Sendón J, Van de Werf F, Kline-Rogers E, Allegrone J, Dabbous OH, Klein W, Fox KAA, Eagle KA, GRACE Investigators . Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005 Aug;118(8):858-865. PubMed PMID: 16084178. Full Text Link to Item
  - Nallamothu BK, Bates ER, Hochman JS, Granger CB, Guetta V, Wilcox RG, White HD, Armstrong PW, Savonitto S, Jia G, Lincoff AM, Topol EJ, GUSTO-V Investigators . Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. European heart journal. 2005 Aug;26(15):1506-1512. PubMed PMID: 15800019. Full Text
  - Kaul P, Newby LK, Fu Y, Mark DB, Goodman SG, Wagner GS, Harrington RA, Granger CB, Van de Werf F, Ohman EM, Armstrong PW, VIGOUR Group . Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns. Heart. 2005 Jul;91(7):876-881. PubMed PMID: 15958353. Full Text Link to Item
  - Wong C-K, French JK, Aylward PEG, Stewart RAH, Gao W, Armstrong PW, Van De Werf FJJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD, HERO-2 Trial Investigators . Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. Journal of the American College of Cardiology. 2005 Jul;46(1):29-38. PubMed PMID: 15992631. Full Text
  - Armstrong PW, Newby LK, Granger CB, Lee KL, Califf RM, Simes RJ, Van de Werf F. Letter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - Response. CIRCULATION. 2005 Jun 14;111(23):E393-E393. Link to Item
  - Mehta RH, Califf RM, Garg J, Pieper KS, Alexander JH, Moliterno DJ, Van de Werf F, Ohman EM, White HD, Topol EJ, Granger CB. Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy. Am J Cardiol. 2005 Jun 1;95(11):1371-1375. PubMed PMID: 15904648. Full Text Link to Item
  - Cohen MG, Kelly RV, Kong DF, Menon V, Shah M, Ferreira J, Pieper KS, Criger D, Poggio R, Ohman EM, Gore J, Califf RM, Granger CB. Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. Am J Med. 2005 May;118(5):482-488. PubMed PMID: 15866250. Full Text Link to Item
  - Granger CB. Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease. ACP J Club. 2005 May;142(3):66-. PubMed PMID: 15862065. Link to Item
  - Mehta RH, Alexander JH, Van de Werf F, Armstrong PW, Pieper KS, Garg J, Califf RM, Granger CB. Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes. JAMA. 2005 Apr 13;293(14):1746-1750. PubMed PMID: 15827313. Full Text Link to Item
  - Kaul P, Armstrong PW, Cowper PA, Eisenstein EL, Granger CB, Van de Werf F, Mark DB. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. American heart journal. 2005 Apr;149(4):637-644. PubMed PMID: 15990746. Full Text
  - Meine TJ, Al-Khatib SM, Alexander JH, Granger CB, White HD, Kilaru R, Williams K, Ohman EM, Topol E, Califf RM. Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J. 2005 Apr;149(4):670-674. PubMed PMID: 15990751. Full Text Link to Item
  - Armstrong PW, Adams PX, Al-Khalidi HR, Hamm C, Holmes D, O'Neill W, Todaro TG, Vahanian A, Van de Werf F, Granger CB, APEX-AMI Steering Committee . Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 2005 Mar;149(3):402-407. PubMed PMID: 15864228. Full Text Link to Item
  - Patel MR, Granger CB. Pexelizumab: a novel therapy for myocardial ischemia-reperfusion. Drugs Today (Barc). 2005 Mar;41(3):165-170. PubMed PMID: 15883613. (Review) Full Text Link to Item
  - Patel MR, Mahaffey KW, Armstrong PW, Weaver WD, Tasissa G, Hochman JS, Todaro TG, Malloy KJ, Rollins S, Theroux P, Ruzyllo W, Nicolau JC, Granger CB, CARDINAL Investigators . Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). The American journal of cardiology. 2005 Mar;95(5):614-618. PubMed PMID: 15721102. Full Text
  - Mehta RH, Granger CB, Alexander KP, Bossone E, White HD, Sketch MH. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol. 2005 Feb 15;45(4):471-478. PubMed PMID: 15708688. (Review) Full Text Link to Item
  - Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ, Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry . Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb;19(1):11-19. PubMed PMID: 15976962. Full Text Link to Item
  - Demers C, McMurray JJV, Swedberg K, Pfeffer MA, Granger CB, Olofsson B, McKelvie RS, Östergren J, Michelson EL, Johansson PA, Wang D, Yusuf S. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. Journal of the American Medical Association. 2005;294(14):1794-1798. PubMed PMID: 16219883. Full Text
  - Granger CB. Trandolapril did not reduce cardiovascular death or other events in stable coronary artery disease. Evidence-Based Medicine. 2005;10(3):78--. Full Text
  - Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. European heart journal. 2005 Jan;26(2):128-136. PubMed PMID: 15618068. Full Text
  - Lim MJ, Eagle KA, Gore JM, Jr FAA, Dabbous OH, Mehta RH, Granger CB, Fox KAA, Spencer FA, Goldberg RJ. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). American Journal of Cardiology. 2005;96(7):917-921. PubMed PMID: 16188516. Full Text
  - Mehta SR, Steg PG, Granger CB, Bassand J-P, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJG, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay J-F, Fox KAA, Yusuf S. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra study in percutaneous coronary intervention: A randomized evaluation (ASPIRE) pilot trial. Circulation. 2005;111(11):1390-1397. PubMed PMID: 15781750. Full Text
  - O'Meara E, Lewis E, Granger C, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Ostergren J, Carlsson J, Olofsson B, McMurray J, Yusuf S, Swedberg K, Pfeffer MA. Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 2005;7(4):650-656. PubMed PMID: 15921807. Full Text
  - Solomon SD, Anavekar N, Skali H, McMurray JJV, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112(24):3738-3744. PubMed PMID: 16330684. Full Text
  - Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman SG. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. American Journal of Cardiology. 2005;96(7):913-916. PubMed PMID: 16188515. Full Text
  - Yusuf S, Ostergren JB, Gerstein HC, Pfeffer MA, Swedberg K, Granger CB, Olofsson B, Probstfield J, McMurray JV. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation. 2005;112(1):48-53. PubMed PMID: 15983242. Full Text
  - Armstrong PW, Newby LK, Granger CB, Lee KL, Simes RJ, Van de Werf F, White HD, Califf RM, Virtual Coordinating Centre for Global Collaborative Cardiovascular Research (VIGOUR) Group . Lessons learned from a clinical trial. Circulation. 2004 Dec 7;110(23):3610-3614. PubMed PMID: 15583090. (Review) Full Text Link to Item
  - Barbagelata A, Califf RM, Sgarbossa EB, Knight D, Mark DB, Granger CB, Armstrong PW, Elizari M, Birnbaum Y, Grinfeld LR, Ohman EM, Wagner GS, GUSTO-1 Investigators . Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. American heart journal. 2004 Nov;148(5):795-802. PubMed PMID: 15523309. Full Text
  - Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004 Oct 6;292(13):1555-1562. PubMed PMID: 15467057. Full Text Link to Item
  - Kaul P, Armstrong PW, Chang W-C, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation. 2004 Sep 28;110(13):1754-1760. PubMed PMID: 15381645. Full Text Link to Item
  - Hauser ER, Crossman DC, Granger CB, Haines JL, Jones CJH, Mooser V, McAdam B, Winkelmann BR, Wiseman AH, Muhlestein JB, Bartel AG, Dennis CA, Dowdy E, Estabrooks S, Eggleston K, Francis S, Roche K, Clevenger PW, Huang L, Pedersen B, Shah S, Schmidt S, Haynes C, West S, Asper D, Booze M, Sharma S, Sundseth S, Middleton L, Roses AD, Hauser MA, Vance JM, Pericak-Vance MA, Kraus WE. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet. 2004 Sep;75(3):436-447. PubMed PMID: 15272420. Full Text Link to Item
  - Curtis JP, Alexander JH, Huang Y, Wallentin L, Verheugt FWA, Armstrong PW, Krumholz HM, Van de Werf F, Danays T, Cheeks M, Granger CB, ASSENT-2 and ASSENT-3 Investigators . Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3). The American journal of cardiology. 2004 Aug;94(3):279-283. PubMed PMID: 15276088. Full Text
  - Chang W-C, Boersma E, Granger CB, Harrington RA, Califf RM, Simoons ML, Kleiman NS, Armstrong PW, GUSTO-IIb and PURSUIT Investigators . Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. American heart journal. 2004 Jul;148(1):62-71. PubMed PMID: 15215793. Full Text
  - Waters RE, Singh KP, Roe MT, Lotfi M, Sketch MH, Mahaffey KW, Newby LK, Alexander JH, Harrington RA, Califf RM, Granger CB. Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004 Jun 16;43(12):2153-2159. PubMed PMID: 15193673. (Review) Full Text Link to Item
  - Kaul P, Armstrong PW, Fu Y, Knight JD, Clapp-Channing NE, Sutherland W, Granger CB, Mark DB, GUSTO-IIb investigators . Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. The Canadian journal of cardiology. 2004 Jun;20(8):760-766. PubMed PMID: 15229756.
  - Sinnaeve PR, Alexander JH, Bogaerts K, Belmans A, Wallentin L, Armstrong P, Adgey JAA, Tendera M, Diaz R, Soares-Piegas L, Vahanian A, Granger CB, Van De Werf FJ. Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction. American heart journal. 2004 Jun;147(6):993-998. PubMed PMID: 15199346. Full Text
  - Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Todaro TG, Rollins S, Mojcik CF, Nicolau JC, Ruzyllo W, Armstrong PW. Why did the anti-C5 complement antibody pexelizumab not reduce infarct size but influence clinical outcomes positively when applied as adjunctive therapy to primary percutaneous coronary intervention? Response. CIRCULATION. 2004 Apr 27;109(16):E195-E196. Link to Item
  - Granger CB, Van Eyk JE, Mockrin SC, Anderson NL, National Heart Lung And Blood Institute Clinical Proteomics Working Group . National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation. 2004 Apr 13;109(14):1697-1703. PubMed PMID: 15078805. Full Text Link to Item
  - Kandzari DE, Granger CB, Simoons ML, White HD, Simes J, Mahaffey KW, Gore J, Weaver WD, Longstreth WT, Stebbins A, Lee KL, Califf RM, Topol EJ, Global Utilization of Streptokinase and tPA for Occluded Arteries-I Investigators . Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). Am J Cardiol. 2004 Feb 15;93(4):458-461. PubMed PMID: 14969623. Full Text Link to Item
  - Kaul P, Newby LK, Fu Y, Mark DB, Califf RM, Topol EJ, Aylward P, Granger CB, Van de Werf F, Armstrong PW. International differences in evolution of early discharge after acute myocardial infarction. Lancet. 2004 Feb 14;363(9408):511-517. PubMed PMID: 14975612. Full Text Link to Item
  - McGuire DK, Newby LK, Bhapkar MV, Moliterno DJ, Hochman JS, Klein WW, Weaver WD, Pfisterer M, Corbalán R, Dellborg M, Granger CB, Van De Werf F, Topol EJ, Califf RM, SYMPHONY and 2nd SYMPHONY Investigators . Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J. 2004 Feb;147(2):246-252. PubMed PMID: 14760321. Full Text Link to Item
  - Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004 Feb;25(4):313-321. PubMed PMID: 14984920. Full Text Link to Item
  - Rebeiz AG, Roe MT, Alexander JH, Mahaffey KW, Granger CB, Peterson ED, Califf RM, Harrington RA. Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes. Am J Med. 2004 Jan 15;116(2):119-129. PubMed PMID: 14715326. (Review) Link to Item
  - Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG. Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational study. American Journal of Medicine. 2004;117(2):73-81. PubMed PMID: 15234641. Full Text
  - Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Werf FVD, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum Á, Flather MD, Fox KAA, Ferreira R. A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. Revista Portuguesa de Cardiologia. 2004;23(7-8):1071-1072.
  - Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Werf FVD, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum Á, Flather MD, Fox KAA. A validated prediction model for all forms of acute coronary syndrome estimating the risk of 6-month postdischarge death in an international registry. Journal of the American Medical Association. 2004;291(22):2727-2733. PubMed PMID: 15187054. Full Text
  - Granger CB, Weaver WD. Reducing cardiac events after acute coronary syndromes. Rev Cardiovasc Med. 2004;5 Suppl 5:S39-S46. PubMed PMID: 15619614. (Review) Link to Item
  - O'Meara E, Solomon S, McMurray J, Pfeffer M, Yusuf S, Michelson E, Granger C, Olofsson B, Young JB, Swedberg K. Effect of candesartan on New York Heart Association functional class - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal. 2004;25(21):1920-1926. PubMed PMID: 15522471. Full Text
  - Pfeffer MA, McMurray JJ, Östergren J, Granger CB, Yusuf S, Pitt B. Candesartan reduced mortality and hospital admissions in chronic heart failure. Evidence-Based Medicine. 2004;9(2):44-45. Full Text
  - Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJV, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004;110(15):2180-2183. PubMed PMID: 15466644. Full Text
  - Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, Mehta RH, Brieger D. Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study. Annals of Internal Medicine. 2004;140(11):857-866+I. PubMed PMID: 15172899.
  - Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, Wallentin L, Werf FVD, Verheugt F, Armstrong PW. Aborted myocardial infarction in patients with ST-segment elevation: Insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy. Journal of the American College of Cardiology. 2004;44(1):38-43. PubMed PMID: 15234403. Full Text
  - Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJV, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K. Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: Results of the CHARM low-left ventricular ejection fraction trials. Circulation. 2004;110(17):2618-2626. PubMed PMID: 15492298. Full Text
  - Kramer JM, Newby LK, Chang WC, Simes RJ, Van de Werf F, Granger CB, Lee KL, White HD, Piegas LS, Topol EJ, Califf RM, Armstrong PW, SYMPHONY and 2nd SYMPHONY Investigators . International variation in the use of evidence-based medicines for acute coronary syndromes. Eur Heart J. 2003 Dec;24(23):2133-2141. PubMed PMID: 14643274. Link to Item
  - Waters RE, Mahaffey KW, Granger CB, Roe MT. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Am Heart J. 2003 Dec;146(6):958-968. PubMed PMID: 14660986. Full Text Link to Item
  - McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S. The CHARM programme - Reply. LANCET. 2003 Nov 15;362(9396):1678-1679. Full Text Link to Item
  - Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KAA, Global Registry of Acute Coronary Events Investigators . Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003 Oct 27;163(19):2345-2353. PubMed PMID: 14581255. Full Text Link to Item
  - Dubois CL, Belmans A, Granger CB, Armstrong PW, Wallentin L, Fioretti PM, López-Sendón JL, Verheugt FW, Meyer J, Van de Werf F, ASSENT-3 Investigators . Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. Journal of the American College of Cardiology. 2003 Oct;42(7):1178-1185. PubMed PMID: 14522476. Full Text
  - Lockwood E, Fu Y, Wong B, Van de Werf F, Granger CB, Armstrong PW, Goodman SG, ASSENT-2 Investigators . Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy. American heart journal. 2003 Oct;146(4):640-645. PubMed PMID: 14564317. Full Text
  - Granger CB, McMurray JJV, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K, CHARM Investigators and Committees . Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003 Sep 6;362(9386):772-776. PubMed PMID: 13678870. Full Text Link to Item
  - Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochman JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW, COMMA Investigators . Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation. 2003 Sep;108(10):1184-1190. PubMed PMID: 12925454. Full Text
  - Gupta M, Chang W-C, Van de Werf F, Granger CB, Midodzi W, Barbash G, Pehrson K, Oto A, Toutouzas P, Jansky P, Armstrong PW, ASSENT II Investigators . International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. European heart journal. 2003 Sep;24(18):1640-1650. PubMed PMID: 14499226. Full Text
  - Mahaffey KW, Granger CB, Nicolau JC, Ruzyllo W, Weaver WD, Theroux P, Hochman JS, Filloon TG, Mojcik CF, Todaro TG, Armstrong PW, COMPLY Investigators . Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation. 2003 Sep;108(10):1176-1183. PubMed PMID: 12925455. Full Text
  - Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AAJ, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, Van de Werf F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003 Jul 7;108(2):135-142. PubMed PMID: 12847070. Full Text
  - Tjandrawidjaja MC, Fu Y, Goodman SG, Van de Werf F, Granger CB, Armstrong PW, ASSENT-2 Investigators . The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2. European heart journal. 2003 Jun;24(11):1024-1034. PubMed PMID: 12788302. Full Text
  - Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, Hasselblad V, Stebbins A, McNulty S, Newby LK. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol. 2003 Apr 15;91(8):936-940. PubMed PMID: 12686331. Link to Item
  - Hauser ER, Mooser V, Crossman DC, Haines JL, Jones CH, Winkelmann BR, Schmidt S, Scott WK, Roses AD, Pericak-Vance MA, Granger CB, Kraus WE, Design of the Genetics of Early Onset Cardiovascular Disease study . Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am Heart J. 2003 Apr;145(4):602-613. PubMed PMID: 12679755. Full Text Link to Item
  - Serebruany VL, Malinin AI, Callahan KP, Binbrek A, Werf FVD, Alexander JH, Granger CB, Gurbel PA, Safety AOT, substudy EOANTAP. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy. American heart journal. 2003 Apr;145(4):636-642. PubMed PMID: 12679759. (Academic Article)
  - Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White HD, Armstrong PW, Topol EJ, Ohman EM, GUSTO-III trial . Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J. 2003 Mar;145(3):515-521. PubMed PMID: 12660676. Full Text Link to Item
  - Khadour FH, Fu Y, Chang W-C, Ma X, Mark D, Granger CB, Topol EJ, Califf RM, Armstrong PW, GUSTO IIb investigators . Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. The Canadian Journal of Cardiology. 2003 Mar;19(3):257-263. PubMed PMID: 12677281.
  - Batchelor WB, Mark DB, Knight JD, Granger CB, Armstrong PW, Califf RM, Peterson ED. Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada. American heart journal. 2003 Feb;145(2):349-355. PubMed PMID: 12595855. Full Text
  - Armstrong PW, Wagner G, Goodman SG, Werf FVD, Granger C, Wallentin L, Fu Y. ST segment resolution in ASSENT 3: Insights into the role of three different treatment strategies for acute myocardial infarction. European Heart Journal. 2003;24(16):1515-1522. PubMed PMID: 12919776. Full Text
  - Fox KAA, Goodman SG, Jr FAA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM. From guidelines to clinical practice: The impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes - The Global Registry of Acute Coronary Events (GRACE). European Heart Journal. 2003;24(15):1414-1424. PubMed PMID: 12909070. Full Text
  - Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials. American Heart Journal. 2003;145(1):47-57. PubMed PMID: 12514654. Full Text
  - Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A, Ohman EM, Granger CB, Van de Werf F, Simoons ML, O'connor CM, Holmes DR. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J. 2003 Jan;145(1):73-79. PubMed PMID: 12514657. Full Text Link to Item
  - McMurray J, Östergren J, Pfeffer M, Swedberg K, Granger C, Yusuf S, Held P, Michelson E, Olofsson B. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: Baseline characteristics of patients in the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure. 2003;5(3):261-270. PubMed PMID: 12798823. Full Text
  - McMurray JJV, Östergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-added trial. Lancet. 2003;362(9386):767-771. PubMed PMID: 13678869. Full Text
  - Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Jr FAA, Fox KAA, Gore JM, Goldberg RJ, Eagle KA. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. American Journal of Cardiology. 2003;92(9):1031-1036. PubMed PMID: 14583352. Full Text
  - Pechlaner C, Gama MG, Rocha G, Mansour J, Peltier M, Oprisiu R, Achard JM, Fournier A, Jorde UP, Fox MT, Möller BHJ, Penston J, McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Cleland JGF, Freemantle N. The CHARM programme [2] (multiple letters). Lancet. 2003;362(9396):1675-1679. Full Text
  - Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, Olofsson B, Östergren J, Yusuf S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-overall programme. Lancet. 2003;362(9386):759-766. PubMed PMID: 13678868. Full Text
  - Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins L-E, Nilsson T, Pehrsson K, Siegbahn A, Swahn E. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction - The ASSENT plus study. European Heart Journal. 2003;24(10):897-908. PubMed PMID: 12714021. Full Text
  - Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL, Olofsson B, Östergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-preserved trial. Lancet. 2003;362(9386):777-781. PubMed PMID: 13678871. Full Text
  - O'Shea JC, Wilcox RG, Skene AM, Stebbins AL, Granger CB, Armstrong PW, Bode C, Ardissino D, Emanuelsson H, Aylward PE, White HD, Sadowski Z, Topol EJ, Califf RM, Ohman EM. Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. Am J Cardiol. 2002 Dec 15;90(12):1374-1377. PubMed PMID: 12480048. Link to Item
  - Lee MS, Wali AU, Menon V, Berkowitz SD, Thompson TD, Califf RM, Topol EJ, Granger CB, Hochman JS. The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb. J Thromb Thrombolysis. 2002 Oct;14(2):91-101. PubMed PMID: 12714828. (Review) Link to Item
  - Mehta RH, Criger DA, Granger CB, Pieper KK, Califf RM, Topol EJ, Bates ER. Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability. J Am Coll Cardiol. 2002 Sep 18;40(6):1034-1040. PubMed PMID: 12354424. Link to Item
  - Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR, GUSTO-IIb GUSTO-III PURSUIT. Global Use of Strategies to Open Occluded Coronary Arteries. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy , PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network . Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002 Aug 20;106(8):974-980. PubMed PMID: 12186803. Link to Item
  - Bahit MC, Criger DA, Ohman EM, Granger CB, Wagner GS. Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa data). Am J Cardiol. 2002 Aug 1;90(3):233-237. PubMed PMID: 12127609. Link to Item
  - Kottke-Marchant K, Bahit MC, Granger CB, Zoldhelyi P, Ardissino D, Brooks L, Griffin JH, Potthoff RF, Van de Werf F, Califf RM, Topol EJ. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy. Eur Heart J. 2002 Aug;23(15):1202-1212. PubMed PMID: 12127922. Link to Item
  - Newby LK, Harrington RA, Bhapkar MV, Van de Werf F, Hochman JS, Granger CB, Simes RJ, Davis CG, Topol EJ, Califf RM, Moliterno DJ, PARAGON A Investigators . An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A. J Thromb Thrombolysis. 2002 Aug;14(1):33-42. PubMed PMID: 12652148. Link to Item
  - Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, Armstrong PW, Van de Werf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002 Jul 16;106(3):309-312. PubMed PMID: 12119245. Link to Item
  - Gilchrist IC, Berkowitz SD, Thompson TD, Califf RM, Granger CB. Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries. Am Heart J. 2002 Jul;144(1):73-80. PubMed PMID: 12094191. Link to Item
  - Newby LK, Califf RM, White HD, Harrington RA, Van de Werf F, Granger CB, Simes RJ, Hasselblad V, Armstrong PW. The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. Am J Med. 2002 Jun 1;112(8):647-658. PubMed PMID: 12034415. Link to Item
  - Granger CB, Alexander JH, Lesaffre E, Wallentin L, Armstrong PW, Van de Werf F. Differential impact of antithrombotic treatments combined with tenecteplase in the elderly with acute myocardial infarction: Results from ASSENT-3. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2002 Mar 6;39(5):306A-306A. Link to Item
  - McGuire DK, Rao SV, Joski PJ, Barsness GW, Peterson ED, Jollis JG, Feinglos MN, Granger CB. Diabetes is associated with a higher risk of death than is prior myocardial infarction in the setting of coronary disease: Results from the Duke cardiovascular database. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2002 Mar 6;39(5):329A-329A. Link to Item
  - Bahit MC, Granger CB, Wallentin L. Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment. Am Heart J. 2002 Feb;143(2):205-216. PubMed PMID: 11835022. (Review) Link to Item
  - Savonitto S, Granger CB, Ardissino D, Gardner L, Cavallini C, Galvani M, Ottani F, White HD, Armstrong PW, Ohman EM, Pieper KS, Califf RM, Topol EJ, GUSTO-IIb Investigators . The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol. 2002 Jan 2;39(1):22-29. PubMed PMID: 11755282. Link to Item
  - Birnbaum Y, Mahaffey KW, Criger DA, Gates KB, Barbash GI, Barbagelata A, Clemmensen P, Sgarbossa EB, Gibbons RJ, Rahman MA, Califf RM, Granger CB, Wagner GS, AMISTAD (Acute Myocardial Infarction Study of Adenosine) Investigators . Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis. Cardiology. 2002 Jan;97(3):166-174. PubMed PMID: 12077570. Full Text
  - Donahue M, Kraus W, Granger C. Genetics in heart failure: Practical incorporation of this new biologic dimension. American Heart Journal. 2002;144(6):938-940. PubMed PMID: 12486417. Full Text
  - Gilchrist IC, Berkowitz SD, Thompson TD, Califf RM, Granger CB. Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience. American Heart Journal. 2002;144(1):73-80. Full Text
  - Goldberg RJ, Steg PG, Sadiq I, Granger CB, Jackson EA, Budaj A, Brieger D, Avezum A, Goodman S. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (The GRACE registry). American Journal of Cardiology. 2002;89(7):791-796. PubMed PMID: 11909560. Full Text
  - Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, Ribichini F, Granger C, Akhras F, Weaver WD, Simes RJ. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. European Heart Journal. 2002;23(7):550-557. PubMed PMID: 11922645. Full Text
  - Roe MT, Granger CB, Puma JA, Hellkamp AS, Hochman JS, Ohman EM, White HD, Van de Werf F, Armstrong PW, Ellis SG, Califf RM, Topol EJ. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Am J Cardiol. 2001 Dec 15;88(12):1403-A6. PubMed PMID: 11741559. Link to Item
  - Angeja BG, Alexander JH, Chin R, Li X, Barron HV, Armstrong PW, Granger CB, Van de Werf F, Gibson CM. Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial. The American journal of cardiology. 2001 Dec;88(11):1240-1245. PubMed PMID: 11728350. Full Text
  - Van de Werf F, Barron HV, Armstrong PW, Granger CB, Berioli S, Barbash G, Pehrsson K, Verheugt FW, Meyer J, Betriu A, Califf RM, Li X, Fox NL, ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic . Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. European heart journal. 2001 Dec;22(24):2253-2261. PubMed PMID: 11728145. Full Text
  - White H, Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators . Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet (London, England). 2001 Dec;358(9296):1855-1863. PubMed PMID: 11741625. Full Text
  - Fu Y, Goodman S, Chang WC, Van De Werf F, Granger CB, Armstrong PW. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation. 2001 Nov;104(22):2653-2659. PubMed PMID: 11723014. Full Text
  - Bahit MC, Alexander JH, She L, Armstrong PW, White HD, Van de Werf F, Granger CB. Increased risk of ICH with standard contraindications to fibrinolytic therapy: Results from ASSENT-2. CIRCULATION. 2001 Oct 23;104(17):539-539. Link to Item
  - Hasdai D, Topol EJ, Kilaru R, Battler A, Simoons ML, Harrington RA, Vahanian A, Ohman EMM, Granger CB, Van de Werf F, O'Connor CM, Holmes DR. Frequency, patient characteristics, and outcomes of mild to moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from four international fibrinolytic therapy trials. CIRCULATION. 2001 Oct 23;104(17):483-483. Link to Item
  - Rao SV, Newby LK, Ohman EM, Granger CB, Hasselblad V, Gibler BB, Christenson R. Elevated cardiac markers across a spectrum of patients with ACS: Defining the role of isolated troponin or CK-MB elevation. CIRCULATION. 2001 Oct 23;104(17):708-709. Link to Item
  - Serebruany VL, Malinin AI, Callahan KP, Binbreck AS, Van de Werf F, Alexander JH, Granger CB, Gurbel PA. Effect of tenecteplase versus alteplase on platelets in patients during the first three hours after acute myocardial infarction (the ASSENT-2 platelet substudy). CIRCULATION. 2001 Oct 23;104(17):539-539. Link to Item
  - Birnbaum Y, Goodman S, Barr A, Gates KB, Barbash GI, Battler A, Barbagelata A, Clemmensen P, Sgarbossa EB, Granger CB, Califf RM, Wagner GS. Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram. The American journal of cardiology. 2001 Oct;88(8):842-847. PubMed PMID: 11676944. Full Text
  - Hudson MP, Granger CB, Topol EJ, Pieper KS, Armstrong PW, Barbash GI, Guerci AD, Vahanian A, Califf RM, Ohman EM. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. Circulation. 2001 Sep 11;104(11):1229-1235. PubMed PMID: 11551872. Link to Item
  - Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, For the PURSUIT Investigators . Systematic adjudication of myocardial infarction end-points in an international clinical trial. (Published online) Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):180-186. PubMed PMID: 11806793. Full Text Link to Item
  - Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, For the PURSUIT Investigators . Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. (Published online) Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):187-194. PubMed PMID: 11806794. Full Text Link to Item
  - Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SG, Granger CB, Moliterno DJ, Van de Werf F, Califf RM, Topol EJ, Armstrong PW, PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network . Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001 Jul;38(1):64-71. PubMed PMID: 11451297. Link to Item
  - Bahit MC, Topol EJ, Califf RM, Armstrong PW, Criger DA, Hasselblad V, Betriu A, Hirsh J, Ardissino D, Granger CB. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. J Am Coll Cardiol. 2001 Mar 15;37(4):1001-1007. PubMed PMID: 11263599. Link to Item
  - Bahit MC, Topol EJ, Califf RM, Armstrong PW, Criger DA, Hasselblad V, Betriu A, Hirsh J, Ardissino D, Granger CB. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Journal of the American College of Cardiology. 2001 Mar;37(4):1001-1007. Full Text
  - Barbash GI, Birnbaum Y, Bogaerts K, Hudson M, Lesaffre E, Fu Y, Goodman S, Houbracken K, Munsters K, Granger CB, Pieper K, Califf RM, Topol EJ, Van De Werf F. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies. Circulation. 2001 Feb 20;103(7):954-960. PubMed PMID: 11181469. Link to Item
  - Al-Khatib SM, Ohman EM, White HD, Granger CB, Califf RM, Kilaru R, Topol EJ. Atrioventricular nodal block in acute myocardial infarction treated with thrombolytic therapy is common and portends poor prognosis: Results from large trials of thrombolytic therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb;37(2):341S-341S. Link to Item
  - Alexander JH, Li X, Chin R, Barron H, Granger CB, Armstrong PW, Van de Werf F. Risk of major bleeding in patients treated with PTCA early following thrombolysis with TNK vs. t-PA. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb;37(2):349A-350A. Link to Item
  - Armstrong PW, Granger C, Van de Werf F. Bolus fibrinolysis: risk, benefit, and opportunities. Circulation. 2001 Feb;103(8):1171-1173. PubMed PMID: 11222483. Full Text
  - Bahit MC, Alexander JH, Tasissa G, Armstrong PW, Califf RM, Granger CB. Higher coronary intervention following acute MI associated with lower rates of evidence-based medical therapy in regions of North America: Results from ASSENT II. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb;37(2):351A-351A. Link to Item
  - Bahit MC, Criger DA, Granger CB, Ohman EM, Wagner GS. Elevation of CK-MB greater than 2 fold and troponin greater than 3 fold are the best thresholds for identifying MI associated with ECG evolution. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb;37(2):115A-116A. Link to Item
  - Mahaffey KW, Roe MT, Sparapani R, Dyke CB, Alexander JH, Berdan LG, Granger CB, Ohman M, Califf RM, Topol EJ, Harrington RA. Cardiac enzyme elevations after coronary artery bypass grafting associated with increased risk of death: Results from PARAGON-B. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb;37(2):359A-359A. Link to Item
  - Bahit MC, Topol EJ, Califf RM, Armstrong PW, Criger DA, Hasselbad V, Betriu A, Hirsh J, Ardissino D, Granger CB. Erratum: Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb (Journal of American College of Cardiology (2001) 37 (1001-1007)) [1]. Journal of the American College of Cardiology. 2001;37(7):2012--.
  - Birnbaum Y, Criger DA, Wagner GS, Strasberg B, Mager A, Gates K, Granger CB, Ross AM, Barbash GI. Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram. American Heart Journal. 2001;141(6):915-924. PubMed PMID: 11376304. Full Text
  - Callahan KP, Malinin AI, Gurbel PA, Alexander JH, Granger CB, Atar D, Serebruany VL. Platelets and thrombolysis: Cooperation or contrariety?. HeartDrug. 2001;1(5):281-290. Full Text
  - Callahan KP, Malinin AI, Gurbel PA, Alexander JH, Granger CB, Serebruany VL. Platelet function and fibrinolytic agents: two sides of a coin?. Cardiology. 2001;95(2):55-60. PubMed PMID: 11423707. (Academic Article)
  - Fox KAA, Gore JM, Eagle KA, Steg PG, Agnelli G, Avezum A, Paulo S, Brieger D, Budaj A, Cannon CP, Goldberg RJ, Goodman S, Gulba DC, Volhard F, Granger C, Kennelly BM, Gurfinkel E, López-Sendón J, Klein W, Montalescot G, Werf FVD. Rationale and design of the grace (global registry of acute coronary events) project: A multinational registry of patients hospitalized with acute coronary syndromes. American Heart Journal. 2001;141(2):190-199. PubMed PMID: 11174331. Full Text
  - Granger C. Acute coronary syndromes: introducing new therapies into established guidelines. Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society. 2001;Suppl:12-15. PubMed PMID: 11434052.
  - Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(1 SUPPL.):64S-94S.
  - Kaul P, Fu Y, Chang W-C, Harrington RA, Wagner GS, Goodman SG, Granger CB, Moliterno DJ, Werf FDV, Califf RM, Topol EJ, Armstrong PW. Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb. Journal of the American College of Cardiology. 2001;38(1):64-71. Full Text
  - Lauer MA, Houghtaling PL, Peterson JG, Granger CB, Bhatt DL, Sapp SK, Simoons ML, Harrington RA, Topol EJ, Lincoff AM. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes obesrvations from the platelet IIb/IIIa in unstable agina: Receptor suppression using integrilin therapy (PURSUIT) trail. Circulation. 2001;104(23):2772-2777. PubMed PMID: 11733393.
  - Roe MT, Ohman EM, Maas AC, Christenson RH, Mahaffey KW, Granger CB, Harrington RA, Califf RM, Krucoff MW. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol. 2001 Jan;37(1):9-18. PubMed PMID: 11153779. (Review) Link to Item
  - Savonitto S, Fusco R, Granger CB, Cohen MG, Thompson TD, Ardissino D, Califf RM. Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes. Ann Noninvasive Electrocardiol. 2001 Jan;6(1):64-77. PubMed PMID: 11174865. Link to Item
  - Sekaran NK, Moliterno DJ, Ferguson JJ, Every MPH, Anderson HV, Aguirre FV, French WJ, Sapp S, Booth JE, Granger CB, Cannon CP. "Hot" unstable angina - Is it worse than subacute unstable angina? Results from the GUARANTEE registry. Journal of Thrombosis and Thrombolysis. 2001;12(3):207-216. PubMed PMID: 11981103. Full Text
  - Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol. 2000 Dec 28;86(12B):4M-9M. PubMed PMID: 11206020. Link to Item
  - Armstrong PW, Granger C, Van de Werf F. Intracranial haemorrhage with bolus thrombolytic agents. Lancet (London, England). 2000 Nov;356(9244):1849-. PubMed PMID: 11117934. (Letter) Full Text
  - Collen D, Sobel B. Intracranial haemorrhage with bolus thrombolytic agents. Lancet (London, England). 2000 Nov;356(9244):1848-. PubMed PMID: 11117932. (Letter) Full Text
  - McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, White HD, Ardissino D, Box JW, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J. 2000 Nov;21(21):1750-1758. PubMed PMID: 11052839. Full Text Link to Item
  - Alexander JH, Poku MB, Card TL, Gibler WB, Granger CB. Randomization in a clinical trial only modestly delays time to treatment in acute myocardial infarction patients undergoing thrombolysis - Results from the ASSENT-2 Emergency Department Registry. CIRCULATION. 2000 Oct 31;102(18):796-796. Link to Item
  - Bahit MC, Granger CB, Alexander KP, Kramer J, Lapointe NMA, Califf RM. Applying the evidence: Opportunity in US for 80,000 additional lives saved per year. CIRCULATION. 2000 Oct 31;102(18):873-873. Link to Item
  - Fu YL, Chang WC, Alexander JH, Granger CB, Newby LK, Betriu A, Aylward PE, Van de Werf F, Armstrong PW. Contemporary changes in early discharge and outcomes in acute myocardial infarction in ASSENT-2. CIRCULATION. 2000 Oct 31;102(18):434-434. Link to Item
  - Granger CB, Alexander JH, Armstrong PW. Caution needed in interpreting the impact of dosing errors: A case study from ASSENT-2. CIRCULATION. 2000 Oct 31;102(18):590-590. Link to Item
  - Gupta M, Chang WC, Van de Werf F, Granger CB, Barbash G, Pehrsson K, Oto A, Toutouzas PK, Jansky P, Armstrong PW. International differences in in-hospital revascularization and outcomes following acute myocardial infarction (AMI) in ASSENT-2. CIRCULATION. 2000 Oct 31;102(18):434-434. Link to Item
  - O'Shea JC, Wilcox RG, Granger CB, Skene AM, Stebbins AL, Aylward PE, Sadowski Z, Bode C, Califf RM, Ohman EM. Neither education level nor social isolation is an independent predictor of short-term mortality after acute myocardial infarction: Results from the GUSTO III trial. CIRCULATION. 2000 Oct 31;102(18):511-511. Link to Item
  - Birnbaum Y, Wagner GS, Gates KB, Thompson TD, Barbash GI, Siegel RJ, Granger CB, Fishbein MC, Crenshaw BS, Califf RM. Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction. Am J Cardiol. 2000 Oct 15;86(8):830-834. PubMed PMID: 11024396. Link to Item
  - Shah MR, Granger CB, Bart BA, McMurray JJ, Petrie MC, Michelson EL, Tudor GE, Swedberg K, Stevenson LW, Califf RM, Pfeffer MA. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med. 2000 Oct 15;109(6):489-492. PubMed PMID: 11042239. Link to Item
  - Chang WC, Fu Y, Ohman EM, Gupta M, Morris A, Roth SN, Granger CB, Califf RM, Topol EJ, Mark DB, Armstrong PW. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. Can J Cardiol. 2000 Oct;16(10):1231-1239. PubMed PMID: 11064297. Link to Item
  - Granger CB, Keavney B, Francomano C, Olsson G, Yusuf S. Recommendations for national and local regulatory authorities concerning research in genetic markers of disease. Am Heart J. 2000 Oct;140(4):S3-S5. PubMed PMID: 11011309. (Review) Full Text Link to Item
  - Granger CB. Genetics of coronary heart disease: current understanding and future prospects. Am Heart J. 2000 Oct;140(4):S1-S2. PubMed PMID: 11011308. Link to Item
  - Hauser ER, Mooser V, Schmidt S, Crossman DC, Haines JL, Jones C, Winkelmann B, Foster C, Haynes C, Dowdy ZE, Estabrooks SE, Middleton LT, Manasco P, Roses AD, Granger CB, Kraus WE, Pericak-Vance MA. Concordance for cardiovascular risk factors in affected sib pairs (ASPs) with early-onset coronary artery disease (CAD). AMERICAN JOURNAL OF HUMAN GENETICS. 2000 Oct;67(4):212-212. Link to Item
  - Winkelmann BR, Hager J, Kraus WE, Merlini P, Keavney B, Grant PJ, Muhlestein JB, Granger CB. Genetics of coronary heart disease: current knowledge and research principles. Am Heart J. 2000 Oct;140(4):S11-S26. PubMed PMID: 11011311. (Review) Full Text Link to Item
  - Fu Y, Chang WC, Mark D, Califf RM, Mackenzie B, Granger CB, Topol EJ, Hlatky M, Armstrong PW. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators. Circulation. 2000 Sep;102(12):1375-1381. PubMed PMID: 10993855. Full Text
  - Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA. 2000 Aug 16;284(7):876-878. PubMed PMID: 10938178. Link to Item
  - Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Knight D, Mark DB, Granger CB, Agranatti DA, Mautner B, Ohman EM, Suárez LD, Armstrong PW, Gates K, Wagner GS. Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial). The American journal of cardiology. 2000 Jul;86(1):24-29. PubMed PMID: 10867087. Full Text
  - Hasdai D, Granger CB, Srivatsa SS, Criger DA, Ellis SG, Califf RM, Topol EJ, Holmes DR. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. J Am Coll Cardiol. 2000 May;35(6):1502-1512. PubMed PMID: 10807453. Link to Item
  - Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J. 2000 Apr;139(4):609-617. PubMed PMID: 10740141. Link to Item
  - Granger CB, Skene A. Acute ischemic heart disease. Am Heart J. 2000 Apr;139(4):S189-S192. PubMed PMID: 10740129. Link to Item
  - Brener SJ, Ellis SG, Sapp SK, Betriu A, Granger CB, Burchenal JE, Moliterno DJ, Califf RM, Topol EJ. Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. Am Heart J. 2000 Mar;139(3):476-481. PubMed PMID: 10689262. Link to Item
  - Shah A, Wagner GS, Granger CB, O'Connor CM, Green CL, Trollinger KM, Califf RM, Krucoff MW. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol. 2000 Mar 1;35(3):666-672. PubMed PMID: 10716469. Link to Item
  - Alexander JH, Granger CB, Califf RM, White HD, Hochman J, Topol EJ, Van de Werf F. Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: Results from ASSENT-2. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):372A-372A. Link to Item
  - Cohen MG, Hudson MP, Granger CB, Kong DF, Gardner LH, Wagner GS, Califf RM, Savonitto S, Topol EJ. Quantitative electrocardiographic variables predict adverse outcomes in Non-ST elevation acute coronary syndromes: Results from GUSTO IIb. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):410A-411A. Link to Item
  - Hudson MP, Barbash GI, Granger CB, Birnbaum Y, Houbracken K, Pieper KS, Ohman EM, Topol EJ, Califf RM, Van de Werf F. Temporal and regional differences in therapy for reinfarction following thrombolysis: Results from GUSTO I and ASSENT II. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):386A-386A. Link to Item
  - Roe MT, Alexander JH, Pacchiana CM, Harrington RA, Granger CB, Califf RM, Topol EJ. Elevated CK-MB following coronary intervention in patients with acute coronary syndromes is associated with a four-fold increase in mortality: Results from the GUSTO-IIb and PURSUIT trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):40A-40A. Link to Item
  - Roe MT, Granger CB, Ohman EM, Califf RM, Hellkamp A, Topol EJ, White HD, Hochman J, Van De Werf F. Hirudin significantly reduces ischemic events following coronary intervention for acute coronary syndromes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):39A-40A. Link to Item
  - Shah MR, Bahit MC, Granger CB, Beasley D, White HD, Topol EJ, Califf RM. Clinical features of patients with heart failure after an acute coronary syndrome: Findings from GUSTO-IIb. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Feb;35(2):212A-213A. Link to Item
  - Batchelor WB, Granger CB, Kleiman NS, Phillips HR, Ellis SG, Betriu A, Criger DA, Stebbins AL, Topol EJ, Califf RM. A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). American Journal of Cardiology. 2000;85(6):692-697. PubMed PMID: 12000041. Full Text
  - Chang WC, Fu Y, Ohman EM, Gupta M, Morris A, Roth SN, Granger CB, Califf RM, Topol EJ, Mark DB, Armstrong PW. Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States. Canadian Journal of Cardiology. 2000;16(10):1231-1239.
  - Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation. 2000;101(1):27-32. PubMed PMID: 10618300.
  - Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. American Journal of Cardiology. 2000;86(12 B):4M-9M.
  - Granger CB. When is angina good? Preconditioning in acute myocardial infarction. American Heart Journal. 2000;139(5):771-772. PubMed PMID: 10783208.
  - Hasdai D, Granger CB, Srivatsa SS, Criger DA, Ellis SG, Califf RM, Topol EJ, Jr DRH. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy. Journal of the American College of Cardiology. 2000;35(6):1502-1512. Full Text
  - O'Shea JC, Wilcox RG, Granger CB, Skene AM, Stebbins AL, Aylward PE, Armstrong PA, Topol EJ, Califf RM, Ohman EM. Educational level and 30-day mortality after acute myocardial infarction: results from the GUSTO III trial. EUROPEAN HEART JOURNAL. 2000;21:223-223. Link to Item
  - O'Shea JC, Wilcox RG, Granger CB, Skene AM, Stebbins AL, Bode C, Sadowski Z, Topol EJ, Califf RM, Ohman EM. Social isolation and 30-day mortality after acute myocardial infarction: results from the GUSTO III trial. EUROPEAN HEART JOURNAL. 2000;21:213-213. Link to Item
  - Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Cannon CP. Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry. American Heart Journal. 1999 Dec 17;138(6 I):1065-1072.
  - O'Connor CM, Gattis WA, Gheorghiade M, Granger CB, Gilbert J, McKenney JM, Messineo FC, Burnett JC, Katz SD, Elkayam U, Kasper EK, Goldstein S, Cody RJ, Massie BM, Investigators USE. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: The US Ecadotril Pilot Safety Study. AMERICAN HEART JOURNAL. 1999 Dec;138(6):1140-1148. Full Text Link to Item
  - O'Connor CM, Gattis WA, Gheorghiade M, Granger CB, Gilbert J, McKenney JM, Messineo FC, Burnett JC, Katz SD, Elkayam U, Kasper EK, Goldstein S, Cody RJ, Massie BM. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J. 1999 Dec;138(6 Pt 1):1140-1148. PubMed PMID: 10577446. Link to Item
  - Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Cannon CP, Investigators GUARANTEE. Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry. AMERICAN HEART JOURNAL. 1999 Dec;138(6):1065-1072. PubMed PMID: 10577436. Full Text Link to Item
  - Holmes DR, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, Vahanian A, Bates ER, Topol EJ. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999 Nov 16;100(20):2067-2073. PubMed PMID: 10562262. Link to Item
  - Cohen MG, Granger CB, Ohman EM, Stebbins AL, Grinfeld LR, Cagide AM, Elizari MV, Betriu A, Kong DF, Topol EJ, Califf RM. Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1999 Nov 15;34(6):1729-1737. PubMed PMID: 10577563. Link to Item
  - Armstrong PW, Fu YL, Chang WC, Kaul P, Granger CB, Ohman EM. Increased early discharge does not compromise mortality: Insights from GUSTO I and GUSTO III. CIRCULATION. 1999 Nov 2;100(18):499-499. Link to Item
  - Chetcuti SJ, Silva S, Granger CB, Berger PB, Bates ER. The effect of infarct location in cardiogenic shock: The GUSTO experience. CIRCULATION. 1999 Nov 2;100(18):302-303. Link to Item
  - Goldmann BU, Ohman EM, Hamm CW, Bastos E, Newby K, Granger CB, Christenson RH, Califf RM. Is the adverse outcome with positive troponin T neutralized by revascularization? Results from GUSTO-IIa. CIRCULATION. 1999 Nov 2;100(18):810-810. Link to Item
  - Hudson MP, Granger CB, Stebbins AL, White HD, Bates ER, Greenbaum AB, Ohman EM. Cardiogenic shock survival and use of intraaortic balloon counterpulsation: Results from the GUSTO I and III trials. CIRCULATION. 1999 Nov 2;100(18):370-370. Link to Item
  - Mahaffey KW, Lee KL, White HD, Gore JM, Weaver WD, Granger CB, Califf RM, Sloan MA. Intracranial hemorrhage on the increase and beyond predicted levels: Serial results from two large thrombolysis trials. CIRCULATION. 1999 Nov 2;100(18):182-182. Link to Item
  - McGuire DK, Emanuelsson H, Charnwood A, Granger CB, White HD. Diabetes mellitus is associated with worse clinical outcomes across the spectrum of acute coronary syndromes: Results from GUSTO-IIb. CIRCULATION. 1999 Nov 2;100(18):432-432. Link to Item
  - Shah MR, Granger CB, Bart BA, McMurray JJ, Petrie MC, Tudor GE, Michelson EL, Stevenson LW, Califf RM, Pfeffer MA. Women are more likely to have adverse effects from angiotensin-converting enzyme inhibitors: Results from the SPICE registry. CIRCULATION. 1999 Nov 2;100(18):537-537. Link to Item
  - Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. Journal of the American College of Cardiology. 1999 Nov;34(6):1711-1720. PubMed PMID: 10577561. Full Text
  - McGuire DK, Granger CB. Diabetes and ischemic heart disease. Am Heart J. 1999 Nov;138(5 Pt 1):S366-S375. PubMed PMID: 10539799. (Review) Link to Item
  - Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. Am Heart J. 1999 Sep;138(3 Pt 1):493-499. PubMed PMID: 10467200. Link to Item
  - Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators , Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, Betriu A, Binbrek AS, Califf R, Diaz R, Fanebust R, Fox K, Granger C, Heikkilä J, Husted S, Jansky P, Langer A, Lupi E, Maseri A, Meyer J, Mlczoch J, Mocceti D, Myburgh D, Oto A, Paolasso E, Pehrsson K, Seabra-Gomes R, Soares-Piegas L, Sùgrue D, Tendera M, Topol E, Toutouzas P, Vahanian A, Verheugt F et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (London, England). 1999 Aug;354(9180):716-722. PubMed PMID: 10475182. Full Text
  - Bart BA, Ertl G, Held P, Kuch J, Maggioni AP, McMurray J, Michelson EL, Rouleau JL, Warner Stevenson L, Swedberg K, Young JB, Yusuf S, Sellers MA, Granger CB, Califf RM, Pfeffer MA. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J. 1999 Aug;20(16):1182-1190. PubMed PMID: 10448027. Full Text Link to Item
  - Berger PB, Ellis SG, Holmes DR, Granger CB, Criger DA, Betriu A, Topol EJ, Califf RM. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999 Jul 6;100(1):14-20. PubMed PMID: 10393675. Link to Item
  - Batchelor WB, Peterson ED, Mark DB, Knight JD, Granger CB, Armstrong PW, Califf RM. A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. Journal of the American College of Cardiology. 1999 Jul;34(1):12-19. PubMed PMID: 10399985. Full Text
  - Mahaffey KW, Harrington RA, Simoons ML, Granger CB, Graffagnino C, Alberts MJ, Laskowitz DT, Miller JM, Sloan MA, Berdan LG, MacAulay CM, Lincoff AM, Deckers J, Topol EJ, Califf RM. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. Circulation. 1999 May 11;99(18):2371-2377. PubMed PMID: 10318656. Link to Item
  - Alexander JH, Granger CB, Sadowski Z, Aylward PE, White HD, Thompson TD, Califf RM, Topol EJ. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. Am Heart J. 1999 May;137(5):799-805. PubMed PMID: 10220627. Link to Item
  - Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, Granger CB. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J. 1999 May;137(5):792-798. PubMed PMID: 10220626. Link to Item
  - Hasdai D, Lerman A, Rihal CS, Criger DA, Garratt KN, Betriu A, White HD, Topol EJ, Granger CB, Ellis SG, Califf RM, Holmes DR. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J. 1999 Apr;137(4 Pt 1):612-620. PubMed PMID: 10097222. Link to Item
  - Hasdai D, Lerman A, Rihal CS, Criger DA, Garratt KN, Betriu A, White HD, Topol EJ, Granger CB, Ellis SG, Califf RM, Holmes DR. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. AMERICAN HEART JOURNAL. 1999 Apr;137(4):612-620. Full Text Link to Item
  - Savonitto S, Ardissino D, Granger CB, Morando G, Prando MD, Mafrici A, Cavallini C, Melandri G, Thompson TD, Vahanian A, Ohman EM, Califf RM, Van de Werf F, Topol EJ. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999 Feb 24;281(8):707-713. PubMed PMID: 10052440. Link to Item
  - Tung CY, Granger CB, Sloan MA, Topol EJ, Knight JD, Weaver WD, Mahaffey KW, White H, Clapp-Channing N, Simoons ML, Gore JM, Califf RM, Mark DB. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. Circulation. 1999 Jan 26;99(3):370-376. PubMed PMID: 9918523. Link to Item
  - Alexander JH, Granger CB, Sadowski Z, Aylward PE, White HD, Thompson TD, Califf RM, Topol EJ. Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials. American Heart Journal. 1999;137(5):799-805. Full Text
  - Barbagelata A, Carli MFD, Sgarbossa EB, Califf RM, Clemmensen P, Criger DA, Gates KB, Gibbons RJ, Casabe H, Granger CB, Wagner GS, Mahaffey KW. The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: An AMISTAD substudy. Journal of Electrocardiology. 1999;32(SUPPL.):111-113.
  - Barbagelata A, Di Carli MF, Sgarbossa EB, Califf RM, Clemmensen P, Criger DA, Gates KB, Gibbons RJ, Casabe H, Granger CB, Wagner GS, Mahaffey KW. The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: an AMISTAD substudy. Acute Myocardial Infarction Study Adenosine. J Electrocardiol. 1999;32 Suppl:111-113. PubMed PMID: 10688313. Link to Item
  - Birnbaum Y, Wagner GS, Barbash GI, Gates K, Criger DA, Sclarovsky S, Siegel RJ, Granger CB, Reiner JS, Ross AM. Correlation of angiographic findings and right (V₁ to V₃) versus left (V₄ to V₆) precordial ST-segment depression in inferior wall acute myocardial infarction. American Journal of Cardiology. 1999;83(2):143-148. PubMed PMID: 10073811. Full Text
  - Cohen MG, Granger CB, Ohman EM, Stebbins AL, Grinfeld LR, Cagide AM, Elizari MV, Betriu A, Kong DF, Topol EJ, Califf RM. Outcome of hispanic patients treated with thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I and -III trials. Journal of the American College of Cardiology. 1999;34(6):1729-1737. Full Text
  - Granger CB, Califf RM. The gusto trials. Journal of Interventional Cardiology. 1999;12(1):13-31.
  - Hasdai D, Lerman A, Rihal CS, Criger DA, Garratt KN, Betriu A, White HD, Topol EJ, Granger CB, Ellis SG, Califf RM, Jr HDR. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. American Heart Journal. 1999;137(4 I):612-620.
  - Kleiman NS, Granger CB, White HD, Armstrong P, Ardissino D, Van de Werf F, Zoldeyhi P, Thompson TD, Califf RM, Topol EJ. Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb. American Heart Journal. 1999 Jan;137(1):12-23. Full Text
  - Kleiman NS, Granger CB, White HD, Armstrong P, Ardissino D, de Werf FV, Zoldeyhi P, Thompson TD, Califf RM, Topol EJ. Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion. Am Heart J. 1999 Jan;137(1):12-23. PubMed PMID: 9878932. Link to Item
  - Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I trial. American Heart Journal. 1999;138(3 I):493-499. Full Text
  - Mahaffey KW, Toth CA, White HD, Stebbins AL, Granger CB, Chatterjee K. Thrombolytic therapy for acute MI in diabetics with retinopathy. Cardiology Review. 1999;16(11):27-32.
  - McGuire DK, Granger CB. Diabetes and ischemic heart disease. American Heart Journal. 1999;138(5 I):S366-S375. Full Text
  - O'Connor CM, Gattis WA, Gheorghiade M, Granger CB, Gilbert J, McKenney JM, Messineo FC, Burnett JC, Katz SD, Elkayam U, Kasper EK, Goldstein S, Cody RJ, Massie BM. A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: The U.S. Ecadotril Pilot Safety Study. American Heart Journal. 1999;138(6 I):1140-1148.
  - Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD, Gibler WB, Stebbins AL, Cianciolo C, Califf RM, Topol EJ. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. American Journal of Cardiology. 1999;84(11):1281-1286. PubMed PMID: 10614791. Full Text
  - Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Arnold A, Sapp SK, Booth JE, Ferguson JJ, Cannon CP. Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry). American Journal of Cardiology. 1999;84(10):1145-1150. PubMed PMID: 10569321. Full Text
  - Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Cannon CP. Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry. American Heart Journal. 1999;138(6 I):1065-1072.
  - Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, Olofsson B, Ostergren J, Yusuf S. Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and design. Journal of Cardiac Failure. 1999;5(3):276-282. PubMed PMID: 10496201. Full Text
  - Tung CY, Granger CB, Sloan MA, Topol EJ, Knight JD, Weaver WD, Mahaffey KW, White H, Clapp-Channing N, Simoons ML, Gore JM, Califf RM, Mark DB. Effects of stroke on medical resource use and costs in acute myocardial infarction. Circulation. 1999;99(3):370-376.
  - Alexander KP, Peterson ED, Granger CB, Casas AC, Van de Werf F, Armstrong PW, Guerci A, Topol EJ, Califf RM. Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial. J Am Coll Cardiol. 1998 Dec;32(7):2023-2030. PubMed PMID: 9857888. Link to Item
  - Newby LK, Christenson RH, Ohman EM, Armstrong PW, Thompson TD, Lee KL, Hamm CW, Katus HA, Cianciolo C, Granger CB, Topol EJ, Califf RM. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation. 1998 Nov 3;98(18):1853-1859. PubMed PMID: 9799204. Link to Item
  - Zabel KM, Granger CB, Becker RC, Bovill EG, Hirsh J, Aylward PE, Topol EJ, Califf RM. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Am Heart J. 1998 Nov;136(5):868-876. PubMed PMID: 9812083. Link to Item
  - Armstrong PW, Fu YL, Chang WC, Granger CB, Betriu A, Van de Werf F, Lee KL. Acute coronary syndromes: Prognostic insights from GUSTO IIb. CIRCULATION. 1998 Oct 27;98(17):630-630. Link to Item
  - Armstrong PW, Fu YL, Chang WC, MacKenzie M, Mark DB, Granger CB, Califf RM. Canadian-American differences in management and outcome of non ST elevation acute coronary syndromes: 6 month follow up from the GUSTO IIb study. CIRCULATION. 1998 Oct 27;98(17):479-480. Link to Item
  - Batchelor WB, Peterson ED, Knight DJ, Armstrong PW, Granger CB. The use of a clinical predictive model for severe coronary artery disease improves the efficiency of cardiac catheterization in both the US and Canada. CIRCULATION. 1998 Oct 27;98(17):135-135. Link to Item
  - Di Carli MF, Barbagelata A, Mahaffey KW, Casas CA, Puma JA, Granger CB. Does preinfarction angina reduce infarct size? An ancillary study from the controlled, randomized AMISTAD trial. CIRCULATION. 1998 Oct 27;98(17):630-630. Link to Item
  - Fu YL, Armstrong PW, Chang WC, Ohman EM, Gupta M, Morris A, Roth SN, Granger CB, Califf RM, Mark DB. Impact of temporal trends in management on outcomes of acute myocardial infarction in Canada versus US. CIRCULATION. 1998 Oct 27;98(17):479-479. Link to Item
  - Miller JM, Ohman EM, Hasselblad V, Granger CB, Sketch MH, Kong DF, Califf RM. Can TIMI grade 3 flow at 60 minutes after thrombolysis substitute as a new angiographic standard? A meta-analytic approach. CIRCULATION. 1998 Oct 27;98(17):784-784. Link to Item
  - Roe MT, Bhatt DL, Houghtaling P, Granger CB. A three-fold subsequent risk of death or reinfarction among patients with creatine kinase elevation after percutaneous coronary intervention: Results of the GUSTO IIb study of acute coronary syndromes. CIRCULATION. 1998 Oct 27;98(17):496-496. Link to Item
  - Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT, Koudstaal P, White HD, Gore JM, Simoons ML, Weaver WD, Green CL, Topol EJ, Califf RM. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation. 1998 Oct 6;98(14):1376-1382. PubMed PMID: 9760291. Link to Item
  - Harrington RA, Kleiman NS, Granger CB, Ohman EM, Berkowitz SD. Relation between inhibition of platelet aggregation and clinical outcomes. Am Heart J. 1998 Oct;136(4 Pt 2 Su):S43-S50. PubMed PMID: 9778087. (Review) Link to Item
  - Gebel JM, Sila CA, Sloan MA, Granger CB, Weisenberger JP, Green CL, Topol EJ, Mahaffey KW. Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke. 1998 Sep;29(9):1799-1801. PubMed PMID: 9731597. Link to Item
  - Granger CB. Heparin management in acute myocardial infarction (AMI). Aust N Z J Med. 1998 Aug;28(4):541-547. PubMed PMID: 9777136. Link to Item
  - Metz BK, White HD, Granger CB, Simes R, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ. Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial. Journal of the American College of Cardiology. 1998 Jun;31(7):1493-1498. Full Text
  - Metz BK, White HD, Granger CB, Simes RJ, Armstrong PW, Hirsh J, Fuster V, MacAulay CM, Califf RM, Topol EJ. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. J Am Coll Cardiol. 1998 Jun;31(7):1493-1498. PubMed PMID: 9626825. Link to Item
  - Hochrein J, Sun F, Pieper KS, Lee KL, Gates KB, Armstrong PW, Weaver WD, Goodman SG, Topol EJ, Califf RM, Granger CB, Wagner GS. Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. Am J Cardiol. 1998 May 1;81(9):1078-1084. PubMed PMID: 9605045. Link to Item
  - Califf RM, Granger CB. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points. Diabetes Care. 1998 Apr;21(4):655-657. PubMed PMID: 9571359. Link to Item
  - Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW. Prognostic significance of ST segment early after resolution ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST segment monitoring substudy. Journal of the American College of Cardiology. 1998 Mar 15;31(4):786-789.
  - Mahaffey KW, Granger CB, Sloan MA, Thompson TD, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation. 1998 Mar 3;97(8):757-764. PubMed PMID: 9498539. Link to Item
  - Christenson RH, Duh SH, Newby LK, Ohman EM, Califf RM, Granger CB, Peck S, Pieper KS, Armstrong PW, Katus HA, Topol EJ. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem. 1998 Mar;44(3):494-501. PubMed PMID: 9510853. Link to Item
  - Esposito GA, Dunham G, Granger BB, Tudor GE, Granger CB. Converting i.v. nitroglycerin therapy to nitroglycerin ointment therapy: a comparison of two methods. Am J Crit Care. 1998 Mar;7(2):123-130. PubMed PMID: 9509226. Link to Item
  - Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke. 1998 Mar;29(3):563-569. PubMed PMID: 9506593. Link to Item
  - Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1998 Mar 1;31(3):497-505. PubMed PMID: 9502626. Link to Item
  - Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. Journal of the American College of Cardiology. 1998 Mar;31(4):783-789. PubMed PMID: 9525547. Full Text
  - Hathaway WR, Peterson ED, Wagner GS, Granger CB, Zabel KM, Pieper KS, Clark KA, Woodlief LH, Califf RM. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA. 1998 Feb 4;279(5):387-391. PubMed PMID: 9459474. Link to Item
  - Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998 Feb;31(2):241-251. PubMed PMID: 9462562. (Review) Link to Item
  - Gilchrist IC, Granger CB, Thompson TD, Califf RM. Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998 Feb;31(2):78A-78A. Full Text Link to Item
  - Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. Circulation. 1998 Feb;97(5):444-450. PubMed PMID: 9490238. Full Text
  - Granger CB, Van de Werf F, Armstrong PW, Simes J, White H, MacAulay CM, Califf RM, Topol EJ, Investigators GUTSTOI. Hirudin reduces death and myocardial (Re)infarction at 6-months: Follow-up results of the GUSTO IIb trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998 Feb;31(2):79A-79A. Full Text Link to Item
  - Krucoff MW, Green CL, Trollinger KM, Granger CB, Ohman EM, O'Connor CM, Harrington RA, Armstrong PW, Simoons ML, Topol EJ, Califf RM. A comparison of static serial vs continuous ST-segment recovery to predict outcome after lytics for MI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998 Feb;31(2):228A-229A. Full Text Link to Item
  - Mahaffey KW, Harrington RA, Graffagnino C, Alberts MJ, Sloan MA, Miller JM, Granger CB, Simoons ML, Topol EJ, Califf RM. Comparison of stroke rates in patients with acute coronary syndromes and patients with acute myocardial infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998 Feb;31(2):406A-406A. Full Text Link to Item
  - Mahaffey KW, Tardiff BE, Granger CB, Lee KL, Harrington RA, Topol EJ, Califf RM. Disagreement between site investigators and clinical event committees is common and can affect trial results. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998 Feb;31(2):184A-185A. Full Text Link to Item
  - Alexander KP, Peterson ED, Granger CB, Casas AC, Werf FVD, Armstrong PW, Guerci A, Topol EJ, Califf RM. Potential impact of evidence-based medicine in acute coronary syndromes: Insights from GUSTO-IIb. Journal of the American College of Cardiology. 1998;32(7):2023-2030. Full Text
  - Ardissino D, Merlini PA, Eisenberg PR, Kottke-Marchant K, Crenshaw BS, Granger CB. Coagulation markers and outcomes in acute coronary syndromes. American Heart Journal. 1998;136(4 II SUPPL.):S7-S18. PubMed PMID: 9778084. Full Text
  - Armstrong PW, Fu Y, Chang W-C, Topol EJ, Granger CB, Betriu A, Werf FVD, Lee KL, Califf RM. Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insights and impact of recurrent ischemia. Circulation. 1998;98(18):1860-1868. PubMed PMID: 9799205.
  - Every NR, Cannon CP, Granger C, Moliterno DJ, Aguirre FV, Talley JD, Booth J, Sapp S, Ferguson JJ. Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: Results from the GUARANTEE Registry. Journal of the American College of Cardiology. 1998;32(2):387-392. PubMed PMID: 9708465. Full Text
  - Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ. Thrombolysis-related intracranial hemorrhage: A radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Stroke. 1998;29(3):563-569.
  - Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: Results from the GUSTO-I trial. Journal of the American College of Cardiology. 1998;31(3):497-505. Full Text
  - Harrington RA, Kleiman NS, Granger CB, Ohman EM, Berkowitz SD. Relation between inhibition of platelet aggregation and clinical outcomes. American Heart Journal. 1998;136(4 II SUPPL.):S43-S50. Full Text
  - Hathaway WR, Peterson ED, Wagner GS, Granger CB, Zabel KM, Pieper KS, Clark KA, Woodlief LH, Califf RM. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. Journal of the American Medical Association. 1998;279(5):387-391. Full Text
  - Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: Mechanisms of action, Pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1998;114(5 SUPPL.):489S-510S.
  - Hochrein J, Sun F, Pieper KS, Lee KL, Gates KB, Armstrong PW, Weaver WD, Goodman SG, Topol EJ, Califf RM, Granger CB, Wagner GS. Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I Substudy). American Journal of Cardiology. 1998;81(9):1078-1084. Full Text
  - Mahaffey KW, Granger CB, Sloan MA. Assessing risk factors for nonhemorrhagic stroke after acute myocardial infarction. Cardiology Review. 1998;15(11):46-50.
  - Pfisterer M, Cox JL, Granger CB, Brener SJ, Naylor CD, Califf RM, Werf FVD, Stebbins AL, Lee KL, Topol EJ, Armstrong PW. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: The GUSTO-I experience. Journal of the American College of Cardiology. 1998;32(3):634-640. PubMed PMID: 9741504. Full Text
  - Sgarbossa EB, Pinski SL, Topol EJ, Califf RM, Barbagelata A, Goodman SG, Gates KB, Granger CB, Miller DP, Underwood DA, Wagner GS. Acute myocardial infarction and complete bundle branch block at hospital admission: Clinical characteristics and outcome in the thrombolytic era. Journal of the American College of Cardiology. 1998;31(1):105-110. PubMed PMID: 9426026. Full Text
  - Straznicky I, White HD, Granger CB, Aylward PE, Barbash GI, Topol EJ, Califf RM. Effects of four thrombolytic regimens in elderly patients. Cardiology Review. 1998;15(1):22-28.
  - Zabel KM, Granger CB, Becker RC, Bovill EG, Hirsh J, Aylward PE, Topol EJ, Califf RM. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I. American Heart Journal. 1998;136(5):868-876. Full Text
  - Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997 Dec;30(7):1606-1610. PubMed PMID: 9385883. Link to Item
  - Aylward PE, Sadowski Z, Granger CB, Ardissino D, Wilcox RG, Armstrong PW, Card T, Hartford M, White HD. International differences in outcomes: Results from the GUSTO-III trial. CIRCULATION. 1997 Oct 21;96(8):1118-1118. Link to Item
  - Batchelor WB, Granger CB, Phillips HR, Kleinman NS, Stebbins AL. Ionic, low osmolar contrast is associated with better outcome following direct PTCA: Results from GUSTO-IIb. CIRCULATION. 1997 Oct 21;96(8):2978-2978. Link to Item
  - Cannon CP, Scirica BM, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE. Racial differences in the management of unstable angina: Results from the GUARANTEE registry. CIRCULATION. 1997 Oct 21;96(8):3329-3329. Link to Item
  - Granger CB, Betriu A, Phillips HR, Stebbins AL, Califf RM. Nearly half of early benefit of direct angioplasty lost in longer term follow-up: 6-month results from the GUSTO-IIb direct angioplasty substudy. CIRCULATION. 1997 Oct 21;96(8):1137-1137. Link to Item
  - Mahaffey KW, Puma JA, Barbagelata A, Casas CA, Lambe L, Orlandi C, Gibbons RJ, Califf RM, Granger CB. Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. CIRCULATION. 1997 Oct 21;96(8):1144-1144. Link to Item
  - Miller JM, Phillips HR, Barness GW, Wildermann N, Betriu AB, Garcia EL, Aylward PE, Granger CB. TIMI grade 3 flow after primary coronary angioplasty predicts both early and late survival following acute myocardial infarction. CIRCULATION. 1997 Oct 21;96(8):2236-2236. Link to Item
  - Newby K, Harrington RA, Bhapkar M, Granger CB, Rames A, Moliterno D. Tight control of aPTT in acute coronary syndrome patients using an automated strategy for bedside heparin adjustment: Results from the PARAGON A trial. CIRCULATION. 1997 Oct 21;96(8):4200-4200. Link to Item
  - Anderson RD, Ohman EM, Holmes DR, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997 Sep;30(3):708-715. PubMed PMID: 9283530. Link to Item
  - Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1997 Jul;30(1):171-179. PubMed PMID: 9207639. Link to Item
  - Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, Granger CB, Ross AM, Califf RM, Topol EJ. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 1997 Jul 1;96(1):116-121. PubMed PMID: 9236425. Link to Item
  - Granger CB. Adenosine for myocardial protection in acute myocardial infarction. Am J Cardiol. 1997 Jun 19;79(12A):44-48. PubMed PMID: 9223363. (Review) Link to Item
  - Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. Circulation. 1997 Jun 3;95(11):2508-2516. PubMed PMID: 9184581. Link to Item
  - Berkowitz SD, Granger CB, Pieper KS, Topol EJ, Califf RM. Incidence and predictors of bleeding after antithrombin therapy for acute coronary syndromes: The GUSTO II trials. THROMBOSIS AND HAEMOSTASIS. 1997 Jun:PS963-PS963. Link to Item
  - Berkowitz SD, Granger CB, Thompson T, Kleiman NS, Topol EJ, Califf RM. Thombocytopenia was associated with greater hemorrhage and higher mortality in GUSTO IIb trial. THROMBOSIS AND HAEMOSTASIS. 1997 Jun:PS962-PS962. Link to Item
  - Alberts MJ, Davis JP, Graffagnino C, McClenny C, Delong D, Granger C, Herbstreith MH, Boteva K, Marchuk DA, Roses AD. Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage. Ann Neurol. 1997 May;41(5):683-686. PubMed PMID: 9153532. Full Text Link to Item
  - Califf RM, Lee KL, Granger CB, Ohman EM. Predictors of outcome of reperfusion therapy. Eur Heart J. 1997 May;18(5):728-735. PubMed PMID: 9152643. (Review) Link to Item
  - Jelesoff NE, Feinglos M, Granger CB, Califf RM. Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials. J Cardiovasc Risk. 1997 Apr;4(2):100-111. PubMed PMID: 9304491. (Review) Link to Item
  - Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators. J Am Coll Cardiol. 1997 Mar 15;29(4):770-777. PubMed PMID: 9091523. Link to Item
  - Barbagelata NA, Granger CB, Oqueli E, Suárez LD, Borruel M, Topol EJ, Califf RM. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis. American heart journal. 1997 Mar;133(3):273-282. PubMed PMID: 9060794. Full Text
  - Alexander KP, Peterson ED, Hellkamp AS, Granger CB, Topol EJ, Califf RM. Early catheterization is standard strategy in unstable angina/NQWMI: Results from GUSTO IIb. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):5614-5614. Link to Item
  - Alexander KP, Peterson ED, Mahaffey KW, Casas AC, Granger CB, VandeWerf F, Armstrong PW, Mark DB, Topol EJ, Califf RM. Medical interventions in unstable angina: Does international clinical practice match evidence-based guidelines?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):23138-23138. Link to Item
  - Amsterdam PB, Hafley GE, Harrington RA, Granger CB, Topol EJ, Califf RM. Is the ECG adequate to identify patients with left circumflex occlusion in acute coronary syndromes?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):78128-78128. Link to Item
  - Barbagelata A, Califf RM, Sgarbossa EB, Goodman S, Knight D, Mark DB, Granger CB, Benazzi MD, Calvo A, Gates K, Agranatti DA, Starr S, Song Q, Mautner B, Wagner GS. Mortality, morbidity, resource use and quality of life following Q- vs non-Q-wave infarction and thrombolytic therapy: A GUSTO-I substudy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):78106-78106. Link to Item
  - Granger CB, Phillips HR, Betriu A, Ellis SG, Weaver WD, Aylward P, Stebbins A, Lee KL, Califf RM, Topol EJ. Direct angioplasty may be less advantageous in patients presenting early after symptom onset: Results from GUSTO IIb. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):7811-7811. Link to Item
  - Krucoff MW, Green CL, Troliinger KM, Pope JE, Harrington RA, Granger CB, Ohman EM, Neuhaus K, Topol EJ, Califf RM. Temporal distribution of important ECG information in patients with MI: When should you take the next ECG after lytics?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):9466-9466. Link to Item
  - Krucoff MW, Green CL, Trollinger KM, Pope JE, Granger CB, Ohman EM, Califf RM. ST-segment recovery parameters predictive of outcome in AMI: Variability with infarct artery location and implications for therapeutic targets. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):3455-3455. Link to Item
  - Mahaffey KW, Granger CB, Tardiff BE, Woodlief L, Lee KL, Weaver WD, Topol EJ, Califf RM. Endpoint adjudication by a clinical events committee can impact the statistical outcome of a clinical trial: Results from GUSTO-IIb. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):3339-3339. Link to Item
  - Vorchheimer DA, Baruch L, Deperalta ET, Guzman IC, Hayes RM, Hellkamp AS, Granger CB, Topol EJ, Califf RM. Weight adjusted antithrombotic regimens eliminate the nitroglycerin-antithrombotic interaction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb;29(2):3453-3453. Link to Item
  - Anderson RD, Ohman EM, Jr DRH, Col J, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: Observations from the GUSTO-I study. Journal of the American College of Cardiology. 1997;30(3):708-715. Full Text
  - Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: A GUSTO-I substudy. Journal of the American College of Cardiology. 1997;29(4):770-777. Full Text
  - Berdan LG, Kleiman NS, Woodlief LH, Harrington RA, Granger CB, Califf RM. Physicians' Use of Heparin Following Thrombolytic Therapy: An International Perspective. J Thromb Thrombolysis. 1997;4(3/4):415-423. PubMed PMID: 10639646. Link to Item
  - Berdan LG, Kleiman NS, Woodlief LH, Harrington RA, Granger CB, Califf RM. Physicians' use of heparin following thrombolytic therapy: An international perspective. Journal of Thrombosis and Thrombolysis. 1997;4(3-4):415-423. Full Text
  - Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. Circulation. 1997;95(11):2508-2516.
  - Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience. Journal of the American College of Cardiology. 1997;30(2):406-413. PubMed PMID: 9247512. Full Text
  - Granger CB. Adenosine for myocardial protection in acute myocardial infarction. American Journal of Cardiology. 1997;79(12 A):44-48. Full Text
  - Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular hemorrhage incidence and location in the GUSTO-I trial. Journal of the American College of Cardiology. 1997;30(7):1606-1610. Full Text
  - Mak K-H, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. Journal of the American College of Cardiology. 1997;30(1):171-179. Full Text
  - Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, Granger CB, Ross AM, Califf RM, Topol EJ. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation. 1997;96(1):116-121.
  - Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Ann Intern Med. 1996 Dec 1;125(11):891-900. PubMed PMID: 8967669. Link to Item
  - Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med. 1996 Oct 31;335(18):1333-1341. PubMed PMID: 8857016. Full Text Link to Item
  - Alexander JH, Granger CB, Thompson TD, Sadowski Z, Aylward PE. Prophylactic lidocaine use in GUSTO-I and GUSTO-II: Incidence and outcomes. CIRCULATION. 1996 Oct 15;94(8):1143-1143. Link to Item
  - Armstrong PW, Califf RM, Granger CB, Woodlief LH, Topol EJ. Recurrent ischemia in the GUSTO IIb trial. CIRCULATION. 1996 Oct 15;94(8):2225-2225. Link to Item
  - Armstrong PW, Granger CB, Knight D, Sutherland W, ClappChanning N, Hlatky M, Mark D. Temporal trends in the process of myocardial infarction management; Canadian/US GUSTO experience. CIRCULATION. 1996 Oct 15;94(8):158-158. Link to Item
  - Armstrong PW, Granger CB, Knight D, Sutherland W, ClappChanning N, Hlatky M, Mark D. Practice patterns and outcomes amongst non ST elevation patients with acute coronary syndromes. CIRCULATION. 1996 Oct 15;94(8):160-160. Link to Item
  - Granger CB, Woodlief LH. Lack of rebound recurrence of reinfarction after discontinuation of antithrombin therapy: Results from the GUSTO IIb trial. CIRCULATION. 1996 Oct 15;94(8):2516-2516. Link to Item
  - Mark DB, Granger CB, Ellis SG, Phillips HR, Knight D, DavidsonRay L, Topol EJ. Costs of direct angioplasty versus thrombolysis for acute myocardial infarction: Results from the GUSTO II randomized trial. CIRCULATION. 1996 Oct 15;94(8):973-973. Link to Item
  - Metz BK, Granger CB, White HD, Simes J, Topol EJ. Streptokinase and hirudin reduces death and reinfarction in acute myocardial infarction compared with streptokinase and heparin: Results from GUSTO IIb. CIRCULATION. 1996 Oct 15;94(8):2509-2509. Link to Item
  - Moliterno DJ, Aguirre FV, Cannon CP, Every NR, Granger CB, Sapp SK, Booth JE, Ferguson JJ. The global unstable angina registry and treatment evaluation (GUARANTEE) study. CIRCULATION. 1996 Oct 15;94(8):1136-1136. Link to Item
  - Simes RJ, Granger CB, Antman EM, Califf RM, Braunwald E, Topol EJ. Impact of hirudin versus heparin on mortality and (re)infarction in patients with acute coronary syndromes: A prospective meta-analysis of the GUSTO-IIb and TIMI 9b trials. CIRCULATION. 1996 Oct 15;94(8):2507-2507. Link to Item
  - Jelesoff NE, Feinglos M, Granger CB, Califf RM. Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials. Coron Artery Dis. 1996 Oct;7(10):732-743. PubMed PMID: 8970764. (Review) Link to Item
  - Peterson ED, Hathaway WR, Zabel KM, Pieper KS, Granger CB, Wagner GS, Topol EJ, Bates ER, Simoons ML, Califf RM. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. J Am Coll Cardiol. 1996 Aug;28(2):305-312. PubMed PMID: 8800102. Full Text Link to Item
  - Mahaffey KW, Granger CB, Collins R, O'Connor CM, Ohman EM, Bleich SD, Col JJ, Califf RM. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. Am J Cardiol. 1996 Mar 15;77(8):551-556. PubMed PMID: 8610601. Link to Item
  - Chang YC, Patz EF, Goodman PC, Granger CB. Significance of hemoptysis following thrombolytic therapy for acute myocardial infarction. Chest. 1996 Mar;109(3):727-729. PubMed PMID: 8617083. Link to Item
  - Granger CB, Hirsch J, Califf RM, Col J, White HD, Betriu A, Woodlief LH, Lee KL, Bovill EG, Simes RJ, Topol EJ. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation. 1996 Mar 1;93(5):870-878. PubMed PMID: 8598077. Link to Item
  - Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, Califf RM. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Journal of Intravenous Nursing. 1996;19(3):147-156.
  - Granger CB. Diet and secondary prevention of coronary disease: Is it time to stop chewing the fat?. Journal of the American College of Cardiology. 1996;28(5):1109-1110. PubMed PMID: 8890802. Full Text
  - Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT, Green CL, Topol EJ. Clinical and radiographic factors associated with mortality following intracranial hemorrhage after thrombolysis for acute myocardial infarction. STROKE. 1996 Jan;27(1):90-90. Link to Item
  - White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ. Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial. Circulation. 1996;94(8):1826-1833. PubMed PMID: 8873656.
  - Karnash SL, Granger CB, White HD, Woodlief LH, Topol EJ, Califf RM. Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial. J Am Coll Cardiol. 1995 Dec;26(7):1651-1656. PubMed PMID: 7594099. Link to Item
  - Barbagelata A, Granger CB, Topol EJ, Worley SJ, Kereiakes DJ, George BS, Ohman EM, Leimberger JD, Mark DB, Califf RM. Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol. 1995 Nov 15;76(14):1007-1013. PubMed PMID: 7484852. Link to Item
  - ANDERSON RD, STEBBINS AL, BATES E, STOMEL R, GRANGER CB, OHMAN EM. UNDERUTILIZATION OF AORTIC COUNTERPULSATION IN PATIENTS WITH CARDIOGENIC-SHOCK - OBSERVATIONS FROM THE GUSTO-1 STUDY. CIRCULATION. 1995 Oct 15;92(8):658-658. Link to Item
  - BERKOWITZ SD, GRANGER CB, PIEPER KS, CALIFF RM. HEMORRHAGIC NON-CNS COMPLICATIONS ASSOCIATED WITH 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION. CIRCULATION. 1995 Oct 15;92(8):2197-2197. Link to Item
  - CRENSHAW BS, WARD SR, STEBBINS AL, GRANGER CB. RISK-FACTORS AND OUTCOMES IN PATIENTS WITH ATRIAL-FIBRILLATION FOLLOWING ACUTE MYOCARDIAL-INFARCTION. CIRCULATION. 1995 Oct 15;92(8):3740-3740. Link to Item
  - GOODMAN SG, LANGER A, WILDERMANN NM, BARBAGELATA A, SGARBOSSA EB, WAGNER GS, GRANGER CB, ROSS AM, ARMSTRONG PW. NON-Q VS Q-WAVE MYOCARDIAL-INFARCTION POST-THROMBOLYSIS - ANGIOGRAPHIC INSIGHTS. CIRCULATION. 1995 Oct 15;92(8):2529-2529. Link to Item
  - GRANGER CB, ARMSTRONG PW. REINFARCTION FOLLOWING DISCONTINUATION OF INTRAVENOUS HEPARIN OR HIRUDIN FOR UNSTABLE ANGINA AND ACUTE MYOCARDIAL-INFARCTION. CIRCULATION. 1995 Oct 15;92(8):2196-2196. Link to Item
  - GRANGER CB, CALIFF RM, VANDEWERF F, WHITE HD, TOPOL EJ. ACTIVATED PARTIAL THROMBOPLASTIN TIME AND CLINICAL OUTCOME AMONG PATIENTS WITH UNSTABLE ANGINA OR NON-Q-WAVE MI TREATED WITH INTRAVENOUS HEPARIN. CIRCULATION. 1995 Oct 15;92(8):1985-1985. Link to Item
  - MAHAFFEY KW, GRANGER CB, STEBBINS AL, CALIFF RM. DIABETIC-RETINOPATHY SHOULD NOT BE A CONTRAINDICATION TO THROMBOLYTIC THERAPY - QUANTIFICATION OF RISK IN 6011 PATIENTS. CIRCULATION. 1995 Oct 15;92(8):1986-1986. Link to Item
  - PETERSON ED, MARK DB, ARMSTRONG PW, KNIGHT D, GRANGER CB. DOES A CONSERVATIVE POST-MI CATHETERIZATION STRATEGY MISS SEVERE CORONARY-DISEASE - COMPARISONS OF USE AND DIAGNOSTIC YIELD IN CANADA AND THE US. CIRCULATION. 1995 Oct 15;92(8):565-565. Link to Item
  - TARDIFF BE, GRANGER CB, WOODLIEF L, MAHAFFEY KW, HARRINGTON RA, CALIFF RM. PROGNOSTIC-SIGNIFICANCE OF POST-INTERVENTION ISOZYME ELEVATIONS. CIRCULATION. 1995 Oct 15;92(8):2599-2599. Link to Item
  - Langer A, Krucoff MW, Klootwin P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW, GUSTO Investigators . Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study. Journal of the American College of Cardiology. 1995 Jun;25(7):1552-1557. Full Text
  - Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Medical care. 1995 Jun;33(6):598-610. PubMed PMID: 7760576.
  - Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation. 1995 Apr 1;91(7):1929-1935. PubMed PMID: 7895349. Link to Item
  - Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Werf FVD, Aylward PE, Topol EJ, Califf RM. Stroke after thrombolysis: Mortality and functional outcomes in the GUSTO-I trial. Circulation. 1995;92(10):2811-2818. PubMed PMID: 7586246.
  - Werf FVD, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW, Barbash GI, Hampton JR, Guerci A, Simes RJ, Ross AM, Califf RM. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: Results from the GUSTO trial. Journal of the American Medical Association. 1995;273(20):1586-1591. PubMed PMID: 7745771. Full Text
  - Granger CB, White HD, Bates ER, Ohman EM, Califf RM. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol. 1994 Dec 15;74(12):1220-1228. PubMed PMID: 7977094. Link to Item
  - Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994 Oct 27;331(17):1130-1135. PubMed PMID: 7935638. Full Text Link to Item
  - KRUCOFF MW, GREEN CL, TROLLINGER KM, SAWCHAK ST, WILDERMAN NM, SHAH A, GRANGER CB, OCONNOR CM, POPE JE. UNIVARIATE RELATIONSHIPS BETWEEN MORTALITY AND PARAMETERS OF CONTINUOUS 12-LEAD ST-SEGMENT DEVIATION AND RECOVERY AFTER THROMBOLYTIC THERAPY FOR ACUTE INFARCTION. CIRCULATION. 1994 Oct;90(4):501-501. Link to Item
  - ZABEL KM, GRANGER CB, BECKER RC, WOODLIEF LH, CHESEBRO JH, CALIFF RM. BEDSIDE APTT MONITORING IS ASSOCIATED WITH LESS BLEEDING AMONG GUSTO PATIENTS RECEIVING IV HEPARIN FOLLOWING THROMBOLYTIC ADMINISTRATION. CIRCULATION. 1994 Oct;90(4):553-553. Link to Item
  - Hillegass WB, Jollis JG, Granger CB, Ohman EM, Califf RM, Mark DB. Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction. Am J Cardiol. 1994 Mar 1;73(7):444-449. PubMed PMID: 8141084. Link to Item
  - MARK DB, NAYLOR CD, HLATKY MA, TOPOL EJ, KNIGHT JD, CLAPPCHANNING N, NELSON CL, CALIFF RM, GRANGER CB, ARMSTRONG PA. PATIENT SATISFACTION WITH HEALTH-CARE IS INSENSITIVE TO VARIATIONS IN CARE RECEIVED AND QUALITY-OF-LIFE - UNITED-STATES CANADA GUSTO SUBSTUDY RESULTS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1994 Feb:A166-A166. Link to Item
  - Califf RM, Granger CB. Trials of new antithrombin agents. Journal of Myocardial Ischemia. 1994;6(6):10-14.
  - Krucoff MW, Green CL, Harrell FE, Simoons ML, Wilderman NM, Trollinger KM, Sawchak ST, Pope JE, Shah A, Granger CB. From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring. J Electrocardiol. 1994;27 Suppl:233-237. PubMed PMID: 7884367. Link to Item
  - Krucoff MW, Croll MA, Pope JE, Granger CB, O'Connor CM, Sigmon KN, Wagner BL, Ryan JA, Lee KL, Kereiakes DJ. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation. 1993 Aug;88(2):437-446. PubMed PMID: 8339407. Link to Item
  - HILLEGASS WB, JOLLIS JG, GRANGER CB, CALIFF RM, MARK DB. HOW MANY LIVES DOES A NEW MORE POTENT THROMBOLYTIC AGENT HAVE TO SAVE TO JUSTIFY ADDITIONAL INTRACRANIAL HEMORRHAGES. CLINICAL RESEARCH. 1993 Apr;41(2):A122-A122. Link to Item
  - Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol. 1993 Mar 15;21(4):920-925. PubMed PMID: 8450161. Link to Item
  - Krucoff MW, Croll MA, Pope JE, Pieper KS, Kanani PM, Granger CB, Veldkamp RF, Wagner BL, Sawchak ST, Califf RM. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 1993 Jan 15;71(2):145-151. PubMed PMID: 8421974. Link to Item
  - Granger CB, Califf RM, Young S, Candela R, Samara J, Worley S, Kereiakes DJ, Topol EJ. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. Journal of the American College of Cardiology. 1993;21(4):920-925.
  - Krucoff MW, Green CL, Langer A, Klootwijk LJ, Trollinger KM, Sawchak ST, Wilderman NM, Veldkamp RF, Pope JE, Simoons ML. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations. Journal of electrocardiology. 1993 Jan;26 Suppl:249-255. PubMed PMID: 8189133.
  - Ross AM, Lundergan C, Thompson M, Reiner J, Deychak Y, Rohrbeck S, Coyne K, Walker P, Cho S, Greenhouse S, al E. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. New England Journal of Medicine. 1993;329(22):1615-1622. Full Text
  - GRANGER CB, CALIFF RM, HIRSH J, WOODLIEF LH, TOPOL EJ. APTTS AFTER THROMBOLYSIS AND STANDARD INTRAVENOUS HEPARIN ARE OFTEN LOW AND CORRELATE WITH BODY-WEIGHT, AGE AND SEX - EXPERIENCE FROM THE GUSTO TRIAL. CIRCULATION. 1992 Oct;86(4):258-258. Link to Item
  - GRANGER CB, OCONNOR CM, BLEICH SD, COL JJ, KEELER GP, OHMAN EM. AN OVERVIEW OF THE EFFECT OF INTRAVENOUS HEPARIN ON CLINICAL END-POINTS FOLLOWING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION. CIRCULATION. 1992 Oct;86(4):259-259. Link to Item
  - GRANGER CB, OHMAN EM, BATES E. POOLED ANALYSIS OF ANGIOGRAPHIC PATENCY RATES FROM THROMBOLYTIC THERAPY TRIALS. CIRCULATION. 1992 Oct;86(4):269-269. Link to Item
  - KLINE EM, SMITH DD, MARTIN JS, DRACUP K, WOODLIEF LH, GRANGER CB, CALIFF RM. IN-HOSPITAL TREATMENT DELAYS IN PATIENTS TREATED WITH THROMBOLYTIC THERAPY - A REPORT OF THE GUSTO TIME TO TREATMENT SUBSTUDY. CIRCULATION. 1992 Oct;86(4):702-702. Link to Item
  - OHMAN EM, CHRISTENSON RH, GRANGER CB, BERRIOS E, WORLEY S, OCONNOR CM, SIGMON K, LEE K, PHILLIPS HR. NONINVASIVE DETECTION OF REPERFUSION AFTER THROMBOLYSIS BASED ON CLINICAL-ASSESSMENT AND RAPID CK-MB ANALYSIS. CIRCULATION. 1992 Oct;86(4):268-268. Link to Item
  - Granger CB, Califf RM, Topol EJ. Thrombolytic Therapy for Acute Myocardial Infarction : A Review. Drugs. 1992 Sep;44(3):293-325. PubMed PMID: 28634913. (Review) Full Text
  - Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. A review . Drugs. 1992 Sep;44(3):293-325. PubMed PMID: 1382931. (Review) Link to Item
  - Granger CB, Gabriel DA, Reece NS, Boothroyd E, Harding MB, Harrison JK, Kong Y, Bashore TM. Fibrin modification by ionic and nonionic contrast media during cardiac catheterization. Am J Cardiol. 1992 Mar 15;69(8):821-823. PubMed PMID: 1546665. Link to Item
  - Califf RM, Granger C. TIMI IIB follow-up. Lessons for clinicians and investigators. Circulation. 1992 Feb;85(2):839-841. PubMed PMID: 1735174. Link to Item
  - KRUCOFF MW, CROLL MA, GRANGER CB, OCONNOR CM, SIGMON KN, POPE JE, WAUGH RA, KERIAKES DJ, GEORGE BS, SAMAHA JK, CALIFF RM. PROSPECTIVE BLINDED NONINVASIVE DETECTION OF FAILED THROMBOLYSIS USING DIGITAL TRENDING FROM CONTINUOUS 12-LEAD ST-SEGMENT MONITORING. CIRCULATION. 1990 Oct;82(4):254-254. Link to Item
  - GRANGER CB, GABRIEL DA, REECE NS, BOOTHROYD E, HARDING MB, HARRISON JK, KONG Y, BASHORE TM. FIBRIN MODIFICATION BY CONTRAST-MEDIA DURING CARDIAC-CATHETERIZATION. ARTERIOSCLEROSIS. 1990;10(5):A928-A928. Link to Item
  - Krucoff MW, Croll MA, Pope JE, Granger CB, Pieper KS, Sigmon KN, Lee KL, Califf RM. Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design. J Electrocardiol. 1990;23 Suppl:6-10. PubMed PMID: 2128637. Link to Item
  - Weissler AM, Miller BI, Granger CB, Henry TD, Sheikh KH, Kirch DL, Guess WB, Krumbach BJ. Augmentation of mortality risk discriminating power of left ventricular ejection fraction by measures of nonuniformity in systolic emptying on radionuclide ventriculography. Journal of the American College of Cardiology. 1990;16(2):387-395. PubMed PMID: 2373817.
  - Granger CB, Karimeddini MK, Smith V-E, Shapiro HR, Katz AM, Riba AL. Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy. Journal of the American College of Cardiology. 1985;5(4):862-868. PubMed PMID: 3156175.
- Other Articles
  - Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, Smith PK, Califf RM, Harrington RA, Jr MHS. Response to letter regarding article, "Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft" [2]. Circulation. 2006;114(25):e649-. Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Awards & Honors

Subject Headings

Selected Grants

Selected Publications

Book Sections

Conference Papers

Journal Articles

Other Articles